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Large-scale genome-wide association studies (GWAS) have produced a rich resource of ge-
netic data over the past decade, urging the need to develop computational and statistical
methods that analyze these data. This dissertation presents four statistical methods that
model the correlation structure between genetic variants and its effect on GWAS summary
association statistics to help understand the genetic basis of complex human traits and dis-
eases.
The first method employs the multivariate Bernoulli distribution to model haplotype data,
allowing for higher-order interactions among genetic variants, and shows better accuracy in
predicting DNase I hypersensitivity status.
The second method partitions heritability into small regions on the genome using GWAS
summary statistics data, while accounting for complex correlation structures among genetic
variants, and uncovers the genetic architectures of complex human traits and diseases.
Extending the second method into pairs of traits, the third method partitions genetic correla-
tion into small genomic regions using GWAS summary statistics data, and provides insights
into the shared genetic basis between pairs of traits.
ii
Finally, the fourth method dissects population-specific and shared causal genetic variants of
complex traits in two continental populations, using GWAS summary statistics data obtained
from samples of different ethnicities, and reveals differences in genetic architectures of two
continental populations.
iii
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CHAPTER 1
Introduction
Complex human traits and diseases are driven by both genetic and environmental factors.
Since genetics is intrinsic to every person, studying the genetic basis of complex traits offers
an unbiased approach to understand the biological mechanisms behind complex traits. A
conceptually simple but highly effective approach to assess the contribution of genetics on
complex traits is genome-wide association study, which scans for association between each
genetic variant and complex trait. The drastic decrease in sequencing and genotyping tech-
nologies enabled genome-wide association studies at a large scale, which have produced a
rich resource of genetic data over the past decade. These large-scale genetic studies revealed
both valuable biological insights and challenges in genetic studies, urging the need to develop
new and efficient computational and statistical methods to analyze these data. The next
four chapters introduce methods for modeling linkage and its effect on GWAS results.
The non-random crossover during meiosis creates dependencies betweens alleles on haplo-
types, sequences of alleles on one copy of chromosome, inducing correlation (linkage dise-
quilibrium) between the alleles. Modeling linkage disequilibrium in haplotypes has a wide
range of applications in population inference and disease gene discovery. The hidden Markov
models (HMM) traditionally used for haplotypes[84] are hindered by the dubious assumption
that dependencies occur only between consecutive pairs of variants. In Chapter 2, we apply
the multivariate Bernoulli (MVB) distribution [30] to model haplotype data. The MVB dis-
tribution relies on interactions among all sets of variants, thus allowing for the detection and
exploitation of long-range and higher-order interactions [30]. We discuss penalized estima-
tion and present an efficient algorithm for fitting sparse versions of the MVB distribution to
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haplotype data. Finally, we showcase the benefits of the MVB model in predicting DNaseI
hypersensitivity (DH) status – an epigenetic mark describing chromatin accessibility– from
population-scale haplotype data. We fit the MVB model to real data from 59 individuals
on whom both haplotypes and DH status in lymphoblastoid cell lines are publicly available.
The model allows prediction of DH status from genetic data (prediction R2 “ 0.12 in cross-
validations). Comparisons of prediction under the MVB model with prediction under linear
regression (best linear unbiased prediction or BLUP) and logistic regression demonstrate that
the MVB model achieves about 10% higher prediction R2 than the two competing methods
in empirical data.
Linkage disequilibrium has profound impact on genome-wide association studies (GWAS) of
complex traits [20]. Modeling the effect of linkage disequilibrium on between GWAS results is
crucial for the correct interpretation of important quantities in genetics, such as heritability,
the fraction of variance in trait explained by genetic variation. While GWAS have identified
thousands of genetic variants associated with complex human traits and diseases, a large
fraction of heritability of complex traits remain unexplained by genetic variants identified
through GWAS [95]. A possible explanation to this discrepancy is that most genetic variants
have effect too small to be detected at the current sample size. Variance components methods
that estimate the aggregate contribution of large sets of variants to the heritability of complex
traits have yielded important insights into the genetic architecture of common diseases. In
Chapter 3, we introduce new methods that estimate the total variance in trait explained by
the typed variants at a single locus in the genome (local SNP-heritability) from summary
GWAS data while accounting for linkage disequilibrium (LD) among variants. We apply our
new estimator to ultra large-scale GWAS summary data of 30 common traits and diseases
to gain insights into their local genetic architecture. First, we find that common SNPs have
a high contribution to the heritability of all studied traits. Second, we identify traits for
which the majority of the SNP heritability can be confined to a small percentage of the
genome. Third, we identify GWAS risk loci where the entire locus explains significantly
more variance in the trait than the GWAS reported variants. Finally, we identify loci that
explain significant amount of heritability across multiple traits.
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The rich resource of genetic data curated through GWAS also facilitate the understand-
ing of shared genetic basis between pairs of complex traits, which has been traditionally
quantified through genetic correlation, correlation between complex traits driven by genetic
variations [18]. Although genetic correlations between complex traits provide valuable in-
sights into epidemiological and etiological studies, a precise quantification of which genomic
regions disproportionately contribute to the genome-wide correlation is currently lacking. In
Chapter 4, we introduce ρ-HESS, a technique to quantify the correlation between pairs of
traits due to genetic variation at a small region in the genome. Our approach only requires
GWAS summary data, and makes no distributional assumption on the causal variant effect
sizes while accounting for linkage disequilibrium (LD) and overlapping GWAS samples. We
analyzed large-scale GWAS summary data across 36 quantitative traits, and identified 25
genomic regions that contribute significantly to the genetic correlation among these traits.
Notably, we find 6 genomic regions that contribute to the genetic correlation of 10 pairs of
traits that show negligible genome-wide correlation, further showcasing the power of local
genetic correlation analyses. Finally, we report the distribution of local genetic correlations
across the genome for 55 pairs of traits that show putative causal relationships.
Genome-wide association studies (GWAS) have been predominantly performed in European
populations, limiting the transferability of GWAS results into other populations. The re-
cent increase in the number GWASs in non-European populations creates opportunities for
trans-ethnic studies to improve disease mapping, fine mapping, risk prediction, and trans-
ferability of GWAS results. Differences in linkage disequilibrium patterns of two continental
populations arose during the history of evolution, and need to be accounted for in trans-
ethnic genetic studies. A quintessential theme of trans-ethnic genetic studies is the degree
of genetic overlap of a complex trait across two populations. In Chapter 5, we introduce
POSC, a method to dissect genetic architectures that are specific to a continental popula-
tions and those are shared by both populations. We applied POSC on summary statistics
data of large-scale GWAS of anthropometric, hematological, immunological, and psychiatric
traits and diseases, obtained from samples of East Asian and European descent. We show
that complex traits harbor genetic architectures that are both specific to a population and
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shared by both populations. We also quantify enrichment of population-specific and shared
causal variants in regions of genes specifically expressed across 53 GTEx tissues, and find
that there are enrichments of both population-specific and shared causal variants.
4
CHAPTER 2
A multivariate Bernoulli model to predict DNaseI
hypersensitivity status from haplotype data
2.1 Introduction
Accidents of history and variable recombination rates have divided the human genome into
blocks of shared recent ancestry [27, 31, 50]. Ancestry sharing manifests itself in complex
haplotype patterns and strong dependencies among variants. (Recall that a haplotype sum-
marizes the sequence of alleles displayed by the sampled markers in a narrow genomic region
of a particular chromosome [77].) Therefore, modeling haplotype data is of paramount im-
portance for a wide range of problems in population genetics and disease gene discovery
[24, 67, 68, 81, 86, 92, 99, 107, 121, 126, 130, 136, 153].
Haplotypes have been traditionally analyzed by hidden Markov models (HMMs) [84, 172],
with emissions corresponding to observed genotypes and transitions to recombination events.
Although HMMs for haplotypes undergird many efficient and accurate algorithms for hap-
lotype phasing [137], genotype imputation [17, 69, 85], and identity-by-descent detection
[16], they suffer from the drawback of modeling only dependencies between consecutive vari-
ants. This assumption leads to the unrealistic conclusion that the previous variant and
This chapter is published in Shi et al., Bioinformatics 2015 [141]
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the next variant are independent given the current variant. Ignoring dependencies among
non-consecutive markers makes it difficult to detect and exploit long range correlations and
higher-order interactions among variants. These complex dependencies definitely exist in
the human genome and are important factors in genetic studies [131, 163].
The current paper applies the multivariate Bernoulli (MVB) distribution to haplotype data.
The MVB distribution captures the entire spectrum of dependencies among the entries of
random binary vectors of length N [30]. The observed haplotypes at N nearby SNPs (single
nucleotide polymorphisms) can be thought of as realizations of such a process. Since there are
2N possible haplotyes for N SNPs, the MVB distribution requires an unsustainable exponen-
tial number of parameters. Vast amounts of training data or clever algorithms cannot com-
pensate for this combinatorial explosion. Here we investigate a Poisson re-parameterization
of the MVB distribution and impose an `1-norm penalty to enforce sparsity in parameter
estimation. These steps allow us to devise an efficient coordinate ascent algorithm for learn-
ing the MVB parameters from haplotype data while restricting the number of parameters
to a manageable level.
We showcase the utility of the MVB model by predicting an individual’s DNaseI hypersen-
sitivity status from haplotypes observed near known DNaseI hypersensitivity sites. DNaseI
hypersensitivity (DH) status is a mark of open chromatin and flags genomic regions where
the DNA is accessible to the DNaseI enzyme. These regions, such as transcription start sites,
correlate with active DNA regulation. DH status is usually assayed through DNase-Seq, a
genome-wide high-throughput technology that sequences genomic regions sensitive to DNa-
seI [94]. Recent research [36] suggests that genetic variants control this epigenetic mark.
Since DH status can be naturally encoded as a binary variable, the MVB model offers a
natural way to integrate DH status and local haplotype data. In predicting DH status from
haplotypes, the MVB model allows all allelic sets to contribute regardless of the order of the
participating SNPs and the physical distances separating them.
Our analysis of data from the 1000 Genomes project [27] demonstrates the superiority of the
sparse MVB distribution in model fitting. In practice, interactions beyond order three play
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little role in determining haplotype frequencies in these data. Our new cyclic coordinate
descent algorithm for estimating the MVB interaction parameters converges quickly and
reliably. The MVB model also turns out to be pertinent to predicting DH status from
haplotype data at known DH sites [34]. On a sample of just 59 subjects, cross-validation
under the MVB yields a prediction R2 of 0.12 for dichotomized DH levels. As expected, the
accuracy of DH prediction decreases as extraneous predictors are added. Finally, prediction
under the MVB achieves about 10% better accuracy than prediction by linear regression
(best unbiased linear predictor or BLUP) and logistic regression. Thus, the MVB model is
recommended for prediction of binary epigenetic status from local haplotype data.
2.2 Methods
2.2.1 The multivariate Bernoulli distribution as a model for haplotype data
The multivariate Bernoulli (MVB) distribution extends the univariate Bernoulli distribution
to binary vectors of fixed length N [30]. The density PrpY “ yq “ ppy1,...,yN q of such a
discrete random vector Y depends on 2N probabilities pp0,0,...,0q, pp0,0,...,1q, . . . , pp1,1...,1q specific
to the different realizations of Y . For example, the bivariate Bernoulli distribution consists
of four realizations p0, 0q, p0, 1q, p1, 0q, and p1, 1q specified by four probabilities pp0,0q, pp0,1q,
pp1,0q, and pp1,1q. By definition the conditional distribution of a subvector, say pY1, Y2, . . . , Ykq,
given the complementary subvector, say pYk`1, . . . , YNq, is also MVB. In the bivariate case,
conditioning on either Y1 or Y2 produces a standard univariate Bernoulli distribution. There
is an alternative parameterization that captures interactions and is conducive to parsimony.
This parameterization substitutes subsets of t1, . . . , Nu for binary vectors. To the realization
y we correspond the index set A “ ti : yi “ 1u. The natural parameters fC of the MVB
model are indexed by interaction subsets C, and the density function PrpY “ yq is written
as the ratio
PrpAq “ exp
`ř
CĎA fC
˘ř
B exp
`ř
CĎB fC
˘ “ exp pSAqř
B exp pSBq
, (2.1)
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where we define SA “ řCĎA fC for notational simplicity. The denominator řB exp pSBq is
the appropriate normalizing constant.
The haplotypes spanning N bi-allelic SNPs can be represented as binary vectors of length
N . We adopt the convention that yi “ 0 indicates the major allele and yi “ 1 indicates
the minor allele at SNP i. One can obviously model the distribution of haplotypes in a
population as MVB. The major advantage of the MVB is its ability to incorporate interac-
tions in the recovery of haplotype frequencies. The number of parameters in both the naive
and interaction parameterizations grows exponentially fast in N . However, the interaction
parameterization organizes interactions by level and suggests limiting model complexity by
imposing an upper bound on interaction level. The next section introduces a lasso penalty
that in combination with maximum likelihood estimation eliminates superfluous interactions
and keeps the number of levels in check.
2.2.2 Estimating MVB parameters from haplotype data
To estimate haplotype frequencies and ultimately infer missing haplotypes, one can randomly
sample a population and count the number XA of haplotypes of each type A. For a fixed
sample size M , the XA jointly follow a multinomial distribution with M total counts and
the count probabilities PrpAq displayed in equation (2.1). Alternatively, one can adopt a
Poisson rather than a multinomial sampling framework. The two share the assumption of
independent samples but differ in whether the total sample size is random (Poisson) or fixed
(multinomial). The law of small numbers justifies the equivalence of the two frameworks.
The Poisson setting invokes a mean sample size µ, which is estimated by the observed sample
size
ř
AXA. One can show [78] that the random variables XA are independent and Poisson
distributed with means µA “ µPrpAq.
In the Poisson framework, it is easier work with the interaction parameters by setting µA “
exppSAq “ exppřBĎA fBq and ignoring µ and the normalizing constant řB exp pSBq. In
effect, these are absorbed into the empty set parameter fH. Independence of the XA now
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yields the likelihood
Lpf |Xq “
ź
A
pµAqXA
XA!
expp´µAq, (2.2)
where X “ pXAq and f “ pfAq are the vectors of haplotype counts and interaction parame-
ters, respectively. Taking logarithms produces the loglikelihood
`pf |Xq “
ÿ
A
fA
ÿ
BĚA
XB ´
ÿ
A
exppSAq ´
ÿ
A
logXA!. (2.3)
It is natural to estimate the MVB parameter vector f “ pfAq by maximizing `pf |Xq.
Unless N is small and the sample size M is large, estimating all 2N MVB parameters is
an exercise in over-fitting. To achieve parsimony, we append an `1-norm (lasso) penalty to
the loglikelihood. Any reasonable model should include the low-order parameters fA with
|A| ď 1, where |A| denotes the cardinality of the set A. Hence, we maximize the penalized
loglikelihood
F pfq “
ÿ
A
fA
ÿ
BĚA
XB ´
ÿ
A
exppSAq ´ λ
ÿ
|A|ě2
|fA|. (2.4)
Here, λ is a tuning constant determining the strength of the penalty. Increasing λ increases
the sparsity of the estimated parameter vector. The analogy with lasso-guided regression is
obvious. The new objective function F pfq is concave and directionally differentiable. It has
kinks introduced by the terms |fA|. We recommend maximization by coordinate ascent.
2.2.3 Coordinate ascent algorithm
Coordinate ascent maximizes the objective function one parameter at a time holding other
parameters fixed. Cycling through the parameters continues until the objective value con-
verges or a maximum number of iterations is reached. Algorithm 1 outlines the coordinate
ascent algorithm for estimating model parameters.
Line 5 of Algorithm 1 requires finding arg maxfA F pfq. To update fA when |A| ď 1, we set
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Algorithm 1 coordinate ascent algorithm for fitting the MVB
1: Let C be the collection of possible haplotypes of length N
2: Initialize fA to 0 for all A P C
3: while stop condition fails do
4: for A in C do
5: fA “ arg maxfA F pfq
6: end for
7: end while
the partial derivative of F pfq
B
BfAF pfq “
ÿ
BĚA
XB ´ efA
ÿ
BĚA
e
ř
CĎB,C‰A fC (2.5)
with respect to fA equal to 0. This yields the update
fA “ ln
ř
BĚAXBř
BĚA e
ř
CĎB,C‰A fC
. (2.6)
When |A| ě 2, the supergradient
B
BfAF pfq “
ÿ
BĚA
XB ´ efA
ÿ
BĚA
e
ř
CĎB,C‰A fC
´ λ
$’’’’’&’’’’’%
1 if fA ą 0
r´1, 1s if fA “ 0
´1 if fA ă 0
(2.7)
must contain 0 [79]. Equating it to 0 yields the update
fA “
$’’’’’&’’’’’%
0 |c| ď λ
ln
ř
BĚAXB´λř
BĚA e
ř
CĎB,C‰A fC c ą λ
ln
ř
BĚAXB`λř
BĚA e
ř
CĎB,C‰A fC c ă ´λ
(2.8)
for the criterion c “ řBĚAXB ´řBĚA eřCĎB,C‰A fC .
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In view of the summations over B Ě A in the denominators of equation (2.6) and equation
(2.8), each coordinate ascent update takes nearly Op2Nq operations. This computational
load restricts estimation to MVB models with small N , say N ď 15. Once parameters are
estimated, prediction under the MVB is relatively straightforward. The normalizing constant
in formula (2.1) must be calculated, but this can be done once and the result stored.
2.2.4 Best linear unbiased predictor (BLUP)
Part of our evaluation of the MVB involves comparison of DNaseI hypersensitivity (DH)
prediction on simulated data. The simulated DH status yi of an individual i was constructed
as a linear combination of individual i’s SNP alleles and SNP pairwise interactions weighted
by effect sizes βj and βjk. In symbols
yi “
ÿ
j
βjhij `
ÿ
tj,ku
βjkhijhik ` εi, (2.9)
where hij is the SNP predictor (standardized version of 0 or 1) of individual i at SNP j,
hijhik is the SNP interaction of individual i for the pair of SNPs j and k, and εi is an
independent normally distributed error term. Simplified versions of the model ignore the
pairwise interactions and take all βjk “ 0.
To make predictions under the linear model, we first estimate the effect sizes βj and βjk
from training data set and then predict the phenotype (DH status) of each individual in the
test data, substituting estimated parameters for true parameters. For notational brevity,
let H “ pHSNP , HINT q be the block matrix of single SNP and interaction SNP predictors
across the training set; for each subject i and SNPs j and k, the matrix HSNP has entries
phijq, and the matrix HINT has entries phijhikq. The effect sizes βj and βjk are estimated by
the least squares formula
βˆ “ pHTHq´1HTy. (2.10)
Finally, the best linear unbiased predictor (BLUP) yˆi of DH status for an individual i is
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computed via
yˆi “
ÿ
j
βˆjhij `
ÿ
tj,ku
βˆjkhijhik. (2.11)
2.2.5 Logistic regression (LOGIT)
We also compared the MVB model with logistic regression (LOGIT); unlike linear regression,
logistic regression directly models binary outcomes. Under logistic regression, the probability
of the DH status yi of individual i given his/her SNP alleles phijq and pairwise interactions
phijhikq is
Prpyi “ yq “
ˆ
eci
1` eci
˙yˆ
1
1` eci
˙1´y
, (2.12)
where ci “ α0 `řj αjhij `řtj,ku αjkhijhik. Here the α’s are the regression coefficients in
logistic regression. As with linear regression, one can simplify the model by ignoring pairwise
interactions and taking all αjk “ 0. To estimate the parameters of the model, one maximizes
the likelihood ź
ti:yi“1u
eci
1` eci
ź
ti:yi“0u
1
1` eci . (2.13)
over the entire sample. Prediction of the DH status of individual i relies on the the predicted
probability
yˆi “ e
cˆi
1` ecˆi , (2.14)
of yi “ 1, where cˆi is the same as ci except for substitution of estimated regression coefficients
for true coefficients.
2.2.6 Hidden Markov model (HMM) for haplotypes
A hidden Markov model (HMM) views a haplotype h of length N as a mosaic of haplotypes
from a set H of R reference haplotypes [84]. The N ˆ R HMM states pi, jq capture the
particular reference haplotype j occurring at SNP i. A transition matrix K models recom-
bination events and controls how switches occur between haplotypes in meiosis. The entries
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Krpijq, pklqs of the transition matrix are 0 unless k “ i ` 1. For neighboring SNPs, the en-
tries depend on the distance between the SNPs. Thus, the larger the distance, the larger the
transition probability for j ‰ l. The emission probabilities Prphi|pijqq allow for mistyping
and occasional mutation events. Inferences based on HMM are achieved efficiently through
the forward, backward, and Viterbi algorithms, all of which have complexity OpNR2q. We
adopt the latest IMPUTE2 [69, 66] implementation of HMM for comparison purposes.
2.3 Results
2.3.1 Assessment of MVB on 1000 Genome haplotypes
In an initial set of experiments, we used the 1000 Genomes EUR (European) haplotypes (505
individuals) to investigate the performance of the MVB model and our coordinate descent
algorithm for fitting it to data. We randomly selected 50 regions on chromosome 1, each
containing 15 SNPs, and fit the MVB under various settings. The first setting imposed no
constraint on the maximum order (max |A|) of the interaction sets A. Thus, in effect, we
estimated all 215 “ 32, 768 parameters. Figure 2.1 shows that the regularization constant λ
has a significant effect on the magnitude of parameters, especially for fA’s where |A| ě 4. For
example, as λ increases from 0.0 to 0.5, the sum
ř
|A|“4 |fA| of estimated parameters decreases
from 87.5 to 30 for interaction sets with |A| “ 4. Furthermore, Figure 2.2 indicates that the
average value of |fA| converges to 0 as |A| tends to N “ 15. Thus, we conclude that the
lower-order interactions fA predominate in determining haplotype frequencies.
We also recorded the number of iterations until convergence of the coordinate descent al-
gorithm. The algorithm invariably converges within 20 to 30 iterations. See Figure 2.3 for
typical results. Finally, Table 2.2 shows that the bulk of computational time is taken in
estimating MVB parameters; once model parameters are estimated, applying the model to
making predictions is relatively trivial.
Next we investigated how well the MVB fits the selected 1000 Genomes haplotypes using just
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lower-order interactions. To measure goodness of fit, we computed the Euclidean distance
between the haplotype frequencies recovered by the MVB model as given in equation (2.1)
and the haplotype frequencies observed in the data. Table 2.1 demonstrates that the MVB
model requires only the lower-order interactions terms to accurately fit typical data. Because
λ “ 0.25 attains the best fit across interaction level bounds (|A| ď bq, we set λ to 0.25 in all
future experiments.
2.3.2 Prediction of DNaseI hypersensitivity status in simulations
To simulate binary DNaseI hypersensitivity (DH) data, we took the 1,010 EUR (European)
haplotypes of the 1000 Genome project [27] and simulated 20,000 haploid individuals at
200 randomly selected 20Kbp regions on chromosome 1 [150]. From each region we selected
15 SNPs with minor allele frequency above 1%. From the 15 chosen SNPs we randomly
selected m causal SNPs and n pairs of interaction SNPs and simulated continuous DH values
according to the linear model sketched in Section 2.2.4. Prior to simulation we standardized
the SNP predictors hij and hijhik to have mean 0 and variance 1. The regression coefficients
for the causal SNPs and SNP pairs were sampled as βj „ Np0, h2{mq and βjk „ Np0, h2int{nq
and the noise for each DH variable as εi „ Np0, 1´ph2`h2intqq, where h2 and h2int denote the
variance of DH values explained by single variants and interactions, respectively. Finally, we
converted the continuous DH values to binary DH values by imposing a threshold chosen so
that 20% of the binary DH values were elevated (status 1 rather than status 0).
For testing under the MVB model, we constructed binary vectors of length 16 by concate-
nating each 15-SNP haplotype and a corresponding simulated binary DH status. Given the
tuning constant λ “ 0.25, this allows us to estimate the fA parameters. To predict DH status
given observed SNP haplotypes, one simply computes a conditional probability under the
MVB model. In one set of MVB trials, we limited the interaction level to |A| ď 2, for a total
of 137 parameters. In a second set of trials, we limited the interaction level |A| ď 3, for a
total of 697 parameters. One can compare MVB prediction to BLUP and LOGIT prediction
based on the same SNP haplotypes and interaction model. For BLUP and LOGIT, we also
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tested a model involving SNPs and interactions between adjacent SNPs.
In linear regression, equation (2.10) supplies effect sizes, and equation (2.11) supplies pre-
dicted values. In logistic regression, equation (2.14) supplies predicted values. For estimation
and prediction under HMM, we concatenated DH status as a pseudo SNP at the end of each
15-SNP haplotype to avoid changing the SNP interactions in the original haplotype. We
also set the physical distance between the pseudo SNP and the last SNP to be the average
distance between consecutive pairs of SNPs in the original 15-SNP haplotype. We employed
half of the simulated individuals as reference panel and ran HMM with IMPUTE2 default
settings on the other half to obtain predicted DH status. All 200 simulations summarized
below involve two causal SNPs (m “ 2) and 2 causal SNP interactions (n “ 2) for 200
randomly sampled individuals. Of these 200 people, 100 served as training individuals and
100 as validation individuals.
We first investigated performance of MVB, BLUP, LOGIT, and HMM prediction for varying
h2 for a fixed interaction h2int of 0.1. Figure 2.4 shows that prediction R
2 achieved by all
models increases as h2 increases. However, the MVB model consistently achieves higher
prediction R2 than BLUP, LOGIT, and HMM under both settings, suggesting that the
MVB model is capable of yielding more accurate estimates of effect sizes for prediction.
Notably as h2 increases, the improvement in prediction R2 also increases. In other words,
as the effect of a single SNP increases, the comparative advantage of the MVB model over
BLUP, LOGIT, and HMM increases.
Next we investigated the accuracy of these approaches at varying h2int values. Figure 2.5
demonstrates that for all pairs of h2 and h2int, the MVB model also achieves higher prediction
R2 than BLUP, LOGIT, and HMM.
Finally we investigated the number of samples required for accurate prediction. Figure 2.6
shows that although the MVB model requires more parameters than BLUP, LOGIT, and
HMM, it is able to outperform these models even if the training sample size is small. This
suggests that the MVB model is less sensitive to noise. Notably, HMM under-performs
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both MVB and LOGIT in most simulation settings, suggesting that HMM is less capable of
detecting long range interactions for reasonable sample sizes. Across all simulated data sets,
we observe no major difference in prediction R2 between the two MVB settings. This is to
be expected since only pairwise interactions are simulated.
2.3.3 Predicting DNaseI hypersensitivity status in empirical data
We now turn to real data on DH status and reach similar conclusions. The data set in
question [36] contains normalized DNaseI hypersensitivity (DH) scores for 70 YRI (Yorubas
in Ibadan, Nigeria) individuals at 1.5 million 100-bp genomic windows. These windows
cover the 5% of the human genome with the highest DNaseI sensitivity. About half of the
windows are expected to be truly sensitive to DNaseI [14]; 8,902 windows have associated
dsQTLs (SNPs showing significant correlations with DH scores across individuals [36]). We
dichotomized DH scores by placing scores above the threshold of 0.0 in one category and
scores below the threshold of 0.0 in the complementary category. Among the 70 YRI indi-
viduals in the sample, 59 are also in the 1000 Genome project [27] and have fully phased
haplotypes. We accordingly used the haplotypes and the binary DH status of these 59 indi-
viduals to evaluate the MVB model. For computational reasons, we selected one haplotype
for each individual and restricted our analysis to 250 random DH sites and the 377 DH sites
with associated dsQTLs on chromosome 22.
In genomic windows with associated dsQTLs, the dsQTLs are on average about 8,000 base
pairs (10 SNPs) away from their windows. This action at a distance renders it difficult
for HMMs to accurately capture interactions between dsQTLs and their genomic windows.
Because sequence order is an important factor for HMMs, the question also arises of where
to place binary DH status (a pseudo SNP) in the haplotype. For this reason, we excluded
HMM from comparisons on real data.
To avoid over-fitting, we assessed prediction accuracy by leave-one-out cross-validation.
Thus, we estimated parameters using data from 58 (all but one) training individuals and
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predicted DH status for the remaining validation individual. Repeating this process across
all 59 individuals allowed us to compare predicted and true DH status. The results can
be summarized in a squared Pearson correlation (prediction R2). Prior to parameter esti-
mation in each of the 59 folds, we selected a small number of relevant SNP predictors by
linear regression and forward selection. Our selection procedure excluded SNPs with minor
allele frequency below 1% or at a distance of 1 Mbp or greater from the center of the win-
dow. Each successive SNP entering the candidate list provided the greatest reduction of the
current residual sum of squares.
Given a candidate set of SNP predictors P in the MVB model, we created binary haplotype
vectors of length |P | ` 1 from the SNPs and the binary DH status. We considered at most
second-order interactions and set the penalty constant λ to 0.25. For BLUP and LOGIT,
we considered three models, one limited to single SNPs, one involving both single SNPs and
two-way interactions, and one involving single SNPs and only interactions between adjacent
SNPs.
Figure 2.7a shows the prediction R2 obtained through leave-one-out cross-validation averaged
over the 250 randomly selected windows. Due to overfitting and our small sample size, the
average prediction R2 decreases for all methods as the number of predictors |P | increases.
The MVB model achieves higher prediction R2 than BLUP and LOGIT over both settings.
We repeated the same experiment on the 377 windows with associated dsQTLs. Again the
MVB model consistently achieves higher prediction R2 than BLUP and LOGIT (see Figure
2.7b). Figures 2.7c and 2.7d depict the distribution of prediction R2’s under each model.
It is clear that the MVB models achieve more high prediction R2’s (greater than 0.2) than
BLUP and LOGIT. One can legitimately conclude that the MVB model predicts DH status
better than BLUP and LOGIT. Table 2.3 summarizes the average and standard error of
prediction R2 for some representative experiments.
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2.4 Discussion
The current paper presents the multivariate Bernoulli (MVB) distribution as a vehicle for
modeling haplotype data. Because the number of distinct haplotypes observed in a narrow
genomic region tends to be small, the MVB model is typically wildly over-parameterized. To
achieve parsimony, we propose a lasso penalty within a Poisson sampling framework. The
penalized MVB model encourages the detection and exploitation of higher-order interactions
among the underlying SNPs. In contrast to Markovian models, interactions extend beyond
nearest neighbor and pairwise interactions. The interaction parameterization adopted here
is more natural than the naive MVB parameterization implicitly seen in BLUP and LOGIT.
Empirically, the interaction parameterization extracts more haplotype information and pre-
dicts with better accuracy.
Our application of the MVB model to predict DNaseI hypersensitivity (DH) status from
observed haplotypes supports the utility of the model. We show that the MVB model
achieves better accuracy than BLUP and LOGIT in predicting simulated DH status. The
overall prediction R2 achieved by MVB, BLUP, and LOGIT on real DH status suggests
substantial heritability of this epigenetic signal.
In likelihood evaluation and parameter estimation, the computational complexity of the
MVB models scales like 2N for N SNPs. This harsh reality limits the applicability of the
model to a small number of variants. Fortunately, even for small N , the MVB model offers
valuable insights into genomic data. The MVB model may well be critical in predicting
binary gene expression when a small number of causal variants localize within a gene. In
particular, MVB profiles in cases and controls may help in fine mapping traits in genome-
wide association studies. Overcoming the computational limits of the MVB model limit is
high on our research agenda. Once this task is accomplished, it will be possible to apply
the MVB model to pre-phasing, a technique for improving genotype imputation by first
imputing haplotypes [66]. We conjecture that Monte Carlo methods will play a decisive
role in extending the range of the model to larger N . Finding an efficient sampling scheme
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to approximate the normalization constant
ř
B exp pSBq is of paramount importance and
doubtless the place to start in accelerating algorithm performance.
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2.5 Tables
λ
max |A| no. param. 0.0 0.25 0.5 0.75 1.0
1 16 0.348 0.348 0.348 0.348 0.348
2 121 0.137 0.072 0.073 0.074 0.075
3 576 0.120 0.054 0.055 0.056 0.056
4 1,941 0.120 0.055 0.056 0.057 0.058
Table 2.1: Euclidean distance between haplotype frequencies recovered by the
MVB model and haplotype frequencies observed in data for different values of
max |A| and λ.
max |A| Learning (sec/iter) Prediction (sec/pred)
1 0.2 ă 0.01
2 1.1 ă 0.01
3 4.4 0.01
4 13.7 0.02
Table 2.2: Learning time (second per iteration) and prediction time (second per
prediction), averaged over 50 loci.
|P | MVB(|A| ď 2) LOGIT BLUP
RANDOM
1 .112˘.015 .093˘.013 .097˘.013
2 .109˘.015 .106˘.015 .100˘.014
dsQTL
1 .120˘.015 .108˘.015 .114˘.015
2 .102˘.014 .100˘.015 .096˘.014
Table 2.3: Average prediction R2 and standard error for |P | ď 2 over 250 randomly
selected windows (RANDOM) and 377 windows with dsQTLs (dsQTL).
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Figure 2.1: Sum of |fA|’s averaged over 50 regions as a function of |A|.
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Figure 2.2: Mean of |fA|’s averaged over 50 loci as a function of |A|.
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Figure 2.3: Objective value averaged over 50 loci at each iteration of the coordinate
ascent algorithm for different values of max |A|.
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Figure 2.4: Prediction R2 across 100 validation individuals averaged over 200
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Figure 2.7: Prediction R2 for MVB, BLUP, and LOGIT. Here “SNP” refers to the
experiment involving only single SNPs, “SNP & INT” refers to the experiment involving both
SNPs and all two-way interactions, and “SNP & ADJ” refers to the experiment involving
both SNPs and only interactions between adjacent SNPs. Figure 2.7a and 2.7b show the
average prediction R2 over different windows as a function of the number of true predictors
|P |. Figure 2.7c and 2.7d show the distribution of prediction R2 for the highest average
prediction R2 over all |P |. For |P | “ 2, the experiments “SNP & INT” and “SNP & ADJ”
are identical.
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CHAPTER 3
Contrasting the genetic architecture of 30 complex
traits from summary association datas
3.1 Introduction
Large-scale genome-wide association studies (GWAS) have identified thousands of single
nucleotide polymorphisms (SNPs) associated with hundreds of traits and diseases [90, 165,
29, 164]. However, only a fraction of the variance in trait can be explained by the risk
SNPs reported by GWAS. The so-called “missing heritability problem” is in part due to the
stringent significance threshold imposed in GWAS, which neglects variants of small effect that
fail to reach the genome-wide significance level at current sample sizes. As an alternative,
variance component (SNP-heritability) analysis aggregates the effect of all SNPs regardless
of their significance [168] and has yielded important insights into the genetic architecture of
complex traits [19, 44, 170, 91, 54, 117].
Heritability has been traditionally estimated using twins or pedigree [13] information with
more recent works showing that SNP-based heritability (i.e. proportion of variance in trait
explained by a given set of SNPs) can be estimated from unrelated individuals [170]. Stan-
dard approaches for SNP-heritability estimation rely on estimating the genetic relationships
This chapter is published in Shi et al., American Journal of Human Genetics 2016 [140]
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between pairs of individuals (estimated genome-wide or across a subset of the genome)
[170, 59, 53]. Therefore, these analyses require individual-level genotype data which pro-
hibits their applicability to ultra-large GWAS that, due to privacy concerns, is typically
available only at the summary level. To solve this bottleneck, recent methods have shown
that SNP-heritability, both genome-wide as well as for different functional categories in the
genome, can be accurately estimated using only summary GWAS data [19, 44]. Although
these methods have enabled powerful analyses making insights into genetic basis of com-
plex traits, they rely on the infinitesimal model assumption (i.e. all SNPs contribute to the
trait) which is invalid at most risk loci [19, 44]. To overcome this drawback, alternative
approaches have proposed to impose a prior on the sparsity of effect sizes to further increase
SNP-heritability estimation accuracy [178]. A potentially more robust approach is to not
assume any distribution for the effect sizes at causal variants and treat them as fixed effects
in the estimation procedure. Indeed, recent works have shown that SNP-heritability estima-
tion can be performed under maximum-likelihood from polygenic scores under a fixed-effect
model assuming no LD among SNPs [117].
Here, we introduce Heritability Estimator from Summary Statistics (HESS), an approach
to estimate the variance in trait explained by all typed SNPs at a single locus in the
genome while accounting for linkage disequilibrium (LD) among SNPs. We build upon
recent works[45, 117] that treat causal effect sizes as fixed effects and model the genotypes
at the locus as random correlated variables. Our estimator can be viewed as a weighted
summation of the squares of the projection of GWAS effect sizes onto the eigenvectors of
the LD matrix at the considered locus, where the weights are inversely proportional to the
corresponding eigenvalues. Through extensive simulations, we show that HESS is unbiased
when in-sample LD is available regardless of disease architecture (i.e. number of causals
and distribution of effect sizes). We extend our method to use LD estimated from reference
panels [28] and show that a principal components based regularization of the LD matrix [57]
yields approximately unbiased and more consistent estimates of local SNP-heritability as
compared to existing methods [19].
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We applied HESS to partition common SNP heritability at each locus in the genome using
GWAS summary data for 30 traits spanning over 10 million SNPs and 2.4 million phenotype
measurements. First, we show that common SNPs explain a large fraction of the total
familial heritability estimated from twin studies, ranging anywhere from 20% to 90% across
the studied quantitative traits. Second, we showcase the utility of local SNP-heritability
estimates in finding loci that explain more variance in trait than the top associated SNP
at the locus – an effect likely due to multiple signals of association. Third, we contrast the
polygenicity of all 30 traits by comparing the fraction of total SNP-heritability attributable
to loci with highest local SNP-heritability. We find that most of the 30 selected traits are
highly polygenic with a small number of traits driven by a small number of loci. Finally, we
report 36 “heritability hotspots” – regions of genome that attain a significant contribution
to the SNP-heritability of multiple traits. Taken together, our results give insights into traits
where further GWAS and/or fine-mapping studies are likely to recover a significant amount
of the missing heritability.
3.2 Materials and methods
3.2.1 Overview of methods
We introduce estimators for the variance in trait explained by typed variants at a single
locus (local SNP-heritability, h2g,local) from summary GWAS data (i.e. Z-scores, effect sizes
and their standard errors). We derive our estimator under the assumption that effect sizes
at typed variants are fixed and genotypes are drawn from a distribution with a pre-specified
covariance structure. The covariance, (i.e. pairwise correlation between any variants at a
locus, LD) can be estimated in-sample, from the genotype data in GWAS, or from external
reference panels (e.g. 1000 Genomes Project[28]). Our estimator can be viewed as a weighted
summation of the squared projections of GWAS effect sizes onto the eigenvectors of the LD
matrix at the considered locus. The finite sample size of the GWAS studies as well as the
reference panels used to estimate LD induces statistical noise that needs to be accounted
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for to obtain an accurate estimation. Since the top projections make up the bulk of the
summation, truncated-SVD lends itself as the appropriate regularization method to account
for noise in the estimated LD matrices. Finally we extend our approach to consider multiple
independent loci each contributing to the trait and show how our local estimator can be
employed when the total genome-wide SNP-heritability is known (or estimated from other
methods).
3.2.2 Estimating SNP-heritability at a single locus from GWAS summary data
Let yi “ xiTβ ` i, where yi is the trait value for individual i, xi are the standardized
(i.e. 0 mean and unit variance) genotypes of individual i at p typed SNPs in the locus,
β “ pβ1, ¨ ¨ ¨ , βpq is the vector of fixed effect sizes for the p SNPs, and i „ Np0, σ2eq is the
environmental effect. Assuming that β is fixed and X is random, the phenotypic variance is
Varrys “ VarrXβs ` σ2e “ βT CovrXsβ ` σ2e “ βTV β ` σ2e (3.1)
where V is a pˆ p variance-covariance matrix of the genotype vector (i.e. the LD matrix).
If we make a standard assumption that the phenotypes are standardized (i.e. Varrys “ 1),
it follows that the amount of variance contributed by the p SNPs to the trait (i.e. local
SNP-heritability) is h2g,local “ βTV β . If the true effect size vector β and the LD matrix V
are given, then computing h2g,local is trivial. In reality, however, the vector β is unknown and
is estimated in GWAS involving n samples and p SNPs, where βˆgwas,i is estimated as the
marginal standardized regression coefficient for SNP i
βˆgwas,i “ 1
n
XTi y “ 1nX
T
i
´”
X1 ¨ ¨ ¨ Xp
ı
β ` 
¯
“
”
1
n
XTi X1 ¨ ¨ ¨ 1nXTi Xp
ı
β ` 1
n
XTi  “
pÿ
j“1
rijβj ` 1
n
XTi 
(3.2)
where X i denotes standardized genotypes for SNP i across the n individuals, and rij denotes
the LD between SNPs i and j. Extending to p SNPs at the locus, if follows that βˆgwas “ V β`
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1
n
XT where V is the LD matrix. With β fixed and  random, βˆgwas is a random variable with
Erβˆgwass “ ErV β ` 1nXTs “ V β , and Covrβˆgwass “ VarrV β ` 1nXTs “ 1n2XT CovrsX “
σ2e
n
V “ 1´h2g,local
n
V . By central limit theorem, βˆgwas „ N
´
V β,
1´h2g,local
n
V
¯
.
As GWAS sample size (n) increases, βˆgwas converges to βgwas “ V β . By simple substitution
in Equation (3.1) it follows that an estimator for h2g,local is
pβTgwasV ´1qV pV ´1βgwasq “ βTgwasV ´1βgwas (3.3)
Unfortunately, the finite sample size of GWAS induces statistical noise in the estimation
of βgwas which leads to biased estimation if we simply replace βgwas with βˆgwas above, as
ErβˆTgwasV ´1βˆgwass “ trpV ´1 Covrβˆgwassq ` βTV β . However, we can correct for the bias
trpV ´1 Covrβˆgwassq as follows.
Let hˆ2g,local be an unbiased estimator of h
2
g,local, then by definition Erhˆ2g,locals must satisfy
Erhˆ2g,locals “ h2g,local. Then it follows that
ErβˆTgwasV ´1βˆgwass “ tr
ˆ
1´ h2g,local
n
V ´1V
˙
` h2g,local “
1´ Erhˆ2g,locals
n
p` Erhˆ2g,locals. (3.4)
A sufficient condition for Equation (3.4) to hold is
1´hˆ2g,local
n
p ` hˆ2g,local “ βˆ
T
gwasV
´1βˆgwas.
Solving for hˆ2g,local gives an unbiased estimator for h
2
g,local
hˆ2g,local “
nβˆ
T
gwasV
´1βˆgwas ´ p
n´ p . (3.5)
Following quadratic form theory [41], the variance of hˆ2g,local is
Varrhˆ2g,locals “
ˆ
n
n´ p
˙2 ˆ
2p
ˆ
1´ h2g,local
n
˙
` 4h2g,local
˙ˆ
1´ h2g,local
n
˙
. (3.6)
Since h2g,local, the true local SNP-heritability, is unknown, we use hˆ
2
g,local instead. For h
2
g,local
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near 0, Varrhˆ2g,locals « 4pn´pq2h2g,local ` 2ppn´pq2 through Taylor expansion around 0. Thus, the
plug in principle yields an estimation of Varrhˆ2g,locals approximately equal to the truth in the
expectation. For small hˆ2g,local (as expected for most loci and traits) Varrhˆ2g,locals is dominated
by 2ppn´pq2 .
3.2.3 Accounting for rank deficiencies in the LD
In the above derivation we made the assumption that the inverse of the LD matrix V exists.
In practice, however, due to pairs of SNPs in perfect LD, V is usually rank deficient, and
thus V ´1 does not exist. In such cases we use the Moore-Penrose pseudoinverse [9] V :.
Let q “ rankpV q, by rank decomposition, V “ V AV B, where V A P Rpˆq and V B P
Rqˆp are matrices with full column rank and full row rank respectively, then trpV :V q “
trpV :BV :AV AV Bq “ trpV BV :BV :AV Aq “ trpIqq “ q. Accounting for rank-deficient LD
matrix, we obtain an unbiased estimator, hˆ2g,local “ nβˆ
T
gwasV
:βˆgwas´q
n´q . We make the same
adjustment (replacing p with q) in the variance estimator for hˆ2g,local.
3.2.4 Adjusting for noise in external reference LD
When genotype data of GWAS samples is not available, we substitute the in-sample LD
matrix V with external reference LD matrix Vˆ estimated from the 1000 Genomes Project
[28] using a population that matches the GWAS samples. However, due to limited sample
size, external reference LD matrices contain statistical noise that biases our estimate. We
apply truncated-SVD regularization to remove noise from external reference LD matrix as
follows.
First note that βˆ
T
gwasV
:βˆgwas “
řq
i“1 si “
řq
i“1
1
wi
pβˆTgwasuiq2 , where wi and ui are the
eigenvalues and eigenvectors of the LD matrix V , and q “ rankpV q. For external reference
LD matrix Vˆ with eigenvalues and eigenvectors wˆi and uˆi, the same decomposition holds
except that si is replaced by sˆi “ 1wˆi pβˆ
T
gwasuˆiq2. In our previous works [122, 72], we propose
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to regularize Vˆ using ridge regression penalty. This regularization method is equivalent to
replacing wˆi with wˆi`λ, where λ is the ridge regression penalty. The ridge regression penalty
shrinks the quadratic term βˆgwasVˆ
:
βˆgwas towards 0, which can lead to downward bias. We
also notice that a large λ is needed to drive down the noise (sˆi for large i), which diminishes
the true signal at the same time. Here we show through simulations that most of the signal
in βˆ
T
gwasV
:βˆgwas comes from si where i ! q and that sˆi « si for i ! q (see Figure 3.1).
These results motivate us to apply truncated-SVD to remove noise in Vˆ , i.e. we estimate
βˆ
T
gwasV
:βˆgwas by
řk
i“1 1{wˆipβˆ
T
gwasuˆiq2, where k ! q. Let gpβˆgwas, kq “
řk
i“1
1
wˆi
pβˆTgwasuˆiq2,
through eigen-decomposition of Vˆ , it can be shown that
Ergpβˆgwas, kqs “
kp1´ h2g,localq
n
`
kÿ
i“1
wˆipuˆTi βq2. (3.7)
Since the true local SNP-heritability is h2g,local “
řq
i“1wipuTi βq2, assuming uˆi “ ui for i ! q,
Equation (3.7) is an approximation of h2g,local with bias
kp1´h2g,localq
n
. Correcting for this bias
yields the estimator for the single-locus case
h˜2g,local “
ngpβˆgwas, kq ´ k
n´ k . (3.8)
In theory, the variance of h˜2g,local is Varrh˜2g,locals « 4pn´kq2 hˆ2g,local` 2kpn´kq2 . In practice, however,
this gives an underestimation of the truth. Thus, we replace k with q “ rankpV q.
3.2.5 Extension to multiple independent loci
For genomes partitioned into m independent loci, the linear model for individual i’s trait
value becomes yi “ xTi,1β1 ` . . . ` xTi,mβm ` i where xi,j denotes the genotypes at the pi
SNPs in the i-th locus for individual i, and β i denotes the effect sizes of SNPs in this locus.
Based on the revised model, we decompose Varrys into
Varrys “ VarrX1β1s ` ¨ ¨ ¨ ` VarrXmβms ` σ2e “ h2g,local,1 ` ¨ ¨ ¨ ` h2g,local,m ` σ2e , (3.9)
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where h2g,local,i denotes the local SNP-heritability contributed by the i-th locus. In the case
of multiple independent loci, the noise term σ2e is equal to 1´
řm
j“1 h
2
g,local,j. Thus, in order
to correct for the bias generated by σ2e , one need to know h
2
g,local,j for all j. Accounting for
bias and adjusting for noise in external reference LD (Vˆ i) following strategies outlined in
previous sections, we arrive at the estimator,
hˆ2g,local,i “
ngpβˆgwas,i, kiq ´ p1´
řm
j“1,j‰i hˆ
2
g,local,jqki
n´ ki , (3.10)
which defines a system of linear equations involving m variables (hˆ2g,local,i) and m equations.
A similar system of linear equations can be solved to obtain the variance estimate,
Varrhˆ2g,is “
ˆ
n
n´ ki
˙2 ˆ
2ki
σˆ2e
n
` 4hˆ2g,local,i
˙
σˆ2e
n
`
ˆ
ki
n´ ki
˙2 mÿ
j“1,j‰i
Varrhˆ2g,local,js, (3.11)
where σˆ2e “ 1´
řm
j“1 hˆ
2
g,local,j.
In the special case when k1 “ ¨ ¨ ¨ “ km “ k (i.e. all loci use the same number of eigenvectors
in the truncated-SVD regularization of LD matrices), Equation (3.10) simplifies as follows:
hˆ2g “
řm
i“1 hˆ
2
g,local,i “
řm
i“1
ngpβˆgwas,i,kq´p1´hˆ2g`hˆ2g,local,iqk
n´k “ nn´k
řm
i“1 gpβˆgwas,i, kq ´ kn´k pm ´
mhˆ2g ` hˆ2gq, yielding the following estimate for the total genome-wide SNP-heritability:
hˆ2g “ nn´mk
mÿ
i“1
gpβˆgwas,i, kq ´ mkn´mk, (3.12)
with variance:
Varrhˆ2gs “
ˆ
n
n´mk
˙2 mÿ
i“1
Varrgpβˆgwas,i, kqs «
ˆ
n
n´mk
˙2
2mk
pn´ kq2 . (3.13)
Thus, if k is chosen such that n ´ mk is small (i.e. n
n´mk large) the genome-wide SNP-
heritability estimates becomes unstable with large variance. To ensure stable estimates and
reduce variance (at the cost of some bias) we recommend choosing k such that n
n´mk is less
than 2 when using our estimator for genome-wide estimation.
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3.2.6 Known genome-wide SNP-heritability
In many cases, the total genome-wide SNP-heritability estimate (h2g) and its variance (Varrh2gs)
of a trait are known (e.g. estimated from individual-level data). In those cases, one can sim-
ply plug h2g into Equation (3.10) to obtain local estimates of heritability h
2
g,local,i:
hˆ2g,local,i “ gpβˆgwas,i, kq ´ knp1´ h
2
gq, (3.14)
from which we conclude
Varrhˆ2g,local,is “ Varrgpβˆgwas,i, kqs `
ˆ
k
n
˙2
Varrh2gs. (3.15)
In general, the sum of local SNP-heritability hˆ2g “
řm
i“1 hˆ
2
g,local,i is not necessarily equal to
h2g due to variance in hˆ
2
g,local,i. Since Varrhˆ2gs “ Varr
řm
i“1 hˆ
2
g,local,is « 2mkpn´kq2 `
`
mk
n
˘2
Varrh2gs,
we recommend choosing k such that mk
n
is less than 0.5 to ensure stable estimate and reduce
variance. We assessed the local SNP-heritability estimation with or without known genome-
wide SNP-heritability using the height GWAS data (see Table 1) with a previously reported
h2g=0.50[165]. The local SNP-heritability estimates were virtually indistinguishable between
the two approaches (R “ 1.0).
3.2.7 Simulation framework
We use HAPGEN2 [150] to simulate genotypes for 50,000 individuals starting from half of
the 505 European (EUR) individuals in the 1000 Genomes Project [28] for SNPs with minor
allele frequency (MAF) greater than 5% in randomly selected regions spanning 0.75 Mb
to 1.5Mb on chromosome 1. We reserve the other half of the EUR individuals as external
reference panel. From the simulated genotypes of the 50,000 individuals, we then simulate
phenotypes based on the linear model y “ Xβ ` , where X is the standardized genotype
matrix with mean 0 and variance 1 at each column.
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We investigated the performance of our method under a wide-range of simulations. We first
select a subset C of |C| causal SNPs at random and then simulate the effect sizes at these
SNPs as βC „ Np0, h2|C|I|C|q, where h2 is the heritability to be simulated. We draw  from
Np0, p1´h2qInq such that Erys “ 0, Varrys “ 1, and that the SNP-heritability for this locus
is h2. For fixed β , we then generate replications of trait values y by re-drawing . Finally, we
compute summary statistics, βˆgwas, following procedures outlined in previous sections. We
simulate 500 set of summary statistics for each simulation scenario. Although within each
of the 500 set of simulated summary statistics, C and β are fixed, they vary across different
set of simulations.
We also investigated simulations where β varies across simulated individuals. In each of the
500 set of simulated GWAS summary statistics, we first select a subset C of |C| causal SNPs
at random. Then, for each individual, we draw βC,i from Np0,αih2q for i “ 1, ¨ ¨ ¨ , |C|, where
α governs the proportion of heritability contributed by each SNP and satisfies
ř|C|
i“1αi “ 1.
In the special case when αi “ 1|C| for all i, each causal SNP contributes the same proportion
of heritability. Here, C and α are fixed in each set of simulation but vary across the 500 set
of simulations.
Since in simulations, we assume that all SNPs are typed and that environmental effect () is
drawn independently for each individual, cryptic relatedness among individuals in the 1000
Genomes Project [28] will have minimal effect on our estimates.
3.2.8 Empirical data sets
We obtained publicly available GWAS summary over European ancestry data for 30 traits
from 11 GWAS consortia (see Table 3.3). For quality control, we restricted our analysis to
GWAS studies involving at least 20,000 samples, and excluded sex chromosomes. We used
the definition of independent loci as defined in [11] (1.6 Mb on the average). To reduce
statistical noise in LD matrix, we focused on estimating heritability attributable to common
SNPs (i.e. SNPs with MAF greater than 5% in the European 1000 Genomes data[28]). Prior
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to estimating heritability, we also removed SNPs with ambiguous alleles as compared to the
reference panel (Table 3.3) and applied our estimator as defined in Equation (3.10). For
each trait, we choose k, the number of eigenvectors used to estimate local heritability across
all loci, based on sample size of the GWAS (see Methods) – a large k is used for GWAS
with large sample size, and a small k is used for GWAS with small sample size. To avoid
inflation due to noise in LD, we cap k at a maximum of 50 (see Table 3.4). To ensure stable
estimates, we also recommend filtering out eigenvectors with corresponding eigenvalues less
than 1.
Most GWAS apply genomic control (GC) factor (λgc) to χ
2 statistics to correct for inflation
due to population structure [158] and publish GC-corrected effect size estimation (βˆgwas,gc).
And we note that all the summary GWAS data we analyze in this work were adjusted for
population structure to various degrees, and had at least one round of genomic correction.
However, recent works [19, 171] show that λgc can not distinguish between inflation and true
polygenicity and overestimates the correction factor needed for population stratification.
Although dividing the χ2 statistics by λgc has little effect on computing the ratios between
local and genome-wide heritability [44], it can result in underestimation of both local and
genome-wide SNP-heritability – when applied on GC-corrected summary data directly, our
method can produce negative and uninformative local and total SNP-heritability estimates.
To account for this, we first estimate λgc from summary GWAS data and re-inflate the effect
sizes (βˆgwas,gc) with estimated
a
λgc before obtaining local SNP-heritability estimates. We
estimate λgc based on the observation that at a locus with no heritability (i.e. h
2
g,local,i “ 0),
ErβˆTgwas,gc,iV :iβˆgwas,gc,is “ 1λgc qin , where βˆgwas,gc,i “
βˆgwas,i?
λgc
denotes GC-corrected effect size
vector, and that ErβˆTgwas,iV :iβˆgwas,is “ qin , where βˆgwas,i is the vector of effect size estimation
without GC correction. To estimate λgc, we treat the bottom 50% of all loci with the
smallest estimated local SNP-heritability as loci having h2g,local,i “ 0, and regress the vector
p qi
n
q against the vector pβˆTgwas,gc,iV :iβˆgwas,gc,iq. We note that using the bottom 50% of all
loci is a conservative measure to account for ascertainment in choosing loci and can result
in estimated λgc less than 1. In practice, we only re-inflate βˆgwas,gc if the estimated λgc is
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greater than 1. We report estimated λgc for all 30 traits in Table S1. Overall, our estimated
λgc is consistent with the reported λgc. For example, our estimated λgc for BMI (1.33), HDL
(1.13), LDL (1.16), TC (1.16), and TG (1.18) are consistent with the reported λgc for BMI
(1.38) [90] and lipid traits (1.10-1.15) [29].
We define GWAS hits as SNPs with p-values less than 5 ˆ 10´8. To avoid overestimation
due to LD tagging, for each locus, we only select the most significant (i.e. smallest p-value)
GWAS hit as the index SNP. Heritability attributable to index SNPs, hˆ2gwas, is then estimated
as
řI
i“1 βˆ
2
i , where βˆi is effect size of the i-th index SNP, and I the number of index SNPs.
We estimate the variance of hˆ2gwas as Varrhˆ2gwass “
řI
i“1 Varrβˆ2i s “
řI
i“1 VarrpZi{
?
nq2s “řI
i“1 Varr 1nχ2i s “ 2I{n2.
For case-control traits, an adjustment factor is needed to correct for ascertainment [82].
We note that this adjustment factor is derived based on the infinitesimal model, and does
not apply to our method, which assumes a fixed effect model. Therefore, we only report
unadjusted heritability estimates for case-control traits. However, we note that ratio between
local to genome-wide SNP-heritability is not affected by this scaling factor.
3.3 Results
3.3.1 Performance of HESS in simulations
We used simulations to assess the performance of our proposed approach under a variety of
disease architectures. First, we confirmed that by accounting for rank deficiency in the LD
matrix we obtain unbiased estimation whereas the approach that uses the number of SNPs
to correct for bias generated by the quadratic form [45] leads to a severe under-estimation
of heritability. Second, we find that using the top 10-50 eigenvectors of the LD matrix (see
Methods) provides a good approximation for the estimated heritability when LD is estimated
from external reference panels (Figure 3.1).
37
Since we use approximately independent loci [11], we also assessed potential bias due to
cross-tagging of heritability resulting from LD across adjacent loci. We simulated summary
statistics based on 10,000 randomly selected SNPs spread across the entire chromosome
22, with 20% of these SNPs being causal and total SNP-heritability varying from 2% to
10%. For each simulation scenario, we simulate 500 set of summary statistics, and obtain
local SNP-heritability estimates using equation (3.10). We obtain total SNP-heritability
estimate by summing all local SNP-heritability estimates. We find that using the top k “ 30
eigenvectors in the truncated-SVD regularization of LD matrices, HESS yields downwardly
biased estimate of total SNP-heritability estimate, whereas at k “ 50 HESS is approximately
unbiased (Figure 3.2). Therefore, we use k “ 50 as the default unless otherwise noted.
Next, we compared HESS to the recently proposed LD-score regression (LDSC)[19, 44]
method that provides estimates of heritability from GWAS summary data. Although LDSC
is not designed for local analyses due to model assumptions on polygenicity, it is able to esti-
mate the variance in trait attributable to any sets of SNPs. As expected, in our simulations,
where all individuals share the same effect size vector (β), we find that LDSC is sensitive
to the underlying polygenicity and, in general, yields biased estimation of heritability. In
contrast, HESS provides an unbiased estimation of heritability across all simulated disease
architectures when in-sample LD is available. For example, in simulations where 20% of the
variants at the locus are causal explaining 0.05% heritability, HESS yields an estimate of
0.054% (s.e. 0.004%) as compared to 0.025% (s.e. 0.0009%) for LDSC (Figure 3.3). We
attribute this to the fact that HESS does not make any assumption on the distribution of
effect sizes at causal variants by treating them as fixed effects in the model. When LD from
the sample is unavailable and has to be estimated from reference panels, both methods are
biased with HESS (with k “ 30, 50 eigenvectors in the truncated-SVD regularization of the
LD matrix) yielding results closer to simulated heritability than LDSC at randomly selected
loci with different width (Figure 3.3). Similar results were obtained in simulations where
the β is drawn independently for each individual. This is expected because conditional on
a fixed β , HESS is unbiased (i.e. Erhˆ2g|βs “ h2g), then the expectation of HESS estimate
integrating over all possible β is still unbiased (i.e. Erhˆ2gs “ ErErhˆ2g|βss “ Erh2gs “ h2g).
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Finally, unlike LDSC that employs a jack-knife approach to estimate variance in the esti-
mated heritability (thus requiring multiple loci), HESS provides a variance estimator follow-
ing quadratic form theory (see Methods). Since external reference LD is typically computed
based on much smaller samples than in-sample LD, subtle patterns in in-sample LD cannot
be captured by external reference LD. Thus, external reference LD matrices usually have
lower rank than their corresponding in-sample LD matrices, resulting in under-estimation of
Varrhˆ2g,local,is (see Equation (3.11)). We verify this in simulations and find that the variance
estimator yields unbiased estimates when in-sample LD is available and under-estimates the-
oretical variance when external reference LD is used. We also note that cryptic relatedness in
GWAS samples can drive down the effective sample size (n), thus our estimates of standard
errors could be deflated for GWAS where the effective sample size is significantly smaller
than the actual sample size.
3.3.2 Common variants explain a large fraction of heritability
Having demonstrated the utility of HESS in simulations, we next applied our method to
empirical GWAS summary data across 30 complex traits and diseases spanning more than
two million phenotypic measurements (see Methods, Table 3.3, Table S1). We estimated the
local SNP-heritability at 1,703 approximately-independent loci [11] using European individ-
uals of the 1000 Genomes to estimate LD [28]. We first investigated the total contribution
of common variants (MAF ą 5%) to the heritability of complex traits. We summed up the
local estimates provided by our method to obtain an estimate for the total genome-wide
heritability for all genotyped SNPs. For traits where the SNP-heritability was previously
reported we find a broad consistency between our estimate and the existing estimates from
the literature (see Table 3.3). For example, HESS estimates a genome-wide SNP heritability
(h2g) of 16.5% (s.e. 0.5%) for BMI and 59.4% (s.e. 0.3%) for height as compared to previously
reported estimates of 21.6% (2.2%) for BMI [90] and 62.5% for height [165]. We also find
that our total SNP-heritability estimates broadly correlates with those obtained by LDSC
(R “ 0.78). Most importantly, we find that common SNPs explain a large fraction of the
39
previously reported familial heritability for all quantitative traits we interrogated ranging
from 21% for Forearm BMD to 94% for HDL(Table 3.3). Although we observe a very high
contribution of common SNPs to case-control traits as well, we note that our estimator can
be biased due to ascertainment in this case (see Methods).
3.3.3 Hidden heritability at known risk loci
Recent works[54, 96] have shown that the total heritability explained by all variants at the
GWAS risk loci (h2g,local,gwas) is higher than heritability explained by GWAS index SNPs
(h2gwas). This suggests that a fraction of the missing heritability is due to multiple causal
variants or poor tagging of hidden causal variants at known risk loci. We used HESS to
quantify the gap between these two estimates of heritability at known risk loci. We find
several traits for which h2g,local,gwas is significantly larger than h
2
gwas. For example, h
2
g,local,gwas
is over two fold higher (32.0%, s.e. 0.2%) than h2gwas (13.9%, s.e. 0.002%) for height (Table
3.3). The difference can be accounted by incomplete tagging of hidden causal variant(s) or
allelic heterogeneity (i.e., multiple causal variants). Indeed, conditional analysis identified
36 GWAS loci that contain multiple signals of associations (for a total of 87 GWAS risk
SNPs at these loci) for height[169]. Restricting to the 28 loci that contain at least 2 of
the 87 GWAS risk SNPs, we estimate h2g,local,gwas=4.6%(s.e. 0.06%), a 2.4-fold increase over
h2gwas=1.9% (s.e. 0.003%). These loci, 5.8% of all GWAS loci for height, contribute to
14.2% of the difference between h2g,local,gwas and h
2
gwas across all loci, thus suggesting that
the difference is likely due to multiple signals of association. To confirm this hypothesis we
applied a conditional analysis from summary GWAS data using GCTA-COJO [169] for the
traits HDL, TG, RA, and SCZ. We observe that a moderate fraction (2% – 16%) of GWAS
loci show multiple signals of association (see Table 3.2) thus confirming that contrasting
h2g,local,gwas with h
2
gwas is indicative of multiple signals of association.
In contrast, the majority of traits show similar hˆ2g,local,gwas and hˆ
2
gwas (see Table 1) suggesting a
single causal variant at these loci very well tagged by the index GWAS variant. For example,
it is known that LDL is strongly regulated by a single non-coding functional variant at the
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SORT1 locus [29, 110] and that bone mineral density trait (FN) is strongly regulated by
WNT16 [177, 75]. We also observe traits (e.g. MCH, MCV, RBC) for which hˆ2g,local,gwas is
estimated to be less than hˆ2gwas. This seemingly contradictory result is due to the fact that
fewer eigenvectors in the truncated-SVD regularization of LD matrices were used to estimate
hˆ2g,local,gwas for GWAS with small sample sizes (see Table S2), resulting in downward bias (see
Methods).
3.3.4 Contrasting polygenicity across multiple complex traits
Most studied common traits exhibit a strong polygenic architecture (i.e. an abundance of
loci of small effect contributing to trait)[91, 90, 165, 29] . We recapitulate this observation
using the HESS analysis and find a strong correlation between chromosome length and the
fraction of heritability it explains for most traits we analyze here (Figures 3.4, 3.5 ). We
also observe, consistent with previous findings [25], regions such as FTO on chromosome 16
and HLA on chromosome 6 contributing disproportionately to the fraction of heritability for
HDL, BMI, and RA, respectively.
Next, we sought to quantify the variability in polygenicity across traits. We rank order loci
based on their estimated local SNP-heritability, sum their contribution and plot it versus the
percentage of genome they occupy (Figure 3.6). For highly polygenic traits, we expect the
cumulative fraction of total SNP-heritability to be proportional to the fraction of genome
covered, whereas for less polygenic traits, we expect to see a small fraction of the genome
accounting for a large fraction of total SNP heritability. For example, in schizophrenia and
height the top 1% of the loci with the highest local SNP-heritability contribute to 4.2%(s.e.
1.0%) and 6.5%(s.e. 1.5%) of the total SNP-heritability of these traits, respectively. This is
consistent with previous reports on the degree of polygenicity of these traits [91, 165, 29].
At the other extremes, RA and lipid traits (HDL, LDL, TC, TG) have a lower degree of
polygenicity, with the top 1% of loci accounting for 14-30% of the total SNP heritability.
However, the low polygenicity of RA is mostly driven by the HLA region on chromosome
6. After removing local SNP-heritability estimates at loci overlapping the HLA region for
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all traits, we observe that RA shows a moderate degree of polygenicity for the rest of the
genome. We also note that the different degrees of polygenic signals across traits reflect both
a difference in disease architecture (i.e. distribution of effect sizes) as well as a difference in
the sample sizes for the GWAS summary data.
A different perspective of polygenicity is to restrict to GWAS risk loci (as they clearly contain
risk variants) and contrast the proportion of explained variance with the proportion of the
genome they occupy. We observe a wide distribution across traits reflecting diverse genetic
architectures as well as different sample sizes for the GWAS performed for these traits. For
example, approximately 30% of loci across the genome harbor a risk variant for height and
account for 50% to the total SNP-heritability (a 1.5-fold enrichment). On the other hand,
while only 5% of the loci contain GWAS risk variants for HDL, these loci collectively explain
25% of the SNP-heritability of HDL (a 4.6-fold enrichment) (Figure 3.7).
3.3.5 Loci that contribute to heritability of multiple traits
It has been previously established that a number of the 30 traits investigated in this study
share a genetic basis [18]. Correlating local SNP-heritability estimates across the entire
genome can serve as a proxy for the magnitude of pleiotropy and we can identify pairs of traits
whose genetic components tend localize within the same regions of the genome. Motivated
by this, we searched for specific pleiotropic loci which we define as loci that contribute
significant non-zero SNP-heritability (one-tailed p-value ă 0.05, Bonferroni corrected for
1,703 loci) for at least 3 out of the 30 analyzed traits. In total, we identified 36 such loci
distributed genome-wide (see Figure 3.9).
As expected, the HLA region (chr6:26-34M), displays strong pleiotropic signal, particularly
for immunologically relevant phenotypes (see Figure 3.9). For instance, the locus chr6:32-
33M contributes significant amount of SNP-heritability for 8 traits, with exceptionally strong
signals for RA, UC, and IBD (see Figure 3.9). We also observe several other pleiotropic loci,
including chr2:199M-202M, contributing to AM, SCZ, and Height; chr6:134-136M, contribut-
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ing to multiple red blood cell traits; and chr19:45-46M, contributing to multiple lipid traits.
It’s well known that there exist genetic correlations among red blood cell traits [160, 46, 23]
as well as among lipid traits [29, 18]. Interestingly, previous research has also revealed that
early age at menarche is associated with later onset of schizophrenia [26]. Our results sug-
gest that these genetic correlations and associations may be caused in part by the pleiotropic
effect of these loci.
We note that the selection of traits can bias the identification of pleitropic loci towards
over-represented traits such as height and lipid traits. Nevertheless, local SNP-heritability
analysis is still a useful tool to quantify the fraction of total SNP heritability contributed by
a single loci and provide valuable insights into identifying pleiotropic loci.
3.4 Discussion
We have presented HESS, an unbiased estimator of local SNP-heritability from GWAS sum-
mary data. We extend existing work [45] that estimate heritability under the fixed-effect
model by proposing to regularize external reference LD matrix via truncated-SVD and gen-
eralizing the estimator to multiple independent loci. Through extensive simulations, we
demonstrate that HESS is unbiased given in-sample LD and yields more consistent and less
biased local SNP-heritability estimates than LDSC given external reference LD. We applied
HESS on GWAS summary data of 30 complex traits from 12 GWAS consortia and showed
that our results recapitulate previous findings. We then used these local SNP-heritability
estimate to contrast polygenicity of complex traits, find loci with multiple causal variants,
and identify heritability hot spots. We note that enrichment of heritability at GWAS risk loci
could be leveraged into prioritizing GWAS or fine-mapping; for example, traits with small
enrichment of heritability at GWAS risk loci are more suitable for larger GWAS, whereas
traits with large enrichment of heritability at known risk loci could be investigated further
through fine-mapping.
In this work, we focus on estimating local heritability attributable to common autosomal
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variants (MAF ą 5%), ignoring potential heritability captured by the sex chromosomes
and rare variants. We also note that our heritability estimates for case-control traits are
not adjusted for ascertainment as it is unclear whether adjustment derived based on the
infinitesimal model can be directly applied for the fixed-effect model. Thus, our reported
heritability estimation for case-control traits can be biased due to ascertainment. Future
work that addresses local heritability estimation including both common and rare variants,
sex chromosomes, as well as adjustment of heritability estimates under the fixed-effect model
for case-control traits will further improve the utility of our approach.
We conclude with several caveats and limitations of our work. First, our method relies on
independent LD blocks, which are often hard to define due to LD across multiple loci. In this
work, we attempt to minimize LD leakage by defining approximately independent loci using
principled approaches. Second, when only external reference LD is available, our method can
yield biased heritability estimate as well as its variance estimate, due to external reference
LD having lower rank than its corresponding in-sample LD as well as cryptic relatedness in
GWAS samples. This makes precise hypothesis testing difficult. However, with in-sample
LD and larger reference panels such as the Haplotype Reference Consortium [103], this bias
will be reduced as LD can be inferred more precisely. We also note that our estimated
λgc can be a potential source of bias, thus our genome-wide estimate should be interpreted
with caution. Third, to obtain stable estimate, the number of eigenvectors used (k) in the
truncated-SVD regularization should be chosen based on the sample size of GWAS study
– GWAS with large sample size can afford large k, whereas GWAS with small sample size
should use a small k. We recommend applying our method on summary data obtained from
GWAS studies involving around or above 50,000 samples. For GWAS with small sample
size, when genome-wide SNP-heritability is known, one can still apply Equation (3.14) to
obtain stable local heritability estimate. We also note that although using the same number
of eigenvectors for all loci facilitates the study of the statistical properties of our estimator,
this approach may not be optimal for all loci. We conjecture that selecting k using more
principled approach (e.g. based on the distribution of eigenvalues) may reduce bias, and we
leave such investigation as future work.
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3.5 Tables
Trait h2g h
2
pub h
2
g{h2pub h2gwas h2g,local,gwas h2˚g,local,gwas Enrichmenta
BMI (Body Mass Index) [90] 16.5(0.5) 42 [61] 0.39 1.6(0.001) 3.1(0.1) 3.1(0.1) 3.7(0.4)
Height (Height) [165] 59.4(0.3) 69 [61] 0.86 13.9(0.002) 32.0(0.2) 24.0(0.2) 1.5(0.1)
HB (Haemoglobin) [160] 17.9(2.1) 37 [47] 0.48 2.2(0.003) 1.9(0.3) 1.8(0.3) 7.6(1.4)
MCH (Mean Cell Haemoglobin) [160] 29.3(2.2) 52 [88] 0.56 7.2(0.003) 6.2(0.4) 6.1(0.4) 9.9(1.9)
MCHC (MCH Concentration) [160] 10.9(2.5) 48 [62] 0.23 0.4(0.003) 0.5(0.2) 0.5(0.2) 6.7(1.8)
MCV (Mean Cell Volume) [160] 26.3(2.0) 52 [88] 0.51 6.5(0.004) 5.7(0.4) 5.6(0.4) 8.1(1.3)
PCV (Packed Cell Volume) [160] 16.7(2.5) 30 [47] 0.56 1.4(0.003) 0.9(0.2) 0.8(0.2) 6.0(1.4)
RBC (Red Blood Cell Count) [160] 22.0(2.3) 56 [88] 0.39 3.6(0.004) 2.6(0.3) 2.6(0.3) 6.4(1.6)
PLT (Number of Platelets) [52] 27.5(1.5) 57 [47] 0.48 3.5(0.003) 3.9(0.3) 3.9(0.3) 5.7(0.9)
FG (Fasting Glucose) [38] 22.3(2.3) 66 [145] 0.34 2.6(0.002) 1.7(0.2) 1.6(0.2) 8.0(2.5)
FI (Fasting Insulin) [38] 19.9(2.4) 36 [133] 0.55 – – – –
HBA1C (HBA1C) [147] 20.8(2.3) 75 [145] 0.28 1.8(0.003) 0.9(0.2) 0.9(0.2) 6.6(1.9)
HOMA-B (HOMA-B) [38] 20.3(2.4) 72 [106] 0.28 0.6(0.001) 0.4(0.1) 0.4(0.1) 7.5(1.9)
HOMA-IR (HOMA-IR) [38] 19.9(2.4) 38 [133] 0.52 – – – –
HDL (High Density Lipoprotein) [29] 39.4(0.9) 42 [174] 0.94 5.8(0.002) 10.7(0.2) 10.5(0.2) 4.6(1.3)
LDL (Low Density Lipoprotein) [29] 33.0(1.0) 40 [174] 0.82 7.8(0.002) 8.4(0.2) 8.3(0.2) 5.1(0.9)
TC (Total Cholesterol) [29] 35.5(0.9) 50 [35] 0.71 8.0(0.002) 9.3(0.2) 9.3(0.2) 4.3(0.6)
TG (Triglycerides) [29] 34.8(0.9) 40 [40] 0.87 5.2(0.002) 8.0(0.2) 8.0(0.2) 5.8(1.4)
EY (Education Years) [134] 19.9(0.8) 40 [134] 0.50 0.1(0.002) 0.2(0.0) 0.2(0.0) 3.2(1.4)
FA (Forearm BMD) [176] 17.4(2.2) 84 [3] 0.21 0.3(0.001) 0.5(0.1) 0.5(0.1) 22.4(7.7)
FN (Femoral Neck BMD) [176] 24.1(2.1) 84 [3] 0.29 2.0(0.003) 2.0(0.2) 2.0(0.2) 7.1(1.0)
LS (Lumbar Spine) [176] 25.1(2.0) 84 [3] 0.30 2.2(0.003) 2.2(0.3) 2.2(0.3) 6.1(0.8)
AM (Age at Menarche) [124] 27.8(0.7) 49 [156] 0.57 2.6(0.002) 3.8(0.2) 3.7(0.2) 2.9(0.2)
COL (College) [134] 19.4(0.8) 40 [134] 0.48 0.1(0.001) 0.1(0.0) 0.1(0.0) 3.5(0.9)
RA (Rheumatoid Arthritis) [114] 66.3(0.9) 55 [58] 1.21 11.2(0.003) 22.0(0.3) 22.1(0.3) 9.8(4.3)
SCZ (Schizophrenia) [113] 64.5(0.7) 81 [152] 0.80 6.2(0.004) 9.2(0.2) 9.2(0.2) 2.3(0.1)
CD (Crohn’s Disease) [89] 35.9(1.8) 53 [159] 0.68 3.8(0.002) 5.9(0.4) 5.9(0.4) 4.8(0.7)
IBDc (Inflammatory Bowel Disease) [89] 35.3(1.4) – – 4.9(0.002) 6.7(0.3) 6.6(0.3) 4.6(0.5)
UC (Ulcerative Colitis) [89] 31.9(2.1) 58 [159] 0.55 2.7(0.002) 4.1(0.3) 4.1(0.3) 5.4(1.0)
T2D (Type 2 Diabetes) [109] 25.4(1.6) 26 [128] 0.98 1.3(0.002) 1.1(0.2) 1.1(0.2) 3.9(0.7)
Table 3.1: Total SNP heritability estimates and the amount of h2g attributable
to loci containing GWAS index SNPs (h2g,local,gwas) and index SNPs only (h
2
gwas).
h2˚g,local,gwas is the same as h2g,local,gwas except that GWAS index SNPs are excluded in the
computation. In Table S2, we report h2:g,local,gwas, obtained by excluding all GWAS hits. We
also report familial heritability (h2pub) estimates obtained from twin or family studies. We
list case-control traits where our estimate of h2g is biased due to ascertainment at the bottom
of the table. aSimilar to [44], we define enrichment as the ratio between the fraction of
h2g attributable to h
2˚
g,local,gwas and the fraction of genome covered by these loci. We obtain
standard errors by jackknife over the loci. bIBD refers to the union of CD and UC.
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Trait No. GWAS No. GWAS loci with hˆ2g,local,gwas hˆ
2
gwas Fraction
hit loci multiple signals (%) (%) (%)
HDL (High Density Lipoprotein) [29] 92 15 6.1(0.14) 2.8(0.003) 67.3
TG (Triglycerides) [29] 66 9 4.6(0.12) 3.0(0.002) 57.1
RA (Rheumatoid Arthritis) [114] 51 4 14.8(0.19) 4.3(0.005) 97.3
SCZ (Schizophrenia) [113] 103 2 0.28(0.003) 0.17(0.003) 3.6
Table 3.2: GCTA-COJO[169] analysis on summary statistics for the traits HDL,
TG, RA, and SCZ. We define loci with multiple association signals as loci containing at
least 2 of the risk SNPs reported by GCTA-COJO. Here, hˆ2g,local,gwas and hˆ
2
gwas are computed
restricting to the loci with multiple association signals. Fraction refers to the fraction of
difference between hˆ2g,local,gwas and hˆ
2
gwas across all loci that is accounted for by loci with
multiple signals of association.
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Trait Sample size No. SNPs No. GWAS hits No. index SNPs Fractiona
BMI (Body Mass Index) [90] 229269 1859666 1851 79 5.31
Height (Height) [165] 244015 1854761 26374 476 31.15
HB (Haemoglobin) [160] 52666 1894024 459 24 1.38
MCH (Mean Cell Haemoglobin) [160] 44658 1892019 1585 37 2.25
MCHC (MCH Concentration) [160] 48252 1893281 223 15 0.9
MCV (Mean Cell Volume) [160] 49808 1893769 1602 46 3.08
PCV (Packed Cell Volume) [160] 46169 1893412 288 14 0.92
RBC (Red Blood Cell Count) [160] 46465 1892553 1132 31 2.1
PLT (Number of Platelets) [52] 66867 1954590 954 40 2.54
FG (Fasting Glucose) [38] 46186 1824182 290 12 0.97
FI (Fasting Insulin) [38] 46186 1822388 – – –
HBA1C (HBA1C) [147] 46368 1870395 187 11 0.6
HOMA-B (HOMA-B) [38] 46186 1820938 119 4 0.24
HOMA-IR (HOMA-IR) [38] 46186 1821061 – – –
HDL (High Density Lipoprotein) [29] 96335 1805617 3445 92 6.28
LDL (Low Density Lipoprotein) [29] 91529 1803637 2971 76 4.87
TC (Total Cholesterol) [29] 96596 1805676 4039 91 5.98
TG (Triglycerides) [29] 92768 1803908 3149 91 3.95
EY (Education Years) [134] 126559 1788888 11 4 0.25
FA (Forearm BMD) [176] 53236 4725343 152 3 0.18
FN (Femoral Neck BMD) [176] 53236 4637340 867 21 1.21
LS (Lumbar Spine) [176] 53236 4636561 1077 24 1.39
AM (Age at Menarche) [124] 132989 1821879 2391 73 4.61
COL (College) [134] 126559 1792881 61 3 0.2
RA (Rheumatoid Arthritis) [114] 14361/43923 4265540 19575 51 3.06
SCZ (Schizophrenia) [113] 32405/42221 4772186 8113 103 6.9
CD (Crohn’s Disease) [89] 17897/33977 4822932 5179 54 3.48
IBDb (Inflammatory Bowel Disease) [89] 13769/33977 4823603 9243 70 4.17
UC (Ulcerative Colitis) [89] 31666/33977 4823578 5114 42 2.45
T2D (Type 2 Diabetes) [109] 12171/56862 1806359 236 13 1.0
Table 3.3: Details of the summary GWSA data for the 30 analyzed traits. aFraction
refers to the fraction of genome with GWAS hits. bIBD refers to the union of CD and UC.
For case-control traits, we list sample size as No. cases / No. controls.
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Trait h2g(HESS) k Estimated λgc h
2:
g,local,gwas Enrichment
a h2g(LDSC)
BMI (Body Mass Index) [90] 16.5(0.5) 50 1.33 2.45(0.11) 3.22(0.27) 14.0(0.9)
Height (Height) [165] 59.4(0.3) 50 1.00 23.86(0.20) 1.73(0.05) 33.0(1.7)
HB (Haemoglobin) [160] 17.9(2.1) 16 1.29 1.40(0.28) 6.19(1.38) 27.4(1.4)
MCH (Mean Cell Haemoglobin) [160] 29.3(2.2) 14 1.32 3.16(0.39) 6.71(1.28) 39.5(2.6)
MCHC (MCH Concentration) [160] 10.9(2.5) 15 1.30 0.40(0.25) 5.41(1.70) 21.6(0.9)
MCV (Mean Cell Volume) [160] 26.3(2.0) 15 1.31 3.08(0.39) 5.66(0.91) 35.2(2.1)
PCV (Packed Cell Volume) [160] 16.7(2.5) 14 1.31 0.64(0.25) 4.71(1.26) 31.4(1.5)
RBC (Red Blood Cell Count) [160] 22.0(2.3) 14 1.32 1.61(0.35) 4.48(0.82) 34.2(1.7)
PLT (Number of Platelets) [52] 27.5(1.5) 20 1.26 2.41(0.25) 4.04(0.44) 30.2(1.4)
FG (Fasting Glucose) [38] 22.3(2.3) 14 1.20 0.66(0.21) 3.58(1.11) 27.6(1.6)
FI (Fasting Insulin) [38] 19.9(2.4) 14 1.19 0.10(0.06) 15.41(0.00) 24.0(1.0)
HBA1C (HBA1C) [147] 20.8(2.3) 14 1.24 0.69(0.20) 5.31(1.89) 31.8(1.2)
HOMA-B (HOMA-B) [38] 20.3(2.4) 14 1.19 0.06(0.12) 1.26(0.68) 24.2(1.1)
HOMA-IR (HOMA-IR) [38] 19.9(2.4) 14 1.20 0.11(0.06) 16.17(0.00) 24.9(1.1)
HDL (High Density Lipoprotein) [29] 39.4(0.9) 29 1.13 4.33(0.24) 2.78(0.26) 33.4(7.5)
LDL (Low Density Lipoprotein) [29] 33.0(1.0) 27 1.16 3.97(0.24) 3.34(0.33) 27.0(4.5)
TC (Total Cholesterol) [29] 35.5(0.9) 29 1.16 5.27(0.25) 3.19(0.28) 27.2(3.8)
TG (Triglycerides) [29] 34.8(0.9) 28 1.18 3.76(0.21) 3.69(0.47) 31.4(5.2)
EY (Education Years) [134] 19.9(0.8) 38 1.05 0.15(0.04) 3.20(1.45) 12.6(0.5)
FA (Forearm BMD) [176] 17.4(2.2) 16 1.18 0.19(0.10) 9.90(4.33) 20.6(0.9)
FN (Femoral Neck BMD) [176] 24.1(2.1) 16 1.17 1.43(0.25) 5.39(0.81) 26.7(1.2)
LS (Lumbar Spine) [176] 25.1(2.0) 16 1.17 1.61(0.26) 4.70(0.61) 26.7(1.1)
AM (Age at Menarche) [124] 27.8(0.7) 40 1.05 3.18(0.17) 2.60(0.16) 16.5(0.7)
COL (College) [134] 19.4(0.8) 38 1.08 0.13(0.04) 3.34(0.98) 11.6(0.5)
RA (Rheumatoid Arthritis) [114] 66.3(0.9) 18 1.20 5.98(0.32) 5.82(1.29) 34.0(8.7)
SCZ (Schizophrenia) [113] 64.5(0.7) 22 1.00 8.36(0.21) 2.20(0.15) 43.7(1.4)
CD (Crohn’s Disease) [89] 35.9(1.8) 16 1.12 3.64(0.37) 3.47(0.43) 31.4(2.1)
IBDc (Inflammatory Bowel Disease) [89] 35.3(1.4) 20 1.09 4.45(0.33) 3.66(0.39) 26.3(1.5)
UC (Ulcerative Colitis) [89] 31.9(2.1) 15 1.11 2.96(0.36) 4.35(0.73) 28.5(1.3)
T2D (Type 2 Diabetes) [109] 25.4(1.6) 19 1.19 0.71(0.16) 2.63(0.49) 24.5(1.1)
Table 3.4: Total SNP-heritability for the 30 traits obtained by HESS and LDSC.
To obtain LDSC estimate, we compute LD scores for all SNPs with MAF greater than
5% using the same reference panel as used by HESS. Since HESS does not account for
population stratification, we obtain LDSC estimate without the intercept. h2:g,local,gwas refers
to the estimated SNP-heritability attributable to loci containing GWAS hit after all GWAS
hits are removed. aWe define enrichment as the ratio between the fraction of h2g attributable
to h2:g,local,gwas and the fraction of genome covered by these loci. We obtain standard errors
by jack-knife over the loci.
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Figure 3.1: si “ pβˆTuiq2{wi as a function of the rank order of eigenvalue wi obtained
under in-sample LD (blue, rank=974) and external reference LD (red, rank=251)
for a locus containing 1,377 SNPs. Each point represents the mean of si over 500
simulations. Figure 3.1a displays the first 300 si. Figure 3.1b focuses on the first 50 si.
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Figure 3.2: Total SNP-heritability estimates in the whole chromosome simulation
for different number (k) of eigenvectors included. We see a slight downward bias
when k is small (e.g. k “ 30), and upward bias when k is large (e.g. k “ 60). When k “ 50,
we attain approximately unbiased estimate of total SNP-heritability.
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Figure 3.3: HESS provides superior accuracy over LDSC in estimating local her-
itability. HESS attains unbiased estimates when in-sample LD is used (top) and approxi-
mately unbiased estimates when reference LD is used (bottom). Mean and standard errors
in these figures are computed based on 500 simulations, each involving 50,000 simulated
GWAS data sets.
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Figure 3.4: Fraction of h2g per chromosome across the 30 traits studied. Here,
the chromosomal heritability is obtained by summing local heritability at loci within the
chromosome. For each chromosome we plot the box plots of estimates at the 30 considered
traits. Chromosomes are ordered by size. With some notable exceptions, all traits show a
strong polygenic signature of genetic architecture.
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Figure 3.5: Heritability attributable to each chromosome for four example traits.
The chromosomal heritability is obtained by summing local heritability at loci within the
chromosome. Standard error is obtained by taking the square root of the sum of variance
estimation.
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Figure 3.6: Stacked bar plot showing the percentage of total heritability at-
tributable to different fractions of genome. We rank ordered all genomic loci by
their explained heritability and quantified the fraction of total heritability attributable to
different percentile ranges. Traits with high polygenicity tend to have bars with height pro-
portional to bin size (e.g. Height and SCZ), whereas less polygenic traits tend to have bars
much larger than bin size (e.g. RA and HDL).
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Figure 3.7: Fraction of h2g explained by all loci that contain a GWAS hit versus
the fraction of genome covered by these loci. Images on the right focus successively
on the traits near the bottom left.
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Figure 3.8: Manhattan-style plots of regional heritability across the genome for
the traits Height, HDL, and SCZ.
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Figure 3.9: Heat map showing the fraction of total SNP-heritability (h2g) con-
tributed by each of the 36 “pleiotropic” loci. For each locus, we only display traits to
which the locus contributes significant amount of heritability. We mark traits to which the
locus contributes more than 5% of the total SNP heritability in dark blue.
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CHAPTER 4
Local genetic correlation gives insights into the shared
genetic architecture of complex traits
4.1 Introduction
Genomic regions that harbor variants contributing to multiple traits provide valuable in-
sights into the underlying biological mechanisms with which genetic variation impacts com-
plex traits [49, 125, 98, 55, 129, 139, 162]. Therefore, both de novo discovery of such regions
as well as the quantification of the correlation in effect sizes at known shared regions are im-
portant to epidemiological and etiological studies. For example, genetic variants associated
with multiple traits in genome-wide associations studies (GWAS) can be used as instru-
mental variables in Mendelian randomization analyses to suggest causal relationships among
complex traits [80, 146, 162, 32]. Unfortunately, many risk variants are left undetected by
existing GWAS due to a combination of high polygenicity (i.e. many variants of small ef-
fects) and sample sizes which limits the power to detect genetic variants of small effect[168].
To improve accuracy at sub-GWAS significant regions, recent works [49, 125] proposed to
utilize the posterior probability of two traits sharing a causal variant at a given risk region
to detect genetic overlap. Although powerful in detecting shared genetic risk variants, the
posterior probability does not convey the direction or magnitude of the genetic effect at the
This chapter is published in Shi et al., American Journal of Human Genetics 2017 [?]
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overlapped genomic regions [49, 125]. Alternative approaches have used genetic correlation
(i.e. correlation of the genetic components of two traits), that summarizes both direction
and magnitude of effects, to gain insights into genetic overlap of complex traits[83, 19, 112].
Traditional methods to estimate genetic correlation are hindered by the lack of availability of
large-scale individual-level data due to privacy concerns as they require individual genotype
and trait measurements on the same set of individuals [112, 83, 59]. More recent works have
shown that GWAS summary data (i.e., effect sizes and standard errors at all variants typed
in the study) are sufficient to estimate genome-wide genetic correlation under a polygenic
trait architecture by aggregating information across all typed variants in the study[18, 119].
In this work, we investigate the correlation between traits due to typed genetic variants
from a small region in the genome (i.e. local genetic correlation) as means to identify
genomic regions that contribute disproportionately to the genetic sharing between traits.
We introduce methods that estimate the local genetic correlation from GWAS summary
data while allowing for overlapping GWAS samples and linkage disequilibrium (LD) among
variants. We partition the genome-wide genetic sharing across approximately independent
LD regions of 1.6Mb in width on average[12]. To allow for a broad range of causal effect
sizes, our approach makes no distributional assumptions on the causal effect sizes by treating
them as fixed quantities. Our method can be viewed as a natural extension to pairs of traits
of recently proposed methods that quantify local SNP-heritability from GWAS summary
data under a fixed-effect model[140].
We illustrate the utility of local genetic correlation through an analysis of GWAS summary
data of 36 quantitative complex traits. We identify 25 genomic regions that show significant
local genetic correlation across 27 pairs of traits; e.g., region chr2:21-23M that harbors APOB
(MIM 107730) shows a significant genetic correlation for the pair of traits High Density
Lipoprotein (HDL) and Triglycerides (TG). Notably, 6 (out of the 25) regions show significant
local genetic correlation although the genome-wide genetic correlation is not significantly
different from 0; e.g. region chr6:134-136M shows a significant in local genetic correlation
for mean cell volume (MCV) and platelet count (PLT) although the genome-wide genetic
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correlation MCV-PLT is negligible (0.02, 95% CI [-0.04, 0.07]). This shows that these traits
are correlated at a local level (e.g., due to pleiotropy and/or shared pathways) that are not
reflected in the genome-wide correlation (due to balancing effect of other loci; e.g., positive
correlation partially canceling a negative correlation, see Figure 4.1). Regions with significant
local genetic correlations can also be used to identify new risk loci. For example, although the
region chr8:9.2M-9.6M shows a significant local genetic correlation between HDL and LDL,
although it does not harbor GWAS variant for HDL and LDL . Finally, we explore putative
causal relations between all the 36 studied traits using a recently proposed approach[125] and
report 55 instances of pairs with putative causality. For most of these pairs, we show that
the local genetic correlation ascertained for GWAS signals specific to each trait is consistent
with the putative causal relation while providing a directly interpretable quantity of the
magnitude of effect.
4.2 Material and methods
4.2.1 Overview of methods
Genetic covariance measures the similarity between a pair of traits driven by genetic vari-
ations, and enjoys wide applications in understanding relations between complex traits[60,
22, 19]. Genetic covariance is traditionally estimated as a single measure across the entire
genome to capture the genome-wide contribution of genetic variations to the correlation be-
tween phenotypes. Here, we introduce local genetic covariance, the similarity between pairs
of traits driven by genetic variations localized at a specific region in the genome (e.g., one LD
block), as a principled way to partition the shared genetic risk between traits. For example,
a high genome-wide genetic covariance can be driven by one genomic region containing a
shared risk variant, or by a large number of regions each with a small contribution reflecting
putative causal relations (where all risk variants for one trait are risk variants for the other
trait) and/or pleiotropy (risk variants contributing to both traits through shared pathways)
(see Figure 4.1). Whereas genetic covariance quantifies the magnitude of co-variation of the
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genetic components of two traits in their original scale, genetic correlation quantifies co-
variation in a standardized scale, and is therefore comparable across pairs of traits and/or
genomic regions for which magnitude of effect size may differ. As a motivating example,
consider two traits modeled by φ “ x1β1 ` x2β2 `  and ψ “ x1γ1 ` x2γ2 ` δ, where x1 and
x2 represent two independent SNPs. In the special case where γ is proportional to β by a
factor of α, i.e. γ “ αβ, the genetic covariance between the two traits is αpβ21 ` β22q, and
is governed by α. However, the genetic correlation between the two traits is always 1 for
positive α (-1 for negative α) regardless of the magnitude of α.
We start by defining local genetic covariance under the fixed effect model, making a distinc-
tion between genetic covariance and covariance of the causal effects, β and γ (see below). We
then describe methods to estimate genetic covariance followed by an approach to standardize
the local genetic covariance to estimate local genetic correlation.
4.2.2 Local genetic covariance under fixed-effect model
Let φ “ xᵀβ` and ψ “ xᵀγ`δ be two traits measured at an individual, standardized so that
Erφs “ Erψs “ 0 and Varrφs “ Varrψs “ 1, where β,γ P Rp are the fixed effect size vectors
for the two traits; x P Rp, the genotype vector of the individual at p SNPs, standardized
so that Erxs “ 0, and Varrxs “ V , the LD matrix; and , δ, random environmental effects
independent of x, β, γ, with Ers “ Erδs “ 0, Varrs “ σ2 , Varrδs “ σ2δ , and Covr, δs “ ρe.
Under these assumptions, one can decompose the phenotypic covariance, ρ, between φ and
ψ into a summation of genetic covariance and environmental covariance, as
ρ “ Covrφ, ψs “ Erφψs ´ ErφsErψs “ Erpxᵀβ ` qpxᵀγ ` δqᵀs
“ Erpxᵀβqpxᵀγqs ` Erδs “ Covrxᵀβ,xᵀγs ` Covr, δs
“ βᵀ Erxxᵀsγ ` Covr, δs “ βᵀV γ ` ρe,
(4.1)
where ρg “ Covrxᵀβ,xᵀγs “ βᵀV γ is the genetic covariance between the two traits (i.e.
covariance between the genetic components of the two traits, xᵀβ and xᵀγ), and ρe the
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environmetal covariance (i.e. covariance between the environmental effects of two traits, 
and δ). The magnitude and sign of local genetic covariance can be interpreted as the effect
and direction of the local genetic component of one trait on that of the other. Thus, given
the true effect size vectors, β, γ, and the LD matrix V , one can obtain ρg by plugging in
these quantities.
4.2.3 Genetic covariance versus covariance of the causal effects
An alternative approach to the covariance of the genetic components of the traits, is to
quantify the covariance (correlation) of the causal effects (i.e. ρg,causal “ βᵀγ). In the
special case where there is no LD (i.e. V “ I, the identity matrix), genetic covariance and
covariance of the causal effects coincide, ρg “ βᵀV γ “ βᵀIγ “ βᵀγ “ ρg,causal. However,
in general genetic covariance is different from covariance of the causal effects as function of
the LD between the causal variants. More importantly, high local genetic covariance does
not necessarily imply high covariance of the causal effects. In fact, high genetic covariance
can be attained even when causal variants are different between the traits. To illustrate the
difference, consider an example involving 2 SNPs. Let β “ p1, 0q and γ “ p0, 1q be the causal
effect vectors of the two traits, i.e. the two traits have two distinct set of causal variants.
And let
V “
»– 1.0 0.9
0.9 1.0
fifl
be the LD matrix between the SNPs. In this example, the covariance of the causal effects is
ρg,causal “ βᵀγ “ 0, whereas the genetic covariance is ρg “ βᵀV γ “ 0.9. Thus, at a region
where the causal variants are distinct for the two traits, covariance of the causal effects is
always zero, whereas genetic covariance may be non-zero depending on the LD (see Figure
4.2). The two definitions measure genetic sharing at different levels of resolution. Local
genetic covariance measures sharing at regional level giving a measure of how similar the
regional genetic components are between the two traits, and has applications in predicting
the regional genetic component of one trait from that of the other. In contrast, local causal
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effect covariance measures sharing at an individual SNP level giving a measure of how similar
the causal effects are between the two traits. Consider a scenario where two traits are each
driven locally by a different SNP in the same gene. In this case, the local causal effect
covariance is zero since the two traits share no causal SNP. However, the local genetic
covariance is non-zero if the two SNPs are in LD, which induces similarity in the genetic
component of the two traits, and is an indication of the gene being shared across the two
traits. Although in this work we focus on genetic covariance, for completeness we discuss an
estimator for covariance of the causal effects (ρg,causal) in Appendix.
4.2.4 Estimating local genetic covariance from GWAS summary data
In two GWASs involving n1 individuals for trait 1 (φ), n2 individuals for trait 2 (ψ), and ns
shared individuals, we assume
»– φ
φs
fifl “
»– Y
Xs
fiflβ `
»– 
s
fifl ,
»– ψ
ψs
fifl “
»– Z
X 1s
fiflγ `
»– δ
δs
fifl , (4.2)
where pφ,φsq P Rn1 and pψ,ψsq P Rn2 are the standardized trait values of all individuals
in each GWAS; pY ,Xsq P Rn1ˆp, pZ,X 1sq P Rn2ˆp, column standardized genotype matrices
of all individuals in each GWAS, where Xs and X
1
s represent the genotype matrices for the
same set of individuals and SNPs but standardized differently in each GWAS; p, sq P Rn1 ,
pδ, δsq P Rn2 , environmental effects of all individuals in each GWAS. We use the subscript
‘s’ to represent individuals shared by both GWASs. We further assume that Ers “ Erδs “
Erss “ Erδss “ 0, Varrs “ Varrss “ σ2I, Varrδs “ Varrδss “ σ2δI, Covr, δs “ 0, and
Covrs, δss “ ρeI.
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In a traditional GWAS, we obtain marginal effect size estimates, βˆgwas and γˆgwas, as
βˆgwas “ 1n1 rY
ᵀ Xᵀss
»– φ
φs
fifl “ 1
n1
pY ᵀY `XᵀsXsqβ ` 1n1 pY
ᵀ`Xᵀssq
γˆgwas “ 1n2
“
Zᵀ X 1ᵀs
‰»– ψ
ψs
fifl “ 1
n2
`
ZᵀZ `X 1ᵀsX 1s
˘
γ ` 1
n2
`
Zᵀδ `X 1ᵀsδs
˘
.
(4.3)
Assuming individuals in both GWASs are drawn from the same population with LD matrix
V , we have βˆgwas „ N
´
V β, σ
2

n1
V
¯
, γˆgwas „ N
´
V γ,
σ2δ
n2
V
¯
. We also find
Covrβˆgwas, γˆgwass “ Erβˆgwasγˆᵀgwass ´ pV βqpV γqᵀ “ ρen1n2 ErX
ᵀ
sX
1
ss “ ρensn1n2V , (4.4)
where the last equality follows from Isserlis’ theorem [70].
Under infinite sample sizes, Varrβˆgwass “ Varrγˆgwass “ Covrβˆgwas, γˆgwass “ 0, and we have
β “ V ´1βˆgwas, γ “ V ´1γˆgwas. Thus, local genetic covariance, ρg,local, can be computed as
ρg,local “ pβˆᵀgwasV ´1qV pV ´1γˆgwasq “ βˆ
ᵀ
gwasV
´1γˆgwas. (4.5)
However, when sample sizes are finite, from bilinear form theory [138], the covariance between
βˆgwas and γˆgwas creates bias, resulting in
ErβˆᵀgwasV ´1γˆgwass “ βᵀV γ ` ρen1n2 tr pV q “ β
ᵀV γ ` ppρ´ ρg,localqns
n1n2
, (4.6)
Correcting for bias, we arrive at the unbiased estimator
ρˆg,local “ n1n2βˆ
ᵀ
gwasV
´1γˆgwas ´ nspρ
n1n2 ´ nsp . (4.7)
For rank-deficient LD matrix V , one replaces V ´1 with the pseudo-inverse (V :) and p with
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q “ rankpV q, yielding the unbiased estimator
ρˆg,local “ n1n2βˆ
ᵀ
gwasV
:γgwas ´ nsqρ
n1n2 ´ nsq . (4.8)
Thus, in order to obtain an unbiased estimate of genetic covariance between a pair of traits,
one needs to know their phenotypic covariance. When phenotypic covariance is not available,
one can obtain an estimate from genome-wide summary association data using cross-trait
LD Score regression [18],
Erzφ,jzψ,j|ljs “
?
n1n2ρg
p
lj ` ρns?
n1n2
, (4.9)
where zφ,j, zψ,j are the Z-scores of SNP j in the two traits, and lj the LD score of SNP j.
Cross-trait LD Score regression regresses the product of Z-scores at each SNP against its
LD score, lj, and accounts for bias generated by overlapping samples through the intercept
term, ρns?
n1n2
[18], from which one can obtain an estimate of phenotypic covariance, ρ.
In the special case when βˆgwas and γˆgwas are obtained for the same trait on the same set
of individuals (i.e. βˆgwas “ γˆgwas, n1 “ n2 “ ns, ρ “ 1) Equation (4.7) reduces to the
local SNP-heritability estimator [140]. When ns “ 0 (i.e. no shared individuals between the
GWASs), the unbiased estimator is simply ρˆg,local “ βˆᵀgwasV ´1γˆgwas. An interpretation for
this simple formula is that in the absence of sample overlap, the covariance in the noise, 
and δ, is 0 and does thus not introduce bias into the estimate of ρg,local.
Following bilinear form theory [138], we can estimate the variance for ρˆg,local as,
Varrρˆg,locals “
ˆ
n1n2
n1n2 ´ nsp
˙2 «ˆpρens
n1n2
˙2
` σ
2
σ
2
δp
n1n2
` σ
2
δh
2
gφ,local
n2
` σ
2
h
2
gψ,local
n1
` 2nsρeρg,local
n1n2
ff
(4.10)
For rank deficient LD matrix with rankpV q “ q, one replaces p with q in Equation (4.10).
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4.2.5 Accounting for statistical noise in LD estimates
Limited sample size of external reference panels creates statistical noise in the estimated LD
matrix that biases our estimates. Following our previous work [140], we apply truncated-SVD
regularization [57] to remove noise in external reference LD. We note that βˆ
ᵀ
gwasV
:γˆgwas “řq
i“1 si “
řq
i“1
1
wi
pβˆᵀgwasuiqpγˆᵀgwasuiq, where wi, ui are the eigenvalues and eigenvectors of
the LD matrix V , and q “ rankpV q. We use sˆi “ 1wˆi pβˆ
ᵀ
gwasuˆiqpγˆᵀgwasuˆiq, to denote the
counterpart obtained from external reference LD matrix Vˆ . We show through simulations
that the bulk of βˆ
ᵀ
gwasV
:γˆgwas comes from si where i ! q and that si « sˆi for i ! q,
thus justifying truncated-SVD as an appropriate regularization method when only external
reference LD (Vˆ ) is available.
Let gpβˆgwas, γˆgwas, kq “
řk
i“1 sˆi “
řk
i“1
1
wˆi
pβˆᵀgwasuˆiqpγˆᵀgwasuˆiq, be the truncated-SVD regu-
larized estimates for βˆ
ᵀ
gwasV
:γˆgwas, then it can be shown that
Ergpβˆgwas, γˆgwas, kqs “ nskpρ´ ρgqn1n2 `
kÿ
i“1
wˆipβᵀuˆiqpγᵀuˆiq. (4.11)
Assuming wˆi “ wi and uˆi “ ui for i ! k, Equation (4.11) is a biased approximation of
ρg,local, with bias
nskpρ´ρgq
n1n2
. Correcting for the bias, we arrive at the estimator
ρˆg,local “ n1n2gpβˆgwas, γˆgwas, kq ´ nsρk
n1n2 ´ nsk , (4.12)
which has variance
Varrρˆg,locals “
ˆ
n1n2
n1n2 ´ nsk
˙2 «ˆ
kρens
n1n2
˙2
` σ
2
σ
2
δk
n1n2
` σ
2
δh
2
gφ,local
n2
` σ
2
h
2
gψ,local
n1
` 2nsρeρg,local
n1n2
ff
(4.13)
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4.2.6 Extension to multiple independent regions
For genome partitioned into m regions, let
φ “ xᵀ1β1 ` ¨ ¨ ¨ ` xᵀmβm ` 
ψ “ xᵀ1γ1 ` ¨ ¨ ¨ ` xᵀmγm ` δ,
(4.14)
denote the phenotype measurements of two traits at an individuals, where we assume that
SNPs in different pairs of regions are independent, i.e. Erxikxils “ 0 for all i ‰ j, k P
t1, ¨ ¨ ¨ , piu, and l P t1, ¨ ¨ ¨ , pju, where pi and pj are the number of SNPs in region i and
j. Under these assumptions, we decompose the phenotypic covariance, ρ, between φ and ψ,
into a summation of per-region genetic covariance and environmental covariance
ρ “ Covrφ, ψs “ Erpxᵀ1β1 ` ¨ ¨ ¨ ` xᵀmβm ` qpxᵀ1γ1 ` ¨ ¨ ¨ ` xᵀmγm ` δqᵀs
“ Erpxᵀ1β1qpxᵀ1γ1qs ` ¨ ¨ ¨ ` Erpxᵀmβmqpxᵀmγmqs ` Erδs
“
mÿ
i“1
Covrxᵀiβi,xᵀiγis ` Covr, δs “
mÿ
i“1
βᵀiV iγi ` ρe
, (4.15)
where ρg,local,i “ Covrxᵀiβi,xᵀiγis “ βᵀiV iγi is the local genetic covariance between the pair
of traits attributed to genetic variants at region i. Following strategies outlined in previous
sections, we arrive at the estimator for genetic covariance at the i-th region,
ρˆg,local,i “
n1n2gpβˆgwas,i, γˆgwas,i, kq ´ nspρ´
řm
j“1,j‰i ρˆg,local,jqki
n1n2 ´ nski , (4.16)
which defines a system of linear equation involving m unknown variables and m equations.
Following bilinear form theory, we obtain variance estimate for ρˆg,local,i as,
Varrρˆg,local,is “
ˆ
n1n2
n1n2 ´ nski
˙2 «ˆkiρens
n1n2
˙2
` σ
2
σ
2
δki
n1n2
` σ
2
δh
2
gφ,local,i
n2
` σ
2
h
2
gψ,local,i
n1
` 2nsρeρg,local,i
n1n2
ff
`
mÿ
j“1,j‰i
ˆ
nskj
n1n2 ´ nski
˙2
Varrρˆg,local,js
(4.17)
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which also defines a system of linear equations with m equations and m variables. In the
special case where there is no sample overlap (ns “ 0), ρˆg,local,i reduces to gpβˆgwas, γˆgwas, kq
with Varrρˆg,local,is “ σ2σ2δkin1n2 `
σ2δh
2
gφ,local,i
n2
` σ2h2gψ,local,i
n1
« σ2σ2δki
n1n2
, i.e. both the local genetic
covariance and its variance can be estimated independent of all other windows.
When k1 “ ¨ ¨ ¨ “ km “ k, i.e. all regions use the same number of eigenvectors in the
truncated-SVD regularization, summing over i on both sides of Equation (4.16) yields
ρˆg “
ÿ
i“1
ρˆg,local,i “ n1n2
n1n2 ´ nsk
mÿ
i“1
gpβˆgwas,i, γˆgwas,i, kq ´ knsn1n2 ´ nsk
mÿ
i“1
˜
r ´
mÿ
j“1,j‰i
ρˆg,local,j
¸
“ n1n2
n1n2 ´ nsk
mÿ
i“1
gpβˆgwas,i, γˆgwas,i, kq ´ knsn1n2 ´ nsk
mÿ
i“1
pρ´ ρˆg ` ρˆg,local,iq
“ n1n2
n1n2 ´ nsk
mÿ
i“1
gpβˆgwas,i, γˆgwas,i, kq ` knsm´ knsn1n2 ´ nsk ρˆg ´
knsmρ
n1n2 ´ nsk .
(4.18)
Solving for ρˆg yields
ρˆg “ n1n2
řm
i“1 gpβˆgwas,i, γˆgwas,i, kq ´ knsmρ
n1n2 ´ knsm , (4.19)
which has variance
Varrρˆgs “
ˆ
n1n2
n1n2 ´ knsm
˙2 mÿ
i“1
Varrgpβˆgwas,i, γˆgwas,i, kqs. (4.20)
Thus, if k is chosen such that pn1n2 ´ knsmq is small (i.e. n1n2n1n2´knsm large), the estimate
of total genetic covariance will have large standard error. To reduce standard error in the
estimates (at the cost of some bias), we recommend choosing k such that n1n2
n1n2´knsm is less
than 2. When testing for statistical significance, we assume that the estimates of local and
genome-wide genetic covariance and correlation follow a normal distribution.
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4.2.7 Standardizing local genetic covariance
We estimate the local genetic correlation for the i-th region as
rˆg,local,i “ ρˆg,local,ib
hˆ2gφ,local,i
b
hˆ2gψ,local,i
, (4.21)
where hˆ2gφ,local,i and hˆ
2
gψ,local,i denote the local SNP-heritability of trait φ and ψ at the i-th
region. In some cases, this estimator of local genetic correlation may yield an estimate with
magnitude greater than 1, and we cap the estimate at -1 or 1. In simulations, we show
that rˆg,local,i is approximately unbiased when both traits are heritable at the i-th region. In
practice, however, the terms, hˆ2gφ,local,i and hˆ
2
gψ,local,i, can be close to zero, greatly inflating the
standard error of rˆg,local,i. Thus, we recommend estimating local genetic correlation only at
regions with significant local SNP-heritability. One can also estimate local genetic correlation
at a set of regions. For example, to estimate genetic correlation at regions indexed by the
index set C, one applies the following formula,
rˆg,C “
ř
iPC ρˆg,local,ibř
iPC hˆ
2
φ,g,local,i
bř
iPC hˆ
2
ψ,g,local,i
, (4.22)
We estimate standard error of local genetic correlation at a single region through a parametric
bootstrap approach [39] and local genetic correlation at a set of regions through jackknife.
4.2.8 Simulation framework
Starting from half (202 individuals) of the EUR reference panel from the 1000 Genomes
Project[28], we simulated genotype data for 50,000 individuals at HapMap3[51] SNPs with
minor allele frequency (MAF) greater than 5% in 100 randomly selected LD-independent
regions defined in ref[12] on chromosome 1 using HAPGEN2[51]. We used the other half of
the EUR reference panel (203 individuals) to obtain external reference LD matrices.
We simulated phenotypes from the genotypes according to the linear model φ “Xβ` and
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ψ “Xγ ` δ, where X is the column-standardized genotype matrix. We drew the effects of
causal SNPs (βC , γC) from the distribution
N
¨˝»– 0
0
fifl ,
»– h2gφ|C| I ρe|C|I
ρe
|C|I
h2gψ
|C| I
fifl‚˛, (4.23)
where C is the index set of causal SNPs, and set the effects of all other SNPs to be zero. We
then drew (, δ) from the distribution
N
¨˝»– 0
0
fifl ,
»– p1´ h2gφqI ρeI
ρeI p1´ h2gψqI
fifl‚˛. (4.24)
Finally, we simulated GWAS summary statistics using methods outlined in previous sections.
For each β and γ drawn from the normal distribution, we simulated 1000 sets of summary
statistics by varying  and δ, and applied ρ-HESS to estimate genetic covariance and genetic
correlation for each set of the simulated summary statistics.
4.2.9 Empirical data sets
We obtained GWAS summary data for 36 quantitative complex traits and diseases from
15 GWAS consortia or institutions (see Table 4.1), all of which are based on individuals
of European ancestry, and have sample size greater than 20,000. We used approximately
independent genomic regions defined in ref[12] to partition the genome, and restricted our
analyses on HapMap3 SNPs with minor allele frequency (MAF) greater than 5% in the
European population in the 1000 Genomes data [28]. We also removed stand-ambiguous
SNPs prior to our analyses. We follow the method outlined in ref[140] to estimate and re-
inflate λgc, and to choose the number of eigenvectors to include in estimating local genetic
covariance and SNP-heritability.
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4.2.10 Local genetic correlation at regions ascertained for GWAS signals
Recent works leverage the difference in correlations of Z-scores at genomic regions ascertained
for GWAS signals specific to each trait to prioritize putative causal models between pairs
of complex traits [125, 98]. We evaluated the local genetic correlation at regions harboring
GWAS signals specific to each trait across all 298 pairs of traits exhibiting significant genome-
wide genetic correlation. We estimate local genetic correlations only for pairs of traits for
which the number of loci harboring GWAS hits specific to each trait is greater than 10. The
confidence intervals (1.96 times jackknife standard error on each side) of the ascertained
local genetic correlations (rˆg,local,trait1 and rˆg,local,trait2) do not overlap; one of the confidence
intervals overlap with 0 and the other does not.
4.3 Results
4.3.1 Local genetic correlation estimation in simulations
We evaluated the performance of our approach (ρ-HESS) through simulations across a wide-
range of disease architectures. We included cross-trait LDSC [18], an approach that assumes
a random-effect model, in the comparison for completeness purposes. When LD is estimated
in-sample, ρ-HESS provides an unbiased estimate of local genetic covariance and nearly
unbiased estimates of genetic correlation (i.e. genetic covariance divided with the square
root of local SNP heritability, see Methods). Next, we quantified the performance in the
more realistic case when in-sample LD is unavailable and needs to be estimated from external
reference panels. Although both cross-trait LDSC and ρ-HESS provide accurate estimates of
genetic correlation, we observe superior accuracy with higher precision for ρ-HESS (Figure
4.4, S4, S6, S7). We attribute the lower standard error of ρ-HESS to the truncated-SVD
regularization of the LD matrix which effectively reduces the degree of freedom of the bi-
linear form in Equation (4.7). Different genomic regions vary in their total amount of LD
and we observed that the accuracy of genetic correlation estimation decreases with the total
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amount of regional LD. This is expected as high LD regions lead to high rank deficiencies
in the LD matrix and small eigenvalues, thus increasing the level of statistical noise in
the estimation. We also evaluated the performance of local genetic correlation estimation in
simulations where we varied the number of causal variants in each region. Overall, we observe
that our estimator of genetic covariance and correlation is not sensitive to the underlying
polygenicity (i.e. number of causal SNPs) (Figure 4.4 S5, S8, S9). Finally, we also evaluated
the performance of the estimator when causal variants are all drawn from DHS regions[157],
and observed that the performance is not sensitive to the uneven distribution of causal
variants.
4.3.2 Local genetic correlation across 36 quantitative traits
We analyzed GWAS summary data from 36 complex traits to obtain local genetic correla-
tions at 1,703 approximately LD-independent regions in the genome („1.6Mb in width on
average)[12]. First, as a quality control step, we aggregated the local estimates into genome-
wide estimates of genetic correlation (see Methods) and compared to the cross-trait LDSC
estimates. Reassuringly, we find a high degree of consistency with genetic correlations esti-
mated by cross-trait LDSC regression (R “ 0.77, Figure 4.5, S13). Our estimator provides
lower standard errors as compared to cross-trait LDSC (likely due to the truncated-SVD regu-
larization procedure), and yields consistently lower estimates for pairs of traits from the same
consortium where we conservatively assume full sample overlap (see Discussion). Overall, we
identify 298 pairs of traits with significant genome-wide genetic correlation (p ă 0.05{630).
These include previously reported correlations, e.g. body mass index (BMI) and triglyceride
(TG), as well as complex traits that have not been studied before using genetic correlation,
e.g. red blood cell count (RBC) and fasting insulin (FI) (Figure 4.5).
Next, we searched for genomic regions that disproportionately contribute to the genetic cor-
relation of the 36 analyzed traits; we excluded the HLA region due to complex LD patterns.
We identify 25 genomic regions that show both significant local genetic correlation (two-tailed
p ă 0.05{1703{630) as well as significant local SNP-heritability (one-tailed p ă 0.05{1703{36)
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(see Table 4.2). For example, the estimate of local genetic correlation between HDL and TG
at chr11:116-117Mb is -0.82 (95% CI [-0.95, -0.69]), suggesting highly shared genetic archi-
tecture at this region for HDL and TG. Indeed, the region chr11:116-117M harbors APOA1
(MIM 107680), which is known to be associated with multiple lipid traits [29]. Interestingly,
4 out of the 25 regions do not contain GWAS significant SNPs (p ă 5e´ 8) for either one or
both traits and can be viewed as new risk regions for these traits.
Since genetic correlation is an aggregation of local genetic covariance, for pairs of traits with
highly positive or negative genetic correlation, we expect the distribution of local genetic
covariances to be shifted towards the positive or negative side (see Figure 4.6); whereas
for pairs of traits with low genetic correlation, we expect the distribution of local genetic
covariances to be centered around zero (see Figure 4.7, 4.8). Indeed, pairs of traits with
higher genome-wide genetic correlation tend to harbor more loci with significant local genetic
covariance. For instance, only one region exhibits significant local genetic covariance for the
pair of traits age at menarche (AM) and height (rg “ 0.13, 95% CI [0.10, 0.13]), whereas four
loci show significant local genetic covariance for the pair of traits LDL and TG (rg “ 0.45,
95% CI [0.42, 0.49]).
4.3.3 Local correlations for pairs of traits with negligible genome-wide correla-
tion
Several pairs of traits show negligible genome-wide genetic correlation although they share
GWAS risk regions. For example HDL and LDL share several GWAS risk loci[29] but the
genome-wide genetic correlation is negligible (-0.05, 95% CI [-0.09, -0.01]) [18]. The absence
of significant genome-wide genetic correlation between these pairs of traits can be attributed
to either symmetric distribution of local genetic covariance (positive local genetic covariance
cancels out negative local genetic covariance, see Figure 4.1) and/or lack of power to declare
significance for genome-wide genetic correlation. Thus, we hypothesize that at the region-
specific level, many loci may manifest significant local genetic covariance even if the genome-
wide genetic correlation between a pair of traits is not significant. Indeed, 11 genomic regions
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show significant local genetic correlation (two-tailed p ă 0.05{1703) for HDL and LDL (see
Figure 4.7). Some of these loci, e.g. chr2:21M-23M, chr11:116M-117M, and chr19:44M-
46M, harbor APOB, APOA1, and APOE (MIM 107741), respectively, which are known
to be involved in lipid genetics[48, 118, 29]. Across all pairs of traits with non-significant
genome-wide correlation, we identify 6 regions across 10 pairs of traits with significant local
genetic correlation (two-tailed p ă 0.05{1703{630) and local SNP-heritability (one-tailed
p ă 0.05{1703{36) (see Table 4.2). For example the region chr6:134-136M harbors HBS1L
(MIM 612450) [148, 160], and contributes to local genetic covariance across many blood
traits (MCH, MCV, RBC, and PLT).
4.3.4 Genetic correlation ascertained for GWAS risk loci
Assessing the correlation in the effects at genomic regions ascertained for trait-specific GWAS
regions can be used to prioritize putative causal models between complex traits. We utilized
a recently proposed approach[125] to assign putative causal relation to 55 pairs of traits.
Restricting to 40 of the 55 pairs of traits that contain at least 10 regions with trait-specific
GWAS signals (see Methods), we quantified the local genetic correlation at genomic regions
containing GWAS loci specific to each trait (see Table 4.4, Figure 4.9). Overall, the local
genetic correlation is highly consistent with the putative causal relationships inferred by
correlating the top signals at these loci[125]. For example, when considering body mass index
(BMI) and triglyceride levels (TG), the correlation at BMI-specific regions is significantly
greater than TG-specific loci (rˆg,local,BM “ 0.47 95% CI [0.37, 0.57] vs. rˆg,local,TG “ ´0.02
95% [-0.14, 0.10]), indicating that loci that increase BMI tend to consistently increase TG,
whereas loci that increase TG do not consistently affect BMI, consistent with the putative
model that BMI causally increases TG [125, 98]. We also observe correlations consistent
with a model in which years of education (EY) consistently decreases hemoglobin level
(HB), LDL, TG (see Table 4.4), in line with previous conclusions on the effect of education
on health [143, 7]. However, we note that education attainment (or other studied traits) may
be confounded by other factors such as social status and that one should exercise caution
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when inferring causality from genetic data. Finally, we also report pairs of traits in which the
genetic correlation approach attains different results form bi-directional regression on the top
signals[125]. For example, when considering body mass index (BMI) and age at menarche
(AM), the local correlation approach do not yield different estimates (rg,local,BMI “ ´0.49
95% CI [-0.63, -0.35] vs rg,local,AM “ ´0.47 95% CI [-0.59, -0.35]), whereas the approach of
ref [125] suggests a putative causal relation. This discrepancy can be due to different model
assumptions, e.g., single causal variant versus allelic heterogeneity, with further investigations
needed to assign causality from these data.
4.4 Discussion
We have described ρ-HESS, a method to estimate local genetic correlation from GWAS sum-
mary association data. Through extensive simulations, we demonstrated that our method
is approximately unbiased and provides consistent results irrespective of causal architec-
ture. We analyzed large-scale GWAS summary association data of 36 quantitative traits.
Compared with cross-trait LDSC, our methods identified considerably more pairs of traits
displaying significant genome-wide genetic correlation likely because of the truncated-SVD
regularization of the LD matrix, which decreases the standard error of the estimates. We
identify genomic regions that are significantly correlated across pairs of traits regardless of
the significance of genome-wide correlation. Finally, we performed bi-directional analyses
over the local genetic correlations to identify putative causal relationships, and report local
genetic correlations at loci harboring GWAS signal specific to each trait.
We conclude with several limitations highlighting areas for future work. First, our estimator
requires phenotype correlation between two traits, as well as the number of shared individ-
uals between the two GWASs. We estimate the phenotype correlation through cross-trait
LDSC assuming full sample overlap between GWAS within the same consortium and no sam-
ple overlap between GWAS across two consortia. Second, we note that our bi-directional
analyses over local genetic correlation can be further extrapolated to infer putative causal
75
models between complex traits. We refrain from making conclusive causal inferences from
the bi-directional analyses because exact inference of causal relations is largely complicated
by unobserved confounders such as socioeconomic status, population stratification and/or bi-
ological pathways. Furthermore, most of the GWAS summary association data are adjusted
for covariates such as age, gender, to increase statistical power [104], and previous works
have shown that adjusting for covariates can potentially lead to false positives [4]. Third,
in our real data analyses, we made the assumption that the loci are independent of each
other. In reality however correlations may exist across adjacent loci due to long range LD,
and can lead to biased estimates. Nevertheless, we note that previous works have indicated
the effect of LD leakage to be minimal [91, 140], and we conjecture that this statement still
hold in estimating local genetic correlation. Lastly, we use truncated-SVD to regularize LD
matrix and to reduce standard error in the estimates of local genetic correlation, at the cost
of introducing bias. Currently, we use a fixed number of eigenvectors in the truncated-SVD
regularization, across all the loci. However, this approach may not be optimal for genomic
regions with different LD structure, and leave a principled approach of estimating the number
of eigenvectors as future work.
4.5 Appendix
4.5.1 Quantifying shared genetics via covariance of the causal effects
An alternative measure of shared genetics is the covariance of the causal effects (β and γ)
of the two traits. Under the fixed-effect model, we define covariance of the causal effects,
ρg,causal, as the dot product between the causal effect size vectors of the two traits,
ρg,causal “ βᵀγ. (4.25)
Here, we make the assumption that the average effect size of each SNP is 0.
The definition of covariance of the causal effects in Equation (4.25) coincides with genetic
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covariance under the random-effect model. As shown in the supplementary of [18], if one
assumes that β and γ have zero mean and
Varrpβ,γqs “ 1
p
»– h2gφ ρg
ρg h
2
gψ
fifl , (4.26)
then it can be shown that the genetic covariance between two traits is
Covrxᵀβ,xᵀγs “
pÿ
i“1
pÿ
j“1
Erxixjβiγjs “
pÿ
i“1
Erx2iβiγis “
pÿ
i“1
Erx2i sErβiγis “ ρg. (4.27)
The random-effect model makes the implicit assumption that many SNPs are causal, which
is appropriate for genome-wide analysis but not for local analysis, where few SNPs are likely
to be causal.
4.5.2 Estimating covariance of the causal effects from GWAS summary data
For completeness, we derive an estimator for ρg,causal. We assume a linear model for the
two traits (see Methods). The effect size estimates from GWAS, βˆgwas and γˆgwas, follow
βˆgwas „ N
´
V β,
1´h2φ
n1
V
¯
and γˆgwas „ N
´
V γ,
1´h2φ
n2
V
¯
, with Covrβˆgwas, γˆgwass “ ρensn1n2V ,
where n1 and n2 are the sample size for the two GWASs, and ns is the number of shared
samples (see Methods).
As the sample size, n1 and n2, of the two GWASs go to infinity, we have βgwas “ limnÑ8 βˆgwas “
V β and γgwas “ limnÑ8 γˆgwas “ V γ, which implies β “ V ´1βgwas and γ “ V ´1γgwas,
suggesting the following estimator for covariance of the causal effects,
ρg,causal “ βᵀγ “ βᵀgwasV ´2γgwas. (4.28)
In reality, however, finite sample sizes of GWAS results in noise in the estimates of β and
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γ, creating bias in the estimate of ρg,causal. From bilinear form theory, it can be shown that
ErβˆᵀgwasV ´2γˆgwass “ βᵀγ ` ρen trpV
´2V q “ βᵀγ ` ρe
n
trpV ´1q, (4.29)
suggesting the unbiased estimator of ρg,causal,
ρˆg,causal “ βˆᵀgwasV ´2γˆgwas ´ nsρen1n2 trpV
´1q, (4.30)
where the environmental covariance can be estimated through cross-trait LD Score regression
[18].
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4.6 Tables
Table 4.1: A summary of the 36 GWAS summary data sets analyzed.
Trait Name Abbreviation Consortium # gen corr
all
consortium
# gen corr
outside
consortium
Approx.
sample size
Age at Menarche [124] AM REPROGEN 21 (4) 21 (4) 133K
Body Mass Index [90] BMI GIANT 27 (17) 23 (14) 231K
Height [165] HEIGHT GIANT 17 (2) 13 (1) 241K
Hip Circumference [142] HIP GIANT 23 (14) 19 (10) 144K
Waist Circumference [142] WC GIANT 26 (18) 22 (15) 153K
Waist-to-hip Ratio [142] WHR GIANT 27 (19) 23 (16) 143K
Haemoglobin [160] HB HAEMGEN 21 (10) 18 (8) 51K
Mean Cell Haemoglobin [160] MCH HAEMGEN 9 (1) 8 (1) 44K
MCH Concentration [160] MCHC HAEMGEN 6 (4) 2 (1) 47K
Mean Cell Volume [160] MCV HAEMGEN 12 (3) 10 (1) 49K
Packed Cell Volume [160] PCV HAEMGEN 18 (11) 14 (8) 45K
Red Blood Cell Count [160] RBC HAEMGEN 20 (10) 17 (8) 46K
Number of Platelets [52] PLT HAEMGEN 9 (1) 6 (1) 67K
Fasting Glucose [38] FG MAGIC 19 (9) 16 (8) 46K
Fasting Insulin [38] FI MAGIC 20 (12) 18 (12) 46K
HBA1C [147] HBA1C MAGIC 19 (14) 18 (13) 46K
HOMA-B [38] HOMA-B MAGIC 17 (11) 15 (11) 46K
HOMA-IR [38] HOMA-IR MAGIC 21 (12) 21 (12) 46K
High Density Lipoprotein [29] HDL LIPID 23 (12) 21 (11) 96K
Low Density Lipoprotein [29] LDL LIPID 19 (6) 17 (4) 91K
Total Cholesterol [29] TC LIPID 18 (3) 15 (1) 96K
Triglycerides [29] TG LIPID 26 (14) 23 (11) 92K
Forearm BMD [176] FA GEFOS 4 (1) 2 (0) 53K
Femoral Neck BMD [176] FN GEFOS 4 (2) 2 (0) 53K
Lumbar Spine BMD [176] LS GEFOS 7 (1) 5 (0) 53K
Education Years [116] EY SSGAC 26 (5) 24 (4) 294K
Neuroticism [115] NEURO SSGAC 5 (2) 3 (0) 171K
Subjective Well-being [115] SWB SSGAC 4 (1) 2 (0) 298K
Age First Birth [8] AFB BIOS 23 (5) 23 (5) 251K
Birth Weight [63] BW EGG 13 (1) 13 (1) 68K
Urinary Albumin-to-Creatinine Ratio [155] UACR DCCT-EDIC 11 (1) 11 (1) 53K
Rest Heart Rate [42] HR EPPINGA 14 (0) 14 (0) 265K
Serum Urate Concentrations [76] URATE GUGC 25 (14) 25 (14) 107K
Body Fat [93] BF Lu 26 (17) 26 (17) 58K
Extra-Glomerular Filtration Rate of Creatinin [123] CRN CKDGEN 10 (1) 10 (1) 133K
Age at Menopause [33] MP BCAC 6 (0) 6 (0) 70K
We list the total number of traits with significant non-zero genome-wide genetic correlation
(two-tailed p ă 0.05{630) and the total number of traits outside the consortium with signif-
icant non-zero genome-wide genetic correlation in the fourth and fifth column, respectively.
Number of traits for which the magnitude of genetic correlation is both significantly non-zero
and greater than 0.2 is shown in parentheses.
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Table 4.2: Loci that show significant local genetic covariance (two-tailed p ă
0.05{1703{630) and local SNP heritability (one-tailed p ă 0.05{1703{36) for both
traits.
Trait1 Trait2 Locus h2g,local,trait1 h
2
g,local,trait2 rg,local
AM HEIGHT chr9:107-109M 0.15 (0.02) 0.05 (0.01) 0.61 ([0.34,0.87])
BMI HIP chr16:53-55M 0.22 (0.02) 0.19 (0.03) 0.99 ([0.76,1.00])
BMI HIP chr18:57-59M 0.14 (0.02) 0.13 (0.02) 0.99 ([0.71,1.00])
BMI WC chr16:53-55M 0.22 (0.02) 0.21 (0.03) 1.00 ([0.78,1.00])
BMI WC chr18:57-59M 0.14 (0.02) 0.13 (0.02) 1.00 ([0.72,1.00])
BW HEIGHT chr12:65-67M 0.14 (0.02) 0.23 (0.02) 0.93 ([0.70,1.00])
HDL TG chr2:21-23M 0.16 (0.03) 0.22 (0.03) -0.94 ([-1.00,-0.65])
HDL TG chr8:19-20M 0.65 (0.04) 0.82 (0.04) -1.00 ([-1.00,-0.91])
HDL TG chr11:116-117M 0.40 (0.04) 1.27 (0.06) -0.82 ([-0.95,-0.69])
HDL TG chr15:58-59M 1.18 (0.06) 0.18 (0.03) 0.89 ([0.68,1.00])
HEIGHT HIP chr16:4-5M 0.06 (0.01) 0.10 (0.02) 0.73 ([0.41,1.00])
HIP WC chr16:53-55M 0.19 (0.03) 0.21 (0.03) 0.99 ([0.73,1.00])
HIP WC chr18:57-59M 0.13 (0.02) 0.13 (0.02) 1.00 ([0.69,1.00])
LDL TG chr1:61-63M 0.14 (0.03) 0.28 (0.03) 0.98 ([0.67,1.00])
LDL TG chr2:21-23M 0.84 (0.05) 0.22 (0.03) 0.62 ([0.46,0.78])
LDL TG chr8:126-128M 0.16 (0.03) 0.32 (0.04) 0.94 ([0.63,1.00])
LDL TG chr19:18-19M 0.18 (0.03) 0.21 (0.03) 0.99 ([0.72,1.00])
PLT RBC chr6:134-136M 0.26 (0.05) 0.66 (0.09) -0.99 ([-1.00,-0.69])
HDL HEIGHT chr11:47-49M 0.17 (0.02) 0.07 (0.01) 0.61 ([0.42,0.80])
HDL LDL chr2:21-23M 0.16 (0.03) 0.84 (0.05) -0.56 ([-0.74,-0.39])
HDL LDL chr8:9-9M 0.14 (0.02) 0.12 (0.02) 0.99 ([0.70,1.00])
MCH MCV chr6:24-25M 0.49 (0.07) 0.37 (0.06) 0.97 ([0.67,1.00])
MCH MCV chr6:134-136M 0.86 (0.09) 0.70 (0.08) 0.98 ([0.76,1.00])
MCH PLT chr6:134-136M 0.86 (0.09) 0.26 (0.05) 1.00 ([0.72,1.00])
MCH RBC chr6:134-136M 0.86 (0.09) 0.66 (0.09) -0.98 ([-1.00,-0.75])
MCV PLT chr6:134-136M 0.70 (0.08) 0.26 (0.05) 1.00 ([0.72,1.00])
MCV RBC chr6:134-136M 0.70 (0.08) 0.66 (0.09) -0.98 ([-1.00,-0.74])
MP HEIGHT chr5:175-177M 0.31 (0.04) 0.10 (0.01) -0.63 ([-0.82,-0.45])
URATE MCH chr6:24-25M 0.13 (0.02) 0.53 (0.07) 0.56 ([0.33,0.79])
URATE MCV chr6:24-25M 0.13 (0.02) 0.41 (0.06) 0.66 ([0.39,0.92])
We list pairs of traits for which the genome-wide genetic correlation is significant (two-tailed
p ă 0.05{630) and negligible in top and bottom half of this table, respectively. Here, we
focus only on the pairs of traits excluding TC (see Table 4.3 for pairs of traits involving
TC). Numbers in parentheses represent standard errors for local SNP heritability estimates
and 95% confidence intervals for local genetic correlation estimates.
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Table 4.3: Loci that show significant local genetic covariance (two-tailed p ă
0.05{1703{630) and local SNP heritability (one-tailed p ă 0.05{1703{36) for both
traits.
Trait1 Trait2 Locus h2g,local,trait1 h
2
g,local,trait2 rg,local
HDL TC chr2:21-23M 0.16 (0.03) 0.63 (0.04) -0.50 ([-0.67,-0.33])
HDL TC chr8:9-9M 0.14 (0.02) 0.16 (0.02) 0.98 ([0.74,1.00])
HDL TC chr9:107-109M 0.28 (0.03) 0.19 (0.03) 0.90 ([0.65,1.00])
HDL TC chr11:116-117M 0.40 (0.04) 0.27 (0.03) -0.41 ([-0.55,-0.27])
HDL TC chr15:58-59M 1.18 (0.06) 0.31 (0.03) 0.98 ([0.83,1.00])
LDL TC chr1:61-63M 0.14 (0.03) 0.28 (0.03) 0.97 ([0.67,1.00])
LDL TC chr1:108-110M 0.74 (0.05) 0.52 (0.04) 1.00 ([0.88,1.00])
LDL TC chr2:21-23M 0.84 (0.05) 0.63 (0.04) 1.00 ([0.87,1.00])
LDL TC chr2:43-44M 0.31 (0.03) 0.31 (0.03) 1.00 ([0.91,1.00])
LDL TC chr5:73-75M 0.28 (0.03) 0.24 (0.03) 1.00 ([0.76,1.00])
LDL TC chr5:155-156M 0.11 (0.02) 0.13 (0.02) 0.98 ([0.58,1.00])
LDL TC chr8:9-9M 0.12 (0.02) 0.16 (0.02) 1.00 ([0.72,1.00])
LDL TC chr8:126-128M 0.16 (0.03) 0.19 (0.03) 0.98 ([0.61,1.00])
LDL TC chr16:71-72M 0.19 (0.03) 0.19 (0.03) 0.99 ([0.70,1.00])
LDL TC chr19:9-11M 0.49 (0.04) 0.33 (0.03) 1.00 ([0.81,1.00])
LDL TC chr19:18-19M 0.18 (0.03) 0.26 (0.03) 0.99 ([0.74,1.00])
LDL TC chr19:44-46M 0.77 (0.05) 0.43 (0.04) 1.00 ([0.86,1.00])
TC TG chr1:61-63M 0.28 (0.03) 0.28 (0.03) 0.99 ([0.77,1.00])
TC TG chr2:21-23M 0.63 (0.04) 0.22 (0.03) 0.60 ([0.43,0.76])
TC TG chr8:126-128M 0.19 (0.03) 0.32 (0.04) 0.96 ([0.69,1.00])
TC TG chr11:116-117M 0.27 (0.03) 1.27 (0.06) 0.89 ([0.73,1.00])
TC TG chr15:58-59M 0.31 (0.03) 0.18 (0.03) 0.97 ([0.69,1.00])
TC TG chr19:18-19M 0.26 (0.03) 0.21 (0.03) 0.98 ([0.75,1.00])
Here, we focus only on the pairs of traits involving TC. The genome-wide genetic correlation
of each pair of traits is also significant (two-tailed p ă 0.05{630). Numbers in parentheses
represent standard errors for local SNP heritability estimates and 95% confidence intervals
for local genetic correlation estimates.
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Table 4.4: Bi-directional analysis of local genetic correlation identifies 40 pairs of
traits for which one is likely a causal factor of the other.
Trait1 rˆg,local,trait1 No. loci Trait2 rˆg,local,trait2 No. loci Direction Ratio
AM -0.47 (0.06) 54 BMI -0.49 (0.07) 51 BMI Ó AM 0.00e+00
AM 0.26 (0.05) 39 HEIGHT 0.09 (0.02) 429 AM Ò HEIGHT 0.00e+00
AM -0.18 (0.05) 60 HIP -0.26 (0.08) 36 HIP Ó AM 7.00e-05
AM -0.23 (0.05) 58 WC -0.36 (0.09) 28 WC Ó AM 1.09e-04
BMI -0.25 (0.06) 60 EY -0.35 (0.04) 133 EY Ó BMI 0.00e+00
BMI -0.47 (0.05) 57 HDL -0.18 (0.04) 81 BMI Ó HDL 0.00e+00
BMI -0.02 (0.04) 39 HEIGHT -0.16 (0.02) 432 HEIGHT Ó BMI 0.00e+00
BMI 0.95 (0.02) 32 HIP 0.77 (0.11) 11 BMI Ò HIP 0.00e+00
BMI 0.47 (0.05) 59 TG -0.02 (0.06) 60 BMI Ò TG 0.00e+00
URATE 0.07 (0.08) 28 BMI 0.55 (0.05) 64 BMI Ó URATE 1.80e-05
BMI 0.69 (0.03) 58 WHR 0.13 (0.13) 22 BMI Ò WHR 0.00e+00
BW -0.22 (0.05) 41 URATE -0.08 (0.09) 28 URATE Ó BW 0.00e+00
URATE -0.13 (0.05) 22 CRN -0.36 (0.08) 36 URATE Ó CRN 1.00e-06
CRN 0.04 (0.06) 41 WHR 0.07 (0.09) 27 CRN Ó WHR 2.06e-04
EY -0.19 (0.05) 138 HB -0.05 (0.10) 15 EY Ó HB 1.00e-06
EY 0.22 (0.03) 134 HDL 0.08 (0.03) 85 EY Ò HDL 3.91e-04
EY 0.16 (0.03) 100 HEIGHT 0.16 (0.02) 420 HEIGHT Ò EY 0.00e+00
EY -0.24 (0.04) 133 NEURO -0.14 (0.11) 11 EY Ó NEURO 0.00e+00
EY -0.20 (0.03) 134 TG -0.05 (0.05) 62 EY Ó TG 0.00e+00
EY -0.30 (0.03) 134 WC -0.25 (0.08) 34 EY Ó WC 0.00e+00
EY -0.34 (0.03) 136 WHR -0.17 (0.06) 27 EY Ó WHR 0.00e+00
HDL -0.12 (0.04) 81 HIP -0.50 (0.05) 36 HIP Ó HDL 2.00e-06
HDL -0.51 (0.07) 52 TG -0.48 (0.10) 29 HDL Ó TG 1.00e-06
HDL -0.25 (0.04) 82 WC -0.64 (0.05) 31 WC Ó HDL 0.00e+00
HDL -0.27 (0.06) 79 WHR -0.59 (0.12) 19 WHR Ó HDL 6.82e-04
HEIGHT 0.44 (0.01) 432 HIP 0.25 (0.06) 18 HEIGHT Ò HIP 0.00e+00
HEIGHT -0.09 (0.02) 420 LDL -0.01 (0.04) 30 HEIGHT Ó LDL 0.00e+00
HEIGHT -0.14 (0.02) 446 PLT -0.08 (0.13) 17 HEIGHT Ó PLT 0.00e+00
HEIGHT -0.12 (0.02) 415 TC -0.05 (0.05) 40 HEIGHT Ó TC 0.00e+00
HEIGHT -0.08 (0.02) 429 TG -0.05 (0.05) 37 HEIGHT Ó TG 1.00e-06
HEIGHT 0.30 (0.02) 443 WC 0.17 (0.05) 23 HEIGHT Ò WC 0.00e+00
HIP 0.26 (0.07) 41 TG -0.09 (0.06) 63 HIP Ò TG 4.59e-04
HIP 0.44 (0.08) 37 WHR -0.14 (0.09) 22 HIP Ò WHR 7.00e-06
LDL 0.93 (0.03) 11 TC 0.80 (0.08) 26 TC Ò LDL 0.00e+00
URATE 0.05 (0.05) 29 MP -0.02 (0.05) 62 URATE Ò MP 1.33e-04
NEURO 0.08 (0.11) 17 PLT -0.04 (0.07) 30 NEURO Ò PLT 4.00e-06
TG 0.09 (0.05) 62 WC 0.56 (0.06) 34 WC Ò TG 0.00e+00
TG 0.28 (0.05) 59 WHR 0.57 (0.10) 22 WHR Ò TG 6.67e-04
URATE 0.07 (0.05) 30 WC 0.69 (0.06) 39 WC Ó URATE 9.70e-05
WC 0.80 (0.02) 29 WHR 0.60 (0.07) 20 WC Ò WHR 0.00e+00
Here, “Trait 1” and “Trait 2” refer to the trait for which the GWAS hit loci were ascertained
in the bi-directional analysis. Traits that are likely a causal factor of the other are marked
with stars. Numbers in parentheses represent standard errors of the local genetic correlation
estimates.
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4.7 Figures
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Figure 4.1: Examples of two different distributions of local genetic covariances
(shown at the top of each bar) that result in the same total genetic covariance
(ρg,total = 0.05). In the left example, the total genetic covariance is a summation of a
large positive local genetic covariance at Region1 and two smaller negative local genetic
covariances at Region2 and Region3 (e.g, Regions 2 and 3 impact traits through a different
pathway than Region1). In the right example, the total genetic covariance is a summation
of small positive local genetic covariances (e.g., all three regions impact both traits through
the same pathway). Positive local genetic covariance can be interpreted as a locus driving a
pathway that regulates two traits in the same direction, and negative local genetic covariance
the opposite direction.
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Figure 4.2: Distribution of simulated genetic covariance and causal effect covari-
ance across 100 LD-independent regions on chromosome 1 binned by average LD
between causal variants. The red lines represent the average local genetic covariance in
each bin. For each region, we simulated 2 traits, each with 3 causal variants with effect sizes
set to 0.01, and with no shared causal variants (see Figure 4.3 for the case where the two
traits share causal variants). Genetic covariance varies with respect to LD whereas causal
effect covariance is always 0 (horizontal dotted line). Since genetic covariance can be thought
as an upper bound of prediction accuracy using causal effects from one trait to another, a
positive genetic covariance indicates that non-zero prediction accuracy could be attained by
virtue of LD tagging.
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Figure 4.3: Distribution of simulated local genetic covariance and causal effect co-
variance across 100 LD-independent regions on chromosome 1 binned by average
LD between causal variants. The red lines represent the average local genetic covariance
in each bin. Both traits each have 3 causal variants with effect size set to 0.01, and share all
the causal variants. Here, local genetic covariance varies with respect to LD whereas local
causal effect covariance is fixed at 0.0003.
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Figure 4.4: Performance of ρ-HESS and cross-trait LDSC using external reference
LD across 100 LD-independent regions, with each region having 1000 simula-
tions. Here, each dot represents the mean (over 100 regions) of the average performance
(over 1000 simulations per region), with error bars representing 1.96 times the standard error
on both sides. Overall, ρ-HESS provides approximately unbiased estimates of local genetic
covariance (see Figure 4.4a) and correlation (see Figure 4.4b), and is not sensitive to the
underlying genetic architectures (see Figure 4.4c for covariance and 4.4d for correlation).
We also observe that ρ-HESS is less biased, more consistent, and has smaller standard error
than cross-trait LDSC.
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Figure 4.5: Genetic correlation across the 36 complex traits obtained by ρ-HESS
(top half) and cross-trait LDSC [18] (bottom half). The magnitude of the correlation
is represented by the color and the size of the square. Among the 630 pairs of traits, ρ-HESS
(cross-trait LDSC) identified 298 (115) pairs showing significant genetic correlation (marked
with dots)
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Figure 4.6: Distribution of standardized local genetic covariance (local genetic
covariance standardized by the square roots of total SNP-heritability of two
traits) for the pairs of traits BMI and TG, NEURO and RBC, AM and BMI.
Pairs of traits with positive (negative) genome-wide genetic correlation show a shift in the
distribution of standardized local genetic covariance away from 0.
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Figure 4.7: Manhattan-style plots showing the estimates of local genetic covariance
for the pairs of traits HDL and LDL. Although the genome-wide genetic correlation
between HDL and LDL does not reach the significance level (p ă 0.05{630), 11 loci exhibit
significant local genetic covariance.
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Figure 4.8: Manhattan-style plots showing the estimates of local genetic covariance
for the pairs of traits BMI and TG. That the local genetic covariance between BMI
and TG is mostly one-sided implies plausible causal relationship between the two traits
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Figure 4.9: Estimates of local genetic correlation at loci ascertained for GWAS
risk variants for 8 examples pairs of traits that show plausible causal relationship.
We obtained standard error using a jackknife approach. Error bars represent 1.96 times the
standard error on each side.
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CHAPTER 5
Dissecting genetic architectures of complex traits
specific to and shared by East Asian and European
populations
5.1 Introduction
Most genome-wide association studies (GWASs) to date are based on samples of European
descent [127, 135, 161, 120]. The lack of GWAS in other continental populations, such as
African and Asians, limits the transferability of GWAS findings in Europeans into other pop-
ulations due to factors including heterogeneity in genetic architectures, linkage disequilibrium
(LD), minor allele frequencies, and environmental background [100, 102, 135, 144, 15]. The
recent increase in the number of GWASs in non-European populations creates immense op-
portunities for trans-ethnic genetic studies [114, 21, 87, 71]. Indeed, analyzing GWAS results
obtained from different continental populations has been shown to greatly improve power
of disease mapping [108, 87, 114], resolution of fine-mapping [167, 5, 72, 173], and accuracy
of risk prediction [101]. A fundamental quantity of interest in trans-ethnic genetic studies
is the similarity of genetic architectures of a complex trait in two continental populations,
and has been measured through trans-ethnic genetic correlation [170, 97, 15]. Methods for
estimating trans-ethnic genetic correlation typically rely on the infinitesimal model, assum-
ing every genetic variant contributes a small effect to the complex trait in both populations
[170, 15], and thus do not explicitly model polygenicity of the complex trait. While previous
study suggests that most common causal variants are shared across continental populations
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[100], what the proportion of shared causal variants is and which genetic variants [44, 43, 56]
are shared / population-specific remain unclear.
Here, we introduce POSC, a method to dissect genetic variants that are causal only in a
single continental population (i.e. population-specific) and those that are causal in both
continental populations (i.e. shared) from GWAS summary statistics data. POSC employs
a Bayesian approach to explicitly model polygenicity of a complex trait and linkage disequi-
librium in both continental populations. POSC yields as output estimates of genome-wide
proportions of population-specific and shared causal variants. These estimates constitute
prior probabilities in an empirical Bayes framework to quantify posterior probability of each
SNP to be population-specific or shared. Further, we define enrichment of population-specific
/ shared causal variants in a functional category as the ratio between the posterior expecta-
tion and prior expectation of the number of population-specific / shared causal variants in
the functional category.
Through extensive simulations, we show that POSC yields accurate estimates of proportion
of population-specific / shared causal variants and well-calibrated statistics for testing en-
richment using either in-sample or external reference LD matrices. We applied POSC on
summary associations statistics of 18 large-scale GWASs of 9 complex traits and diseases
in East Asian and European populations (average NEAS “ 94, 621 NEUR “ 103, 507) using
1000 Genomes Project [28] as the external reference panel. First, we estimated genome-wide
proportion of population-specific and shared causal variants. Next, we quantified posterior
probability for each SNP to be population-specific / shared, and estimated expected number
of population-specific / shared causal variants at GWAS risk regions. Finally, we estimated
enrichment of population-specific / shared causal variants in specifically expressed genes in
53 GTEx tissues [43]. We found that all the traits analyzed were highly polygenic in both
populations, that while a large proportion of causal variants of these traits and diseases
were shared by both populations, each population also possessed a substantial proportion
of population-specific causal variants, and that regions of genes expressed in trait-relevant
tissues harbor both population-specific and shared causal variants.
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5.2 Methods
5.2.1 Overview of methods
We introduce POSC, a method for dissecting population-specific and shared causal variants
from GWAS summary statistics data, while accounting for linkage disequilibrium in two
continental populations. POSC explicitly models the SNP causal status vectors in two
continental populations (see Figure 5.1), and imposes a mixture of zero and normal prior on
SNP effect sizes [73, 10, 64]. POSC yields estimates of numbers of population-specific and
shared causal variants using a expectation maximization (EM) algorithm [37] coupled with
Markov Chain Monte Carlo (MCMC) sampling. These estimates are subsequently used to
quantify posterior probability of each SNP to be population-specific or shared in an empirical
Bayes framework. We also provides method to quantify enrichment of population-specific /
shared causal variants in a functional category, analogous to but conceptually different from
definitions of enrichment of SNP-heritability [44, 149].
5.2.2 The multivariate Bernoulli (MVB) distribution
The multivariate Bernoulli (MVB) is a generalization of the Bernoulli for modeling distribu-
tion of binary vectors of arbitrary size [30, 141]. Let B P t0, 1up represent a random binary
vector of size p, then the distribution of B under MVB can be described by 2p probabilities,
namely PrpB “ 0, ¨ ¨ ¨ , 0q ¨ ¨ ¨PrpB “ 1, ¨ ¨ ¨ , 1q, one for each of the 2p possible realizations of
B [30, 141]. Alternatively, one can adopt an index set representation of the binary vector
B, A “ ti : Bi “ 1u, a set of indices of 1’s in B, and represent the distribution of B as the
ratio,
PrpBq “ PrpAq “ exp
`ř
CĎA fC
˘ř
D exp
`ř
CĎD fC
˘ “ exp pSAqř
D exp pSDq
, (5.1)
where fC ’s are the natural parameters of the MVB [30, 141], and SA “ řCĎA fC .
We use the convention that the right-most bit in the binary vector is the first bit, and the
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left-most bit is the last bit. For the sake of convenience, we use binary string and index set
representation of binary vectors interchangeably (e.g. both the binary string 011 and the
index set t1, 2u represent the binary vector p0, 1, 1q).
As a concrete example, consider binary vectors of size 2. The probabilities of each possible
realization of binary vectors of size 2 under the MVB are
Prp00q “ Prpφq “ exppf00q
exppf00q ` exppf00 ` f01q ` exppf00 ` f10q ` exppf00 ` f01 ` f10 ` f11q
Prp01q “ Prpt1uq “ exppf00 ` f01q
exppf00q ` exppf00 ` f01q ` exppf00 ` f10q ` exppf00 ` f01 ` f10 ` f11q
Prp10q “ Prpt2uq “ exppf00 ` f10q
exppf00q ` exppf00 ` f01q ` exppf00 ` f10q ` exppf00 ` f01 ` f10 ` f11q
Prp11q “ Prpt1, 2uq “ exppf00 ` f01 ` f10 ` f11q
exppf00q ` exppf00 ` f01q ` exppf00 ` f10q ` exppf00 ` f01 ` f10 ` f11q
.
(5.2)
5.2.3 Modeling GWAS summary statistics in two ancestral populations
5.2.3.1 MVB prior for SNP causal status in two ancestral populations
We use binary vector of size 2, Ci “ pci1, ci2q, to model the causal statuses of SNP i in two
ancestral populations. In total, there are 4 possible binary vectors of size 2: (1) Ci “ 00,
the SNP is causal for none of the population; (2) Ci “ 01, the SNP is causal in population
1; (3) Ci “ 10, the SNP is causal in population 2; (4) Ci “ 11, the SNP is causal in both
populations.
Ci can be modeled using a multinomial distribution, Multpp00, p01, p10, p11q, where p00, p01,
p10, and p11 represent the probability of each possible binary vector of size 2. Equivalently,
one can model Ci through the MVB as,
PrpCi “ 00q “ exppf00q
η
, PrpCi “ 01q “ exppf01 ` f00q
η
PrpCi “ 10q “ exppf10 ` f00q
η
, PrpCi “ 11q “ exppf11 ` f10 ` f01 ` f00q
η
,
(5.3)
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where η “ exppf00q ` exppf01 ` f00q ` exppf10 ` f00q ` exppf11 ` f10 ` f01 ` f00q is the
normalization constant, and f “ pf00, f01, f10, f11q parameters of the MVB (see Equation
(5.2)).
The MVB distribution is invariant with respect to the parameter f00, and we enforce f00 to
be 0 as a convention [30]. The parameters, f01 and f10, govern the probability of a SNP being
specific to a population, and f11, the dependence of causal status between two populations
– a zero f11 indicates independence, and a non-zero f11, dependence [30, 141]. Each MVB
parameter is a real number (i.e. f P R4), one can apply unconstrained optimization to
estimate the MVB parameters.
5.2.3.2 Joint distribution of GWAS summary statistics in two ancestral popu-
lations
We model phenotypes in two ancestral populations, Y 1 and Y 2, using the linear model,
Y 1 “ X1β1 ` 1 and Y 2 “ X2β2 ` 2, where Y 1 P Rn1 and Y 2 P Rn2 are the phenotype
measurements of the phenotype in the two populations, with sample size n1 and n2, X1 P
Rn1ˆp and X2 P Rn2ˆp column-standardized genotype matrix at p SNPs, β1 P Rp and
β2 P Rp standardized effect size of SNPs on the phenotype in two populations, and 1 P Rn1
and  P Rn2 environmental effect. We further assume that each row of X1 and X2 is
drawn from a distribution where the covariance structure is V 1 and V 2, the LD matrix of
each population, respectively, and that 1i „ N p0, σ2e1q, β2i „ N p0, σ2e2q, where σ2e1 and σ2e2
represent variance of the environmental effects.
In typical GWASs, one obtains association statistics (Z-scores) of every SNP as
Z1 “ 1?
n1
Xᵀ1Y 1,
Z2 “ 1?
n2
Xᵀ2Y 2,
(5.4)
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and have been shown to follow a multivariate normal distribution [140],
Z1|β1 „ N
`?
n1V 1β1, σ
2
e1V 1
˘
,
Z2|β2 „ N
`?
n2V 1β2, σ
2
e2V
˘
.
(5.5)
Further, given causal status vectors, c1 and c2, of every SNP in each population, one obtains
the conditional distribution Z1|β1, c1 and Z2|β2, c2 as
Z1|β1, c1 „ N
`?
n1V 1pβ1 ˝ c1q, σ2e1V 1
˘
,
Z2|β2, c2 „ N
`?
n2V 2pβ2 ˝ c2q, σ2e2V 2
˘
,
(5.6)
where ˝ denotes the Hadamard product [74].
Following Equation (5.6), one can evaluate the likelihood of Z1 and Z2 given the true causal
effect size vectors β1 and β2. However, in reality the true causal effect size vectors are not
given, and estimating these parameters from data will likely lead to over-fit. Instead, we
impose a normal prior on the causal SNPs in β1 and β2,
β1|c1 „ N
ˆ
0,
h2g1
|c1| diagpc1q
˙
,
β2|c2 „ N
ˆ
0,
h2g2
|c2| diagpc2q
˙
,
(5.7)
where h2g1, h
2
g2 are the SNP-heritability of the phenotype in the two populations, and |c1|,
|c2| denote the number of 1’s (i.e. number of causal SNPs) in the binary vectors [73, 10, 64].
With the normal prior on β1 and β2, the conditional distribution, Z1|c1 and Z2|c2, is then
Z1|c1 „ N
`
0,V 1 ` σ21V 1 diagpc1qV 1
˘
,
Z2|c2 „ N
`
0,V 2 ` σ22V 2 diagpc2qV 2
˘
,
(5.8)
where σ21 “ n1h
2
g1
|c1| and σ
2
2 “ n2h
2
g2
|c2| .
Incorporating the MVB prior on the causal status vectors, one obtains the distribution of
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Z1 and Z2, parameterized by the MVB parameters, f “ pf00, f01, f10, f11q,
PrpZ1,Z2;fq “
ÿ
c1
ÿ
c2
PrpZ1,Z2, c1, c2;fq “
ÿ
c1
ÿ
c2
PrpZ1|c1qPrpZ2|c2qPrpc1, c2;fq
“
ÿ
c1
ÿ
c2
»– NpZ1; 0,V 1 ` σ21V 1 diagpc1qV 1qˆ
NpZ2; 0,V 2 ` σ22V 2 diagpc2qV 2q ˆ
śp
i“1
exppSCi qř
B exppSBq
fifl (5.9)
To model joint distribution of GWAS summary statistics across L LD-independent loci, we
take the product of the probability of Z-scores at each loci,
PrpZ1t1,¨¨¨ ,Lu,Z2t1,¨¨¨ ,Luu;fq “
Lź
l“1
PrpZ1l,Z2l;fq
“
Lź
l“1
$&%ÿ
c1l
ÿ
c2l
»– NpZ1l; 0,V 1l ` σ21lV 1l diagpc1lqV 1lqˆ
NpZ2l; 0,V 2l ` σ22lV 2l diagpc2lqV 2lq ˆ
śpl
i“1
exppSCli qř
B exppSBq
fifl,.- .
(5.10)
5.2.4 Model fitting using Expectation Maximization
5.2.4.1 Expectation step
We use expectation-maximization (EM) to estimate the model parameters f . First, we
derive the complete log-likelihood of the data
`
`
f |Z1t1,¨¨¨ ,Lu,Z2t1,¨¨¨ ,Lu, c1t1,¨¨¨ ,Lu, c2t1,¨¨¨ ,Lu
˘
“ log
$&% Lź
l“1
»– NpZ1l; 0,V 1l ` σ21lV 1l diagpc1lqV 1lqˆ
NpZ2l; 0,V 2l ` σ22lV 2l diagpc2lqV 2lq ˆ
śpl
i“1
exppSCli qř
B exppSBq
fifl,.-
“
Lÿ
l“1
“
logNpZ1l; 0,V 1l ` σ21lV 1l diagpc1lqV 1lq ` logNpZ2l; 0,V 2l ` σ22lV 2l diagpc2lqV 2lq
‰
`
Lÿ
l“1
plÿ
i“1
SCli ´ log
˜ÿ
B
exppSBq
¸
Lÿ
l“1
pl.
(5.11)
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In the expectation step of the EM algorithm, one finds the expectation of the log likelihood
with respect to the causal status vectors c1t1,¨¨¨ ,Lu, c2t1,¨¨¨ ,Lu, conditioned on the current
estimate of the model parameter f ptq,
Q
´
f |f ptq
¯
“ E “` `f |Z1t1,¨¨¨ ,Lu,Z2t1,¨¨¨ ,Lu, c1t1,¨¨¨ ,Lu, c2t1,¨¨¨ ,Lu˘‰
“
Lÿ
l“1
ÿ
c1l,c2l
Pr
´
c1l, c2l|f ptq,Z1l,Z2l
¯»– logNpZ1l; 0,V 1l ` σ21lV 1l diagpc1lqV 1lq
` logNpZ2l; 0,V 2l ` σ22lV 2l diagpc2lqV 2lq
fifl
`
Lÿ
l“1
ÿ
c1l,c2l
Pr
´
c1l, c2l|f ptq,Z1l,Z2l
¯˜ plÿ
i“1
SCli
¸
´ log
˜ÿ
B
exppSBq
¸
Lÿ
l“1
pl,
(5.12)
where Pr
´
c1l, c2l|f ptq,Z1l,Z2l
¯
can be found as,
Pr
´
c1l, c2l|f ptq,Z1l,Z2l
¯
“
Pr
´
c1l, c2l,Z1l,Z2l|f ptq
¯
ř
b1l,b2l
Pr
´
b1l, b2l,Z1l,Z2l|f ptq
¯ . (5.13)
5.2.4.2 Maximization step
In the maximization step, one finds
f pt`1q “ argmaxf Q
´
f |f ptq
¯
“ argmaxf gpfq, (5.14)
where
gpfq “
Lÿ
l“1
ÿ
c1l,c2l
Pr
´
c1l, c2l|f ptq,Z1l,Z2l
¯˜ plÿ
i“1
SCli
¸
´ log
˜ÿ
B
exppSBq
¸
Lÿ
l“1
pl, (5.15)
removing the irrelevant constant in Qpf |f ptqq.
Evaluating gpfq involves a summation over all possible causal status vectors, which has time
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complexity on the order of Op22plq and is intractable. Instead we recognize that
gpfq “
Lÿ
l“1
ÿ
c1l,c2l
E
«
plÿ
i“1
SCli
ff
´ log
˜ÿ
B
exppSBq
¸
Lÿ
l“1
pl
« hpfq “
Lÿ
l“1
«
1
J
Jÿ
j“1
˜
plÿ
i“1
S
C
pjq
li
¸ff
´ log
˜ÿ
B
exppSBq
¸
Lÿ
l“1
pl,
(5.16)
where C
pjq
li “
´
c
pjq
1i , c
pjq
2i
¯
represents the causal status of the i-th SNP at locus l in the two
populations, from the causal status vectors, c
pjq
1 , c
pjq
2 , sampled from the posterior distribution
Pr pc1l, c2l|Z1l,Z2l,f˚q. We use Gibbs sampling to efficiently sample causal status vectors
from the posterior (see Section 5.2.5).
It can be shown that the following parameter updates maximizes hpfq,
f
pt`1q
00 “ 0,
f
pt`1q
01 “ log q¯01 ´ log q¯00,
f
pt`1q
10 “ log q¯10 ´ log q¯00,
f
pt`1q
11 “ log q¯11 ´ log q¯01 ´ log q¯10 ` log q¯00,
(5.17)
where q¯00, q¯01, q¯10, and q¯11 represent the average count of 01, 10, and 11 causal status at a
single SNP in two ancestral populations across MCMC samples from the Gibbs sampler (see
Section 5.2.5).
5.2.5 Sampling causal status vectors from posterior distribution
We use Gibbs sampling to sample C “ pc1, c2q from the posterior distribution,
C „ Pr pC|f ,Z1,Z2q9Pr pZ1,Z2,C|fq . (5.18)
For notational simplicity, here, we drop the index l, representing different loci. To advance
the Markov chain from step j to step j`1 in Gibbs sampling, at step j we select SNP k and
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evaluate the probability of the four possible cross-population causal configurations at that
SNP,
Pr
´
Z1,Z2,Ck “ 00,Cpjq j|f
¯
Pr
´
Z1,Z2,Ck “ 01,Cpjq j|f
¯
Pr
´
Z1,Z2,Ck “ 10,Cpjq j|f
¯
Pr
´
Z1,Z2,Ck “ 11,Cpjq j|f
¯
,
(5.19)
where C
pjq
 j denotes the rest of the causal configurations excluding that of SNP k in the j-th
step. Then we sample Cpj`1q based on the following probability
Pr
´
Cpt`1q “
´
Ck “ b1,Cpjq j
¯¯
“
Pr
´
Z1,Z2,Ck “ b1,Cpjq j|f
¯
ř
b Pr
´
Z1,Z2,Ck “ b,Cpjq j|f
¯ . (5.20)
To evaluate PrpZ1,Z2, c1, c2|fq “ PrpZ1|c1qPrpZ2|c2qPrpc1, c2|fq, we note that previous
work has shown that
PrpZ1|c1q “ N
`
Z1|0,V 1 ` σ21V 21
˘9N `Z1c1 |0,V 1c1 ` σ21V 21c1˘
N pZ1c1 |0,V 1c1q ,
(5.21)
where BF1 “ NpZ1c1 |0,V 1c1`σ
2
1V
2
1c1
q
NpZ1c1 |0,V 1c1q is the Bayes factor at only the causal SNPs, reducing the
time complexity of evaluating the probability from p3 to p3causal. Let V 1c1 “
řpcausal
i“1 wiuiu
ᵀ
i be
the eigenvalue decomposition of V 1c1 , where wi and ui are the eigenvalues and eigenvectors
of V 1c1 , we further note that BF1 can be expressed as
BF1 “ detpV 1c1 ` σ
2
1V
2
1c1
q´ 12 exp “´1
2
Zᵀ1c1pV 1c1 ` σ21V 21c1q´1Z1c1
‰
detpV 1c1q´ 12 exp
`´1
2
Zᵀ1c1V
´1
1c1
Z1c1
˘
9
˜
pcausalź
i“1
1
1` σ21wi
¸ 1
2
exp
«
1
2
pcausalÿ
i“1
σ21
1` σ21wi
`
Zᵀ1c1ui
˘2ff
,
(5.22)
avoiding numerical instability introduced by small eigenvalues. The Bayes factor for Z2c2
can be obtained using the same approach.
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5.2.6 Posterior probability of each SNP to be ancestry-specific or shared
We use posterior probability of each SNP to be ancestry-specific or shared to assess evidence
of specific or shared genetic architecture at single-SNP resolution. Specifically, we evaluate
PrpCi “ b|Z1,Z2,f˚q (5.23)
for b P t01, 10, 11u at each SNP i, where f˚ denotes the estimated MVB parameter. We
show below that the per SNP posterior probability in Equation (5.23) can be evaluated using
the Gibbs sampling procedure outlined in Section 5.2.5. First, we note that
PrpCi “ b|Z1,Z2,f˚q “
ÿ
C i
PrpCi “ b,C i|Z1,Z2f˚q
“
ÿ
C i
PrpCi “ b|C i,Z1,Z2f˚qPrpC i|Z1,Z2f˚q
“ E rPrpCi “ b|C i,Z1,Z2f˚qs “ E
“
Er1tCi“bu|C i,Z1,Z2f˚s
‰
“ Er1tCi“bu|Z1,Z2f˚s «
řJ
j“1 1tCpjqi “bu
J
,
(5.24)
where Cpjq is the j-th causal status vectors (out of a total of J samples) sampled from the
posterior distribution PrpC|Z1,Z2,f˚q (see Section 5.2.5). To ensure stable estimates of the
posterior probability, we run the Gibbs sampling procedure 20 times and report the average
posterior probability.
5.2.7 Defining approximately independent LD blocks in both ancestral popu-
lations
We adapted LDetect [12] to define blocks of SNPs that are approximately independent
in both East Asian and European populations. Briefly, LDetect is a method to define
approximately independent blocks of SNPs in a single population [12]. It involves estimating
a regularized LD matrix of a single population and identifying block structures in the LD
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matrix, which constitute the approximately independent LD blocks[12].
To define approximately independent blocks of SNPs for two populations, we first com-
pute regularized LD matrices of both populations (V EAS and V EUR), following the LDetect
procedure[12]. Then we construct a new matrix (V trans) by taking the maximum LD in East
Asian and European LD matrices for each pair of SNPs,
V trasn,ij “
$’&’%V EAS,ij if|V EAS,ij| ą |V EUR,ij|V EUR,ij if|V EUR,ij| ą |V EAS,ij| . (5.25)
The matrix V trans is block diagonal due to shared recombination hot spots in both popula-
tions. We then applied LDetect procedure [12] to identify block structure in V trans.
Using the above procedure, we identified 1,368 approximately independent LD blocks (2Mb
wide on average) in both East Asian and European populations.
5.2.8 Simulation framework
We used genotype data of chromosome 22 from CONVERGE [21] and UK Biobank [151]
to simulate GWAS summary statistics for East Asian and European populations. We used
genotype data from 1000 Genomes Project [2] as the reference panel. Since SNPs in perfect
LD have identical Z-scores, we performed minimal LD pruning (at R2 threshold of 0.95) on
reference LD matrix using PLINK 1.9 [132], to remove perfectly correlated SNPs. We also
removed strand-ambiguous SNPs and SNPs with minor allele frequency (MAF) less than 1%
in either population, resulting in a total of 8,599 SNPs on chromosome 22.
We simulated phenotypes based on the linear model Y 1 “ X1β1 ` 1,Y 2 “ X2β2 ` 2,
where effects of causal SNPs, β1c1 and β2c1 , in each population, were drawn from
β1c1 „ N
ˆ
0,
h2g1
|c1|I
˙
,β2c2 „ N
ˆ
0,
h2g2
|c2|I
˙
, (5.26)
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and effects of non-causal SNPs were set to 0. Here, c1 and c2 are the index set of causal
SNPs in each population. We simulated environmental effect of each individual i, 1i and
2i, from 1i „ Np0, 1 ´ h2g1q and 2i „ Np0, 1 ´ h2g2q. We then simulated Z-scores for the
entire chromosome 22.
5.2.8.1 Specifically expressed genes annotation
We obtained SNP annotations for genes specifically expressed in a tissue across 53 GTEx
tissues from Finucane et al. [43]
5.3 Results
5.3.1 Performance of POSC in simulations
We assessed the performance of POSC through extensive simulations. First, we evaluated
the computation efficiency of POSC. The EM-MCMC algorithm for estimating the number of
population-specific / shared causal variants typically converged in 200 iterations (see Figure
5.2), with run time increasing with total number of causal SNPs (see Figure 5.2). For exam-
ple, in simulations where we randomly drew 20 causal variants for each population, POSC
terminated in 90 minutes on average, increasing to 360 minutes in simulations involving 100
causal variants. We note, however, that the EM-MCMC procedure can be parallelized to
decrease run time. Evaluating per-SNP posterior probability to be population-specific or
shared using the estimated prior took on average 5 minutes in simulations where 20 causal
variants were drawn for each population, and 28 minutes in simulations involving 100 causal
variants (see Figure 5.3).
Next, we evaluated the accuracy of POSC in estimating the number of population-specific
and shared causal variants. When in-sample LD was used, POSC yielded approximately
unbiased estimates of the number of population-specific and shared causal variants (see
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Figure 5.4). And when external reference LD obtained from 1000 Genomes Project [28]
was used, POSC yielded slightly upwardly biased estimates (see Figure 5.4 bottom panel).
For example, in simulations where we randomly chose (out of a total of 8,599 SNPs) 50
East Asian-specific, 50 European-specific, and 50 shared causal variants, POSC yielded an
estimates of 37.8 (S.E. 4.5), 40.3 (S.E. 4.9), and 64.9 (S.E. 6.3), respectively, when in-sample
LD was used, and an estimates of 48.0 (S.E. 5.9), 53.7 (S.E. 7.44), and 78.8 (S.E. 7.6),
respectively, when external reference LD was used.
We also assessed the effect of SNP-heritability of the trait and sample size of the GWAS
on the estimates of POSC. We saw a slight decrease in accuracy as the product between
SNP-heritability and sample size decreases (see Figure 5.5). This is not unexpected since the
likelihood of GWAS summary statistics is a function of the product between SNP-heritability
of the trait and sample size of the GWAS – as the product decreases to zero, Z-scores give
little information regarding the causal status, leading to inaccurate estimates.
Finally, we obtained statistics testing enrichment of population-specific and shared causal
variants in annotations defined by specifically expressed genes in 53 GTEx tissues [43] in
simulations. Since we drew causal variants at random, the simulations constituted null
simulations with no enrichment in any functional annotation. Overall, the statistics were
conservative with either in-sample LD or external reference LD (see Figure 5.10), at different
levels of polygenicity, or with different power (product between SNP-heritability and sample
size) of the GWAS.
5.3.2 Number of population-specific and shared causal variants in complex
traits
We analyzed 18 publicly available summary association statistics of GWAS of 9 complex
traits in East Asian (EAS) and European (EUR) populations (see Table 5.1). For computa-
tional efficiency, we first estimated number of population-specific and shared causal variants
on each chromosome separately in parallel, with 500 EM iterations for each chromosome
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to ensure convergence. The EM algorithm converged after 200 iterates for all traits except
BMI, which didn’t converge until after 300 iteration, likely due to its high polygenicity.
Next, we aggregated the chromosomal estimates to obtain genome-wide number of population-
specific and shared causal variants. The complex traits we analyzed displayed a wide range
of degrees of polygenicity, with number of causal variants ranging from 877 (S.E. 8) and
1,228 (S.E. 11) in EAS and EUR for rheumatoid arthritis (RA), to 25,296 (S.E. 85) and
26,206 (S.E. 66) in EAS and EUR for BMI (see Table 5.2). Notably, we highlight that our
estimated proportion of causal variants for BMI in EUR, 10.1%, was consistent with an
estimate obtained by a recent method using individual-level data [175].
As expected, in all analyzed traits, a large fraction of causal variants in each population
were shared with the other population (see Table 5.2), consistent with similar conclusions
reached a by previous study [100]. For example, we estimated that among the 25,296 (S.E.
85) and 26,206 (S.E. 66) (EUR) causal variants for BMI in EAS and EUR, 22,664 (S.E. 141)
were shared by both populations, comprising 90% and 86% of the total causal variants of
BMI in each population, respectively. However, for some complex traits, each population
also possessed a substantial proportion of population-specific causal variants. For example,
out of the estimated total of 6,356 (S.E. 19) and 5,892 (S.E. 27) causal variants for total
cholesterol (TC) in East Asians and Europeans, 2,467 (S.E. 22) and 2,003 (S.E. 16) were
specific to each population, comprising 39% and 34% of the estimated total number of causal
variants in each population, respectively (see Table 5.2).
5.3.3 Causal variants of complex traits are spread across the entire genome
We divided the estimated number of population-specific / shared causal variants by the total
number of SNPs in each GWAS study to obtain proportion estimates, and used them as prior
probabilities in an empirical Bayes framework to evaluate posterior probability of each SNP
to be population-specific / shared (see Figure 5.7). We aggregated the posterior probabilities
of SNPs in each defined approximately LD-independent regions to obtain expected number
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of population-specific / shared causal variants at each region. For most analyzed traits,
both population-specific and shared causal variants were widely spread across the entire
genome (see Figure 5.8). As an example, mean corpuscular hemoglobin (MCH) harbored
0.68 (S.D. 0.42) EAS-specific, 0.53 (S.D. 0.40) EUR-specific, and 2.19 (S.D. 1.46) shared
causal variants, per LD-independent region (see Figure 5.8). Interestingly, we found that for
rheumatoid arthritis (RA), nearly all the population-specific causal variants concentrated in
the MHC (chr6:25M–35M) region. Indeed, selection at MCH region may give rise to different
causal variants in each population [105], although we caution that complex LD structures
around the MHC region might introduced bias our estimates. Next, we aggregated the
posterior probabilities by chromosome to obtain the expected number of population-specific
/ shared causal variants on each chromosome. The expected number of both population-
specific and shared causal variants was highly proportional to the size of the chromosome,
recapitulating similar findings using local SNP-heritability [91, 140].
5.3.4 GWAS risk regions contain multiple causal variants in both populations
We investigated whether genomic regions harboring significant associations (GWAS risk re-
gions) in only one population contained causal variants that are shared by both populations.
We quantified the expected number of shared as well as population-specific causal variants in
regions that contained GWAS-significant associations in only the East Asian (EAS) GWAS
or European (EUR) GWAS. First, regions with GWAS-significant associations in both EAS
and EUR GWAS harbored multiple causal variants that were shared across the two popu-
lations (see Figure 5.9), recapitulating previous findings on allelic heterogeneity of complex
traits [65, 140, 54]. Second, regions with GWAS-significant associations only in EAS or EUR
GWAS contained causal variants shared by both populations (see Figure 5.9). For exam-
ple, regions with GWAS-significant associations for mean corpuscular volume (MCV) only
in the EAS / EUR GWAS harbored 3.0 (S.D. 1.7) / 3.3 (S.D. 1.5) shared causal variants
on average, respectively (see Figure 5.9), consistent with previous study suggesting that
the lack of shared GWAS associations in two continental populations is likely in part due
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to heterogeneity in LD structures of the two populations [100]. In addition, we didn’t ob-
serve a noticeable difference in the expected number of EAS-specific and EUR-specific causal
variants at regions harboring GWAS-significant associations only in East Asian / European
GWAS (see Figure 5.9). Finally, regions that contained no GWAS-significant association in
either population also harbored multiple causal variants shared (see Figure 5.9), suggesting
that a large fraction of causal variants of complex traits resided in sub-GWAS regions.
5.3.5 Enrichment analysis of population-specific and shared causal variants
Recent work has found enrichment of SNP-heritability in regions of specifically expressed
genes (SEG) in trait-relevant tissues and cell types [43, 44]. Here, we investigated whether
genetic architectures of complex traits were consistent in SEG in trait-relevant tissues across
East Asians (EAS) and Europeans (EUR). First, we estimated enrichments of population-
specific and shared causal variants for each analyzed trait in SEG across 53 GTEx tissues
using SNP annotations described in [43], and tested for significance with a stringent Bon-
ferroni corrected threshold of 0.05/53 (see Figure 5.10). All analyzed traits except major
depressive disorder (MDD) exhibited significant enrichment of shared causal variants in at
least one SEG in a trait-relevant tissue (see Figure 5.10), suggesting that in regions of genes
that are expressed in trait-relevant tissues, there were more shared causal variants across
EAS and EUR than the rest of the genome.
Next, we investigated whether there was heterogeneity in genetic architectures in SEG across
EAS and EUR. Out of the 9 analyzed traits, 7 traits showed significant enrichment of
population-specific causal variants in at least one SEG (see Figure 5.10). We highlight the
two hematological traits, mean corpuscular hemoglobin (MCH) and mean corpuscular vol-
ume (MCV), which displayed significant enrichments of both population-specific and shared
causal variants in SEG in multiple tissues (see Figure 5.10). For example, MCV showed a
1.3x (S.E. 0.0041, p=5.3 ˆ 10´14) enrichment of shared causal variants in SEG in blood,
and also a 1.1x (S.E. 0.0031, p=2.0ˆ 10´4) and 1.3x (S.E. 0.0062, p=3.6ˆ 10´6) enrichment
of EAS-specific and EUR-specific causal variants in SEG in whole blood (see Figure 5.11),
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respectively, suggesting that regions of genes that are expressed in whole blood harbor both
more population-specific and shared causal variants across EAS and EUR than the rest of
the genome.
5.4 Discussion
We have presented POSC, a method to dissect population-specific and shared causal vari-
ants of complex traits across two continental populations from GWAS summary association
statistics data. POSC employs a Bayesian approach to explicitly model polygenicity of a
trait and LD structures in both populations. In extensive simulations using either in-sample
or external reference LD, POSC yielded accurate and robust estimates of proportion of
population-specific / shared causal variants and well-calibrated statistics for testing enrich-
ment in functional annotations. We applied POSC on 18 summary association statistics
data of 9 complex traits obtained from samples of East Asian (EAS) and European (EUR)
descent to glean insights into the underlying genetic architectures of complex traits in both
populations.
First, we showed that while East Asian and European populations shared a large proportion
of causal variants for multiple complex traits, each population also possessed a substantial
proportion of population-specific causal variants. Second, our results suggested that regions
that harbor GWAS risk variants for one population was enriched for causal variants in the
other population, indicating that the lack of GWAS signal was likely attributable to differ-
ences in LD structure and power of GWAS. Third, our analysis of enrichment of population-
specific / shared causal variants in SEG annotations [43] demonstrated that regions of genes
expressed in trait-relevant tissues harbored an excess of both shared and population-specific
causal variants for multiple complex traits. Overall, our analysis provides valuable insights
into the underlying genetic architectures of complex traits in different populations, and high-
lights the importance of performing GWAS in non-European populations.
We conclude by highlighting caveats and limitations of our analysis. First, we note that the
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estimates of proportion of population-specific and shared causal variants can be influenced
by gene-environment interactions, and that one should exercise caution when interpreting
these results. For example, if a SNP has effect on a trait only under the East Asian envi-
ronment, then POSC will interpret that SNP as an EAS-specific causal variant, even though
the SNP may still be biologically causal in Europeans. Second, our analysis only included
genetic variants with minor allele frequency (MAF) greater than 1% in both populations for
the sake of numerical stability. Therefore, our estimates of proportion of population-specific
and shared causal variants will be an underestimate if there is a substantial proportion of
rare variants contributing to the trait. We note however that a large fraction of trait vari-
ance can be attributable to common variants [168, 100]. Third, POSC relies on LD blocks
that are approximately independent in both populations for computational efficiency, and
will result in biased estimates in case of LD leakage. Thus, we recommend that LD blocks
are specifically defined for each pair of population one analyzes. Fourth, we observed that
performance of POSC decreases as the product between trait SNP-heritability and GWAS
sample size decreases. Therefore, we recommend that POSC is applied only on highly herita-
ble traits and (or) GWAS with large sample size. In light of the global efforts on developing
biobanks [151, 111], we anticipate that future GWASs will have sufficient power to study
traits with wide range of heritability. Fifth, POSC doesn’t explicitly model correlation of
the effect sizes of shared causal variants across two populations for computational efficiency.
And we conjecture that explicitly modeling correlation of the trans-ethnic SNP effect sizes
can further improve accuracy of POSC.
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5.5 Tables
Trait name Population SNP-heritability (S.E.) % Sample size Reference
Body Mass Index (BMI)
EAS 19.8 (0.67) 224,698 [90]
EUR 20.6 (0.91) 158,284 [1]
Mean Corpuscular Hemoglobin (MCH)
EAS 18.6 (2.2) 108,054 [71]
EUR 22.7 (3.2) 172,332 [6]
Mean Corpuscular Volume (MCV)
EAS 21.0 (2.13) 108,256 [71]
EUR 23.6 (3.1) 172,433 [6]
High Density Lipoprotein (HDL)
EAS 20.7 (3.03) 70,657 [71]
EUR 16.4 (2.2) 89,614 [154]
Low Density Lipoprotein (LDL)
EAS 9.5 (1.3) 72,866 [71]
EUR 13.6 (1.93) 85,491 [154]
Total Cholesterol (TC)
EAS 8.1 (0.84) 128,305 [71]
EUR 22.5 (2.1) 89,865 [154]
Triglyceride (TG)
EAS 13.5 (3.3) 105,597 [71]
EUR 13.6 (2.2) 86,502 [154]
Major Depressive Disorder (MDD)
EAS 35.6 (3.4) 10,640 [21]
EUR 19.0 (1.8) 18,759 [166]
Rheumatoid Arthritis (RA)
EAS 28.9 (18.3) 22,515 [114]
EUR 9.5 (1.9) 58,284 [114]
Table 5.1: A list of GWAS summary statistics data set analyzed. We obtain genome-
wide SNP-heritability estimates of these traits using LD score regression [19], with intercept
term constrained to 1.
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Trait name Total no.
of SNPs
Estimated
no. of
EAS-specific
causal SNPs
(S.E.)
Estimated
no. of
EUR-specific
causal SNPs
(S.E.)
Estimated
no. of shared
causal SNPs
(S.E.)
Estimated
total no. of
causal SNPs
in EAS
(S.E.)
Estimated
total no. of
causal SNPs
in EUR
(S.E.)
BMI 258,536 2,632 (58) 3,542 (79) 22,664 (141) 25,296 (85) 26,206 (66)
MCH 481,402 993 (13) 784 (11) 2,805 (14) 3,799 (22) 3,589 (12)
MCV 481,396 933 (10) 739 (5) 3,055 (14) 3,989 (16) 3,795 (16)
HDL 268,673 4,016 (19) 1,309 (39) 4,099 (16) 8,115 (14) 5,408 (30)
LDL 268,676 1,434 (19) 927 (23) 2,681 (22) 4,116 (23) 3,608 (13)
TC 268,672 2,467 (22) 2,003 (16) 3,889 (36) 6,356 (19) 5,892 (27)
TG 268,673 2,689 (10) 756 (12) 3,193 (11) 5,882 (12) 3,949 (12)
MDD 96,863 324 (15) 4,897 (24) 5,519 (51) 5,844 (41) 10,417 (53)
RA 529,404 187 (3) 539 (8) 689 (7) 877 (8) 1,228 (11)
Table 5.2: Total number of SNPs, estimated number of population-specific and
shared causal variants for BMI, MCH, and MCV. We estimated the standard errors
of the numbers of population-specific and shared causal variants using the last 25 iterations
of the EM-MCMC algorithm for estimating the prior proportion of population-specific and
shared causal variants.
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5.6 Figures
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Figure 5.1: Example of how differences in genetic architectures and LD pattern
between East Asians and Europeans affect observed GWAS associations. a) We
use filled and unfilled circles to represent SNPs causal and not causal in each ancestral
population. b) Four possible causal statuses of a SNP in the two ancestral populations.
Namely, the SNP is not causal in either ancestral populations; the SNP is only causal in
East Asians; the SNP is only causal in Europeans; the SNP is causal in both ancestral
populations. c) and d) LD pattern in East Asian and European population, respectively.
e) and f) Manhattan plots of GWASs in East Asians and Europeans, respectively. SNPs
passing the significance threshold are marked in black.
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Figure 5.2: Estimated number of population-specific and shared causal variants
across iterations of the EM algorithm. We randomly selected 60 causal SNPs (out of
8,599) in both populations, and set the product between SNP-heritability and GWAS sample
size in both populations to 500. Each curve represents the average across 25 simulations.
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Figure 5.3: Average run time for estimating the prior (MVB parameters) and
evaluating per-SNP posterior probability to be population-specific and shared.
Each dot represents the average run time across all simulations with total causal variants in
each population specified on the x-axis. Error bars represent 1.96 times the standard error
on each side.
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Figure 5.4: Performance of POSC in simulations. POSC yielded approximately unbi-
ased estimates of the number of population-specific and shared causal variants in simulations
when in-sample LD was used (top panel), and slightly upwardly biased estimates when ex-
ternal reference LD was used (bottom panel). We set the product of SNP-heritability of the
trait and sample size of the GWAS to 500 in both populations. Mean and standard error
were obtained across 25 simulations. Error bars represent 1.96 times the standard error on
each side.
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Figure 5.5: Performance of POSC in simulations. We simulated 20 to 100 causal vari-
ants for each population, where 75% of these causal variants were shared by both populations.
We set the product between SNP-heritability of the trait and sample size of the GWAS to
500 (left column), 375 (middle column), and 250 (right column). Each dot represents the
mean across 25 simulations, and errorbars represent 1.96 times the standard error on each
side.
116
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1
2
3
4
ob
se
rv
ed
 
lo
g 1
0P
EAS specific
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
expected log10P
0
1
2
3
4
EUR specific
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1
2
3
4
shared
using in-sample LD
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1
2
3
4
ob
se
rv
ed
 
lo
g 1
0P
EAS specific
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
expected log10P
0
1
2
3
4
EUR specific
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
1
2
3
4
shared
using 1000 Genomes Project reference LD
Figure 5.6: Q-Q plot for p-values testing enrichment of population-specific and
shared causal variants in SEG annotations [43]. We obtained of p-values for SEG
annotations across 53 GTEx tissues from 25 null simulation, where we drew 25 EAS-specific,
25 EUR-specific, and 75 shared causal variants at random. In all simulations, we set the
product of SNP-heritability of the trait and sample size of the GWAS to 500 in both pop-
ulations. The top and bottom three figures represent results obtained using in-sample and
1000 Genomes Project reference LD matrix, respectively.
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Figure 5.7: Manhattan-style plots for posterior probability of each SNP to
population-specific or shared for MCH.
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Figure 5.8: Distribution of number of population-specific and shared causal vari-
ants per region. Each violin plot shows the distribution of population-specific and shared
causal variants across the genome, where the dark line represents the mean of the distribu-
tion. We sort the traits based on the average regional number of shared causal variants.
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Figure 5.9: Distribution of regional number of causal variants at GWAS risk re-
gions. Each violin plot shows the distribution of population-specific or shared causal variants
at regions harboring significant associations (p ă 5ˆ10´5) in the East Asian GWAS only, in
the European GWAS only, in both GWASs, and in neither GWAS. The dark line represents
the mean of the distribution.
120
Adipose
Blood/Immune
CNS
Cardiovascular
Digestive
Endocrine
Liver
Musculoskeletal/connective
Other
0
1
2
3
4
5
lo
g 1
0P
EAS specific
0
1
2
3
4
5
EUR specific
0
1
2
3
4
5
shared
Body Mass Index (BMI)
0
5
10
15
20
lo
g 1
0P
EAS specific
0
5
10
15
20
EUR specific
0
5
10
15
20
shared
Mean Corpuscular Hemoglobin (MCH)
0
5
10
15
20
lo
g 1
0P
EAS specific
0
5
10
15
20
EUR specific
0
5
10
15
20
shared
Mean Corpuscular Volume (MCV)
0
1
2
3
4
5
lo
g 1
0P
EAS specific
0
1
2
3
4
5
EUR specific
0
1
2
3
4
5
shared
High Density Lipoprotein (HDL)
0
1
2
3
4
5
6
7
8
lo
g 1
0P
EAS specific
0
1
2
3
4
5
6
7
8
EUR specific
0
1
2
3
4
5
6
7
8
shared
Low Density Lipoprotein (LDL)
0
1
2
3
4
5
lo
g 1
0P
EAS specific
0
1
2
3
4
5
EUR specific
0
1
2
3
4
5
shared
Total Cholesterol (TC)
0
2
4
6
8
10
lo
g 1
0P
EAS specific
0
2
4
6
8
10
EUR specific
0
2
4
6
8
10
shared
Triglyceride (TG)
0
1
2
3
4
5
lo
g 1
0P
EAS specific
0
1
2
3
4
5
EUR specific
0
1
2
3
4
5
shared
Major Depressive Disorder (MDD)
0
2
4
6
8
10
lo
g 1
0P
EAS specific
0
2
4
6
8
10
EUR specific
0
2
4
6
8
10
shared
Rheumatoid Arthritis (RA)
Figure 5.10: Enrichment of population-specific and shared causal variants for BMI,
MCH, and MCV in specifically expressed genes (SEG) annotations across 53
GTEx tissues. We used a consistent significance threshold of 0.05 / 53 (´ log10 P “ ´3.03)
as represented by the dotted line to test for enrichment across all traits. We represent
annotations passing the significance threshold using larger dots.
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Figure 5.11: Enrichment of population-specific and shared causal variants in specif-
ically expressed genes annotation across 53 GTEx tissues. Error bars represent 1.96
times the standard error on each side. The darker the color, the more significant an enrich-
ment is. We mark enrichment with p-value less than 0.05{53 with a star.
122
REFERENCES
[1] Masato Akiyama, Yukinori Okada, Masahiro Kanai, Atsushi Takahashi, Yukihide Mo-
mozawa, Masashi Ikeda, Nakao Iwata, Shiro Ikegawa, Makoto Hirata, Koichi Matsuda,
et al. Genome-wide association study identifies 112 new loci for body mass index in
the japanese population. Nature genetics, 49(10):1458, 2017.
[2] Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel AJR Aparicio, Sam
Behjati, Andrew V Biankin, Graham R Bignell, Niccolo Bolli, Ake Borg, Anne-Lise
Børresen-Dale, et al. Signatures of mutational processes in human cancer. Nature,
500(7463):415, 2013.
[3] NK Arden, J Baker, C Hogg, K Baan, and TD Spector. The heritability of bone mineral
density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal
twins. Journal of Bone and Mineral Research, 11(4):530–534, 1996.
[4] Hugues Aschard, Bjarni J Vilhja´lmsson, Amit D Joshi, Alkes L Price, and Peter Kraft.
Adjusting for heritable covariates can bias effect estimates in genome-wide association
studies. The American Journal of Human Genetics, 96(2):329–339, 2015.
[5] Jennifer L Asimit, Konstantinos Hatzikotoulas, Mark McCarthy, Andrew P Morris,
and Eleftheria Zeggini. Trans-ethnic study design approaches for fine-mapping. Euro-
pean Journal of Human Genetics, 24(9):1330, 2016.
[6] William J Astle, Heather Elding, Tao Jiang, Dave Allen, Dace Ruklisa, Alice L Mann,
Daniel Mead, Heleen Bouman, Fernando Riveros-Mckay, Myrto A Kostadima, et al.
The allelic landscape of human blood cell trait variation and links to common complex
disease. Cell, 167(5):1415–1429, 2016.
[7] David P Baker, Juan Leon, Emily G Smith Greenaway, John Collins, and Marcela
Movit. The education effect on population health: a reassessment. Population and
development review, 37(2):307–332, 2011.
[8] Nicola Barban, Rick Jansen, Ronald de Vlaming, Ahmad Vaez, Jornt J Mandemakers,
Felix C Tropf, Xia Shen, James F Wilson, Daniel I Chasman, Ilja M Nolte, et al.
Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Na-
ture genetics, 2016.
[9] Adi Ben-Israel and Thomas NE Greville. Generalized inverses: theory and applications,
volume 15. Springer Science & Business Media, 2003.
[10] Christian Benner, Chris CA Spencer, Aki S Havulinna, Veikko Salomaa, Samuli Ri-
patti, and Matti Pirinen. Finemap: efficient variable selection using summary data
from genome-wide association studies. Bioinformatics, 32(10):1493–1501, 2016.
123
[11] Tomaz Berisa and Joseph K Pickrell. Approximately independent linkage disequilib-
rium blocks in human populations. Bioinformatics, page btv546, 2015.
[12] Tomaz Berisa and Joseph K Pickrell. Approximately independent linkage disequi-
librium blocks in human populations. Bioinformatics (Oxford, England), 32(2):283,
2016.
[13] Dorret Boomsma, Andreas Busjahn, and Leena Peltonen. Classical twin studies and
beyond. Nature reviews genetics, 3(11):872–882, 2002.
[14] Alan P Boyle, Sean Davis, Hennady P Shulha, Paul Meltzer, Elliott H Margulies,
Zhiping Weng, Terrence S Furey, and Gregory E Crawford. High-resolution mapping
and characterization of open chromatin across the genome. Cell, 132(2):311–322, 2008.
[15] Brielin C Brown, Chun Jimmie Ye, Alkes L Price, Noah Zaitlen, Asian Genetic
Epidemiology Network Type 2 Diabetes Consortium, et al. Transethnic genetic-
correlation estimates from summary statistics. The American Journal of Human Ge-
netics, 99(1):76–88, 2016.
[16] Brian L Browning and Sharon R Browning. A fast, powerful method for detecting
identity by descent. The American Journal of Human Genetics, 88(2):173–182, 2011.
[17] Sharon R Browning and Brian L Browning. Rapid and accurate haplotype phasing
and missing-data inference for whole-genome association studies by use of localized
haplotype clustering. The American Journal of Human Genetics, 81(5):1084–1097,
2007.
[18] Brendan Bulik-Sullivan, Hilary K Finucane, Verneri Anttila, Alexander Gusev, Felix R
Day, Po-Ru Loh, Laramie Duncan, John RB Perry, Nick Patterson, Elise B Robinson,
et al. An atlas of genetic correlations across human diseases and traits. Nature genetics,
2015.
[19] Brendan K Bulik-Sullivan, Po-Ru Loh, Hilary K Finucane, Stephan Ripke, Jian Yang,
Nick Patterson, Mark J Daly, Alkes L Price, Benjamin M Neale, Schizophrenia Work-
ing Group of the Psychiatric Genomics Consortium, et al. Ld score regression dis-
tinguishes confounding from polygenicity in genome-wide association studies. Nature
genetics, 47(3):291–295, 2015.
[20] William S Bush and Jason H Moore. Genome-wide association studies. PLoS compu-
tational biology, 8(12):e1002822, 2012.
[21] Na Cai, Tim B Bigdeli, Warren Kretzschmar, Yihan Li, Jieqin Liang, Li Song, Jingchu
Hu, Qibin Li, Wei Jin, Zhenfei Hu, et al. Sparse whole-genome sequencing identifies
two loci for major depressive disorder. Nature, 523(7562):588, 2015.
[22] Gregory Carey. Inference about genetic correlations. Behavior genetics, 18(3):329–338,
1988.
124
[23] Zhao Chen, Hua Tang, Rehan Qayyum, Ursula M Schick, Michael A Nalls, Robert
Handsaker, Jin Li, Yingchang Lu, Lisa R Yanek, Brendan Keating, et al. Genome-
wide association analysis of red blood cell traits in african americans: the cogent
network. Human molecular genetics, 22(12):2529–2538, 2013.
[24] Charles C Chung, Peter A Kanetsky, Zhaoming Wang, Michelle A T Hildebrandt,
Roelof Koster, Rolf I Skotheim, Christian P Kratz, Clare Turnbull, Victoria K Cortes-
sis, Anne C Bakken, D. Timothy Bishop, Michael B Cook, R. Loren Erickson, So-
phie D Foss, Kevin B Jacobs, Larissa A Korde, Sigrid M Kraggerud, Ragnhild A
Lothe, Jennifer T Loud, Nazneen Rahman, Eila C Skinner, Duncan C Thomas, Xifeng
Wu, Meredith Yeager, Fredrick R Schumacher, Mark H Greene, Stephen M Schwartz,
Katherine A McGlynn, Stephen J Chanock, and Katherine L Nathanson. Meta-
analysis identifies four new loci associated with testicular germ cell tumor. Nature
Genetics, 45(6):680–685, Jun 2013.
[25] Melina Claussnitzer, Simon N Dankel, Kyoung-Han Kim, Gerald Quon, Wouter Meule-
man, Christine Haugen, Viktoria Glunk, Isabel S Sousa, Jacqueline L Beaudry, Vijitha
Puviindran, et al. Fto obesity variant circuitry and adipocyte browning in humans.
New England Journal of Medicine, 373(10):895–907, 2015.
[26] Robin Z Cohen, Mary V Seeman, Andrew Gotowiec, and Lili Kopala. Earlier pu-
berty as a predictor of later onset of schizophrenia in women. American Journal of
Psychiatry, 1999.
[27] 1000 Genomes Project Consortium, Gonalo R. Abecasis, David Altshuler, Adam Au-
ton, Lisa D. Brooks, Richard M. Durbin, Richard A. Gibbs, Matt E. Hurles, and
Gil A. McVean. A map of human genome variation from population-scale sequencing.
Nature, 467(7319):1061–1073, Oct 2010.
[28] 1000 Genomes Project Consortium et al. An integrated map of genetic variation from
1,092 human genomes. Nature, 491(7422):56–65, 2012.
[29] Global Lipids Genetics Consortium et al. Discovery and refinement of loci associated
with lipid levels. Nature genetics, 45(11):1274–1283, 2013.
[30] Bin Dai, Shilin Ding, Grace Wahba, et al. Multivariate bernoulli distribution.
Bernoulli, 19(4):1465–1483, 2013.
[31] Mark J. Daly, John D. Rioux, Stephen F. Schaffner, Thomas J. Hudson, and Eric S.
Lande. High-resolution haplotype structure in the human genome. Nature Genetics,
29(6):229–232, Jun 2001.
[32] George Davey Smith and Shah Ebrahim. mendelian randomization: can genetic epi-
demiology contribute to understanding environmental determinants of disease? Inter-
national journal of epidemiology, 32(1):1–22, 2003.
[33] Felix R Day, Katherine S Ruth, Deborah J Thompson, Kathryn L Lunetta, Natalia
125
Pervjakova, Daniel I Chasman, Lisette Stolk, Hilary K Finucane, Patrick Sulem, Bren-
dan Bulik-Sullivan, et al. Large-scale genomic analyses link reproductive aging to
hypothalamic signaling, breast cancer susceptibility and brca1-mediated dna repair.
Nature genetics, 47(11):1294–1303, 2015.
[34] Gustavo de los Campos, Ana I Vazquez, Rohan Fernando, Yann C Klimentidis, and
Daniel Sorensen. Prediction of complex human traits using the genomic best linear
unbiased predictor. PLoS genetics, 9(7):e1003608, 2013.
[35] SV de Miranda Chagas, S Kanaan, H Chung Kang, M Cagy, RE de Abreu, LA da Silva,
RC Garcia, and ML Garcia Rosa. Environmental factors, familial aggregation and
heritability of total cholesterol, low density lipoprotein-cholesterol and high density
lipoprotein-cholesterol in a brazilian population assisted by the family doctor program.
public health, 125(6):329–337, 2011.
[36] Jacob F Degner, Athma A Pai, Roger Pique-Regi, Jean-Baptiste Veyrieras, Daniel J
Gaffney, Joseph K Pickrell, Sherryl De Leon, Katelyn Michelini, Noah Lewellen, Gre-
gory E Crawford, et al. Dnase [thinsp] i sensitivity qtls are a major determinant of
human expression variation. Nature, 482(7385):390–394, 2012.
[37] Arthur P Dempster, Nan M Laird, and Donald B Rubin. Maximum likelihood from
incomplete data via the em algorithm. Journal of the royal statistical society. Series
B (methodological), pages 1–38, 1977.
[38] Jose´e Dupuis, Claudia Langenberg, Inga Prokopenko, Richa Saxena, Nicole Soranzo,
Anne U Jackson, Eleanor Wheeler, Nicole L Glazer, Nabila Bouatia-Naji, Anna L
Gloyn, et al. New genetic loci implicated in fasting glucose homeostasis and their
impact on type 2 diabetes risk. Nature genetics, 42(2):105–116, 2010.
[39] Bradley Efron. Bayesian inference and the parametric bootstrap. The annals of applied
statistics, 6(4):1971, 2012.
[40] SC Elbein and SJ Hasstedt. Quantitative trait linkage analysis of lipid-related traits
in familial type 2 diabetes evidence for linkage of triglyceride levels to chromosome
19q. Diabetes, 51(2):528–535, 2002.
[41] Richard S Elman, Nikita Karpenko, and Alexander Merkurjev. The algebraic and
geometric theory of quadratic forms, volume 56. American Mathematical Soc., 2008.
[42] Ruben N Eppinga, Yanick Hagemeijer, Stephen Burgess, David A Hinds, Kari Ste-
fansson, Daniel F Gudbjartsson, Dirk J van Veldhuisen, Patricia B Munroe, Niek
Verweij, and Pim van der Harst. Identification of genomic loci associated with resting
heart rate and shared genetic predictors with all-cause mortality. Nature Genetics,
48(12):1557–1563, 2016.
[43] Hilary Finucane, Yakir Reshef, Verneri Anttila, Kamil Slowikowski, Alexander Gusev,
Andrea Byrnes, Steven Gazal, Po-Ru Loh, Giulio Genovese, Arpiar Saunders, et al.
126
Heritability enrichment of specifically expressed genes identifies disease-relevant tissues
and cell types. bioRxiv, page 103069, 2017.
[44] Hilary K Finucane, Brendan Bulik-Sullivan, Alexander Gusev, Gosia Trynka, Yakir
Reshef, Po-Ru Loh, Verneri Anttila, Han Xu, Chongzhi Zang, Kyle Farh, et al. Parti-
tioning heritability by functional annotation using genome-wide association summary
statistics. Nature genetics, 47(11):1228–1235, 2015.
[45] Eric R Gamazon, Nancy J Cox, and Lea K Davis. Structural architecture of snp effects
on complex traits. The American Journal of Human Genetics, 95(5):477–489, 2014.
[46] Santhi K Ganesh, Neil A Zakai, Frank JA van Rooij, Nicole Soranzo, Albert V Smith,
Michael A Nalls, Ming-Huei Chen, Anna Kottgen, Nicole L Glazer, Abbas Dehghan,
et al. Multiple loci influence erythrocyte phenotypes in the charge consortium. Nature
genetics, 41(11):1191–1198, 2009.
[47] C Garner, T Tatu, JE Reittie, T Littlewood, J Darley, S Cervino, M Farrall, P Kelly,
TD Spector, and SL Thein. Genetic influences on f cells and other hematologic vari-
ables: a twin heritability study. Blood, 95(1):342–346, 2000.
[48] Godfrey S Getz and Catherine A Reardon. Apoprotein e as a lipid transport and
signaling protein in the blood, liver, and artery wall. Journal of lipid research,
50(Supplement):S156–S161, 2009.
[49] Claudia Giambartolomei, Damjan Vukcevic, Eric E Schadt, Lude Franke, Aroon D
Hingorani, Chris Wallace, and Vincent Plagnol. Bayesian test for colocalisation be-
tween pairs of genetic association studies using summary statistics. PLoS Genet,
10(5):e1004383, 2014.
[50] Richard A Gibbs, John W Belmont, Paul Hardenbol, Thomas D Willis, Fuli Yu, et al.
The international hapmap project. Nature, 426(6968):789–796, Dec 2003.
[51] Richard A Gibbs, John W Belmont, Paul Hardenbol, Thomas D Willis, Fuli Yu, Huan-
ming Yang, Lan-Yang Ch’ang, Wei Huang, Bin Liu, Yan Shen, et al. The international
hapmap project. Nature, 426(6968):789–796, 2003.
[52] Christian Gieger, Aparna Radhakrishnan, Ana Cvejic, Weihong Tang, Eleonora Porcu,
Giorgio Pistis, Jovana Serbanovic-Canic, Ulrich Elling, Alison H Goodall, Yann
Labrune, et al. New gene functions in megakaryopoiesis and platelet formation. Na-
ture, 480(7376):201–208, 2011.
[53] David Golan, Eric S Lander, and Saharon Rosset. Measuring missing heritability:
Inferring the contribution of common variants. Proceedings of the National Academy
of Sciences, 111(49):E5272–E5281, 2014.
[54] Alexander Gusev, Gaurav Bhatia, Noah Zaitlen, Bjarni J Vilhjalmsson, Dorothe´e
Diogo, Eli A Stahl, Peter K Gregersen, Jane Worthington, Lars Klareskog, Soumya
127
Raychaudhuri, et al. Quantifying missing heritability at known gwas loci. Plos Genet-
ics, 2013.
[55] Alexander Gusev, Arthur Ko, Huwenbo Shi, Gaurav Bhatia, Wonil Chung,
Brenda WJH Penninx, Rick Jansen, Eco JC De Geus, Dorret I Boomsma, Fred A
Wright, et al. Integrative approaches for large-scale transcriptome-wide association
studies. Nature genetics, 2016.
[56] Alexander Gusev, S Hong Lee, Gosia Trynka, Hilary Finucane, Bjarni J Vilhja´lmsson,
Han Xu, Chongzhi Zang, Stephan Ripke, Brendan Bulik-Sullivan, Eli Stahl, et al.
Partitioning heritability of regulatory and cell-type-specific variants across 11 common
diseases. The American Journal of Human Genetics, 95(5):535–552, 2014.
[57] Per Christian Hansen. The truncatedsvd as a method for regularization. BIT Numer-
ical Mathematics, 27(4):534–553, 1987.
[58] SMJ Harney, C Vilarin˜o-Gu¨ell, IE Adamopoulos, A-M Sims, RW Lawrence, LR Car-
don, JL Newton, C Meisel, JJ Pointon, C Darke, et al. Fine mapping of the mhc class
iii region demonstrates association of aif1 and rheumatoid arthritis. Rheumatology,
47(12):1761–1767, 2008.
[59] JK Haseman and RC Elston. The investigation of linkage between a quantitative trait
and a marker locus. Behavior genetics, 2(1):3–19, 1972.
[60] Joseph P Hegmann and Bernard Possidente. Estimating genetic correlations from
inbred strains. Behavior genetics, 11(2):103–114, 1981.
[61] Gibran Hemani, Jian Yang, Anna Vinkhuyzen, Joseph E Powell, Gonneke Willemsen,
Jouke-Jan Hottenga, Abdel Abdellaoui, Massimo Mangino, Ana M Valdes, Sarah E
Medland, et al. Inference of the genetic architecture underlying bmi and height with
the use of 20,240 sibling pairs. The American Journal of Human Genetics, 93(5):865–
875, 2013.
[62] Jesse D Hinckley, Diana Abbott, Trudy L Burns, Meadow Heiman, Amy D Shapiro, Kai
Wang, and Jorge Di Paola. Quantitative trait locus linkage analysis in a large amish
pedigree identifies novel candidate loci for erythrocyte traits. Molecular genetics &
genomic medicine, 1(3):131–141, 2013.
[63] Momoko Horikoshi, Robin N Beaumont, Felix R Day, Nicole M Warrington, Mar-
jolein N Kooijman, Juan Fernandez-Tajes, Bjarke Feenstra, Natalie R van Zuydam,
Kyle J Gaulton, Niels Grarup, et al. Genome-wide associations for birth weight and
correlations with adult disease. Nature, 538(7624):248–252, 2016.
[64] Farhad Hormozdiari, Emrah Kostem, Eun Yong Kang, Bogdan Pasaniuc, and Eleazar
Eskin. Identifying causal variants at loci with multiple signals of association. Genetics,
198(2):497–508, 2014.
128
[65] Farhad Hormozdiari, Anthony Zhu, Gleb Kichaev, Chelsea J-T Ju, Ayellet V Segre,
Jong Wha J Joo, Hyejung Won, Sriram Sankararaman, Bogdan Pasaniuc, Sagiv Shif-
man, et al. Widespread allelic heterogeneity in complex traits. The American Journal
of Human Genetics, 100(5):789–802, 2017.
[66] Bryan Howie, Christian Fuchsberger, Matthew Stephens, Jonathan Marchini, and
Gonc¸alo R Abecasis. Fast and accurate genotype imputation in genome-wide asso-
ciation studies through pre-phasing. Nature genetics, 2012.
[67] Bryan Howie, Christian Fuchsberger, Matthew Stephens, Jonathan Marchini, and Go-
nalo R Abecasis. Fast and accurate genotype imputation in genome-wide association
studies through pre-phasing. Nature Genetics, 44(8):955–959, Aug 2012.
[68] Bryan N Howie, Peter Donnelly, and Jonathan Marchini. A flexible and accurate geno-
type imputation method for the next generation of genome-wide association studies.
PLoS Genetics, 5(6):e1000529, Jun 2009.
[69] Bryan N Howie, Peter Donnelly, and Jonathan Marchini. A flexible and accurate geno-
type imputation method for the next generation of genome-wide association studies.
PLoS genetics, 5(6):e1000529, 2009.
[70] Leon Isserlis. On a formula for the product-moment coefficient of any order of a normal
frequency distribution in any number of variables. Biometrika, 12(1/2):134–139, 1918.
[71] Masahiro Kanai, Masato Akiyama, Atsushi Takahashi, Nana Matoba, Yukihide Mo-
mozawa, Masashi Ikeda, Nakao Iwata, Shiro Ikegawa, Makoto Hirata, Koichi Matsuda,
et al. Genetic analysis of quantitative traits in the japanese population links cell types
to complex human diseases. Nature genetics, 50(3):390, 2018.
[72] Gleb Kichaev and Bogdan Pasaniuc. Leveraging functional-annotation data in trans-
ethnic fine-mapping studies. The American Journal of Human Genetics, 97(2):260–
271, 2015.
[73] Gleb Kichaev, Megan Roytman, Ruth Johnson, Eleazar Eskin, Sara Lindstroem, Pe-
ter Kraft, and Bogdan Pasaniuc. Improved methods for multi-trait fine mapping of
pleiotropic risk loci. Bioinformatics, 33(2):248–255, 2017.
[74] Gleb Kichaev, Wen-Yun Yang, Sara Lindstrom, Farhad Hormozdiari, Eleazar Eskin,
Alkes L Price, Peter Kraft, and Bogdan Pasaniuc. Integrating functional data to
prioritize causal variants in statistical fine-mapping studies. Plos Genetics, 2014.
[75] Daniel L Koller, Hou-Feng Zheng, David Karasik, Laura Yerges-Armstrong, Ching-
Ti Liu, Fiona McGuigan, John P Kemp, Sylvie Giroux, Dongbing Lai, Howard J
Edenberg, et al. Meta-analysis of genome-wide studies identifies wnt16 and esr1 snps
associated with bone mineral density in premenopausal women. Journal of Bone and
Mineral Research, 28(3):547–558, 2013.
129
[76] Anna Ko¨ttgen, Eva Albrecht, Alexander Teumer, Veronique Vitart, Jan Krum-
siek, Claudia Hundertmark, Giorgio Pistis, Daniela Ruggiero, Conall M O’Seaghdha,
Toomas Haller, et al. Genome-wide association analyses identify 18 new loci associated
with serum urate concentrations. Nature genetics, 45(2):145–154, 2013.
[77] L. Kruglyak. Prospects for whole-genome linkage disequilibrium mapping of common
disease genes. Nature Genetics, 22(2):139–144, Jun 1999.
[78] K. Lange. Applied Probability. Springer Texts in Statistics. Springer New York, 2010.
[79] K. Lange. Optimization. Springer Texts in Statistics. Springer, 2013.
[80] Debbie A Lawlor, Roger M Harbord, Jonathan AC Sterne, Nic Timpson, and George
Davey Smith. Mendelian randomization: using genes as instruments for making causal
inferences in epidemiology. Statistics in medicine, 27(8):1133–1163, 2008.
[81] Daniel John Lawson, Garrett Hellenthal, Simon Myers, and Daniel Falush. Inference
of population structure using dense haplotype data. PLoS genetics, 8(1):e1002453,
2012.
[82] Sang Hong Lee, Naomi R Wray, Michael E Goddard, and Peter M Visscher. Estimating
missing heritability for disease from genome-wide association studies. The American
Journal of Human Genetics, 88(3):294–305, 2011.
[83] Sang Hong Lee, Jian Yang, Michael E Goddard, Peter M Visscher, and Naomi R
Wray. Estimation of pleiotropy between complex diseases using single-nucleotide
polymorphism-derived genomic relationships and restricted maximum likelihood.
Bioinformatics, 28(19):2540–2542, 2012.
[84] Na Li and Matthew Stephens. Modeling linkage disequilibrium and identifying recom-
bination hotspots using single-nucleotide polymorphism data. Genetics, 165(4):2213–
2233, 2003.
[85] Yun Li, Cristen J Willer, Jun Ding, Paul Scheet, and Gonc¸alo R Abecasis. Mach:
using sequence and genotype data to estimate haplotypes and unobserved genotypes.
Genetic epidemiology, 34(8):816–834, 2010.
[86] Yun Li, Cristen J. Willer, Jun Ding, Paul Scheet, and Gonalo R. Abecasis. Mach:
using sequence and genotype data to estimate haplotypes and unobserved genotypes.
Genet Epidemiol, 34(8):816–834, Dec 2010.
[87] Zhiqiang Li, Jianhua Chen, Hao Yu, Lin He, Yifeng Xu, Dai Zhang, Qizhong Yi,
Changgui Li, Xingwang Li, Jiawei Shen, et al. Genome-wide association analysis
identifies 30 new susceptibility loci for schizophrenia. Nature genetics, 49(11):1576,
2017.
[88] Jing-Ping Lin, Christopher J O’Donnell, Li Jin, Caroline Fox, Qiong Yang, and L Adri-
130
enne Cupples. Evidence for linkage of red blood cell size and count: Genome-wide scans
in the framingham heart study. American journal of hematology, 82(7):605–610, 2007.
[89] Jimmy Z Liu, Suzanne van Sommeren, Hailiang Huang, Siew C Ng, Rudi Alberts,
Atsushi Takahashi, Stephan Ripke, James C Lee, Luke Jostins, Tejas Shah, et al.
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and
highlight shared genetic risk across populations. Nature genetics, 47(9):979–986, 2015.
[90] Adam E Locke, Bratati Kahali, Sonja I Berndt, Anne E Justice, Tune H Pers, Fe-
lix R Day, Corey Powell, Sailaja Vedantam, Martin L Buchkovich, Jian Yang, et al.
Genetic studies of body mass index yield new insights for obesity biology. Nature,
518(7538):197–206, 2015.
[91] Po-Ru Loh, Gaurav Bhatia, Alexander Gusev, Hilary K Finucane, Brendan K Bulik-
Sullivan, Samuela J Pollack, Teresa R de Candia, Sang Hong Lee, Naomi R Wray,
Kenneth S Kendler, et al. Contrasting genetic architectures of schizophrenia and other
complex diseases using fast variance-components analysis. Nature genetics, 2015.
[92] Kirk E. Lohmueller, Carlos D. Bustamante, and Andrew G. Clark. Methods for human
demographic inference using haplotype patterns from genomewide single-nucleotide
polymorphism data. Genetics, 182(1):217–231, May 2009.
[93] Yingchang Lu, Felix R Day, Stefan Gustafsson, Martin L Buchkovich, Jianbo Na,
Veronique Bataille, Diana L Cousminer, Zari Dastani, Alexander W Drong, To˜nu
Esko, et al. New loci for body fat percentage reveal link between adiposity and car-
diometabolic disease risk. Nature communications, 7, 2016.
[94] Pedro Madrigal and Pawe l Krajewski. Current bioinformatic approaches to identify
dnase i hypersensitive sites and genomic footprints from dnase-seq data. Frontiers in
genetics, 3, 2012.
[95] Brendan Maher. Personal genomes: The case of the missing heritability. Nature News,
456(7218):18–21, 2008.
[96] Nicholas Mancuso, Nadin Rohland, Kristin A Rand, Arti Tandon, Alexander Allen,
Dominique Quinque, Swapan Mallick, Heng Li, Alex Stram, Xin Sheng, et al. The
contribution of rare variation to prostate cancer heritability. Nature genetics, 2015.
[97] Nicholas Mancuso, Nadin Rohland, Kristin A Rand, Arti Tandon, Alexander Allen,
Dominique Quinque, Swapan Mallick, Heng Li, Alex Stram, Xin Sheng, et al. The
contribution of rare variation to prostate cancer heritability. Nature genetics, 48(1):30,
2016.
[98] Nicholas Mancuso, Huwenbo Shi, Page´ Goddard, Gleb Kichaev, Alexander Gusev, and
Bogdan Pasaniuc. Integrating gene expression with summary association statistics to
identify genes associated with 30 complex traits. The American Journal of Human
Genetics, 100(3):473–487, 2017.
131
[99] Jonathan Marchini, Bryan Howie, Simon Myers, Gil McVean, and Peter Donnelly. A
new multipoint method for genome-wide association studies by imputation of geno-
types. Nature Genetics, 39(7):906–913, Jul 2007.
[100] Urko M Marigorta and Arcadi Navarro. High trans-ethnic replicability of gwas results
implies common causal variants. PLoS genetics, 9(6):e1003566, 2013.
[101] Carla Ma´rquez-Luna, Po-Ru Loh, and Alkes L Price. Multiethnic polygenic risk scores
improve risk prediction in diverse populations. Genetic epidemiology, 41(8):811–823,
2017.
[102] Alicia R Martin, Christopher R Gignoux, Raymond K Walters, Genevieve L Wojcik,
Benjamin M Neale, Simon Gravel, Mark J Daly, Carlos D Bustamante, and Eimear E
Kenny. Human demographic history impacts genetic risk prediction across diverse
populations. The American Journal of Human Genetics, 100(4):635–649, 2017.
[103] Shane McCarthy, Sayantan Das, Warren Kretzschmar, Richard Durbin, Goncalo
Abecasis, and Jonathan Marchini. A reference panel of 64,976 haplotypes for genotype
imputation. bioRxiv, page 035170, 2015.
[104] Joel Mefford and John S Witte. The covariate’s dilemma. PLoS Genet, 8(11):e1003096,
2012.
[105] Diogo Meyer and Glenys Thomson. How selection shapes variation of the human major
histocompatibility complex: a review. Annals of human genetics, 65(1):1–26, 2001.
[106] GW Mills, PJ Avery, MI McCarthy, AT Hattersley, JC Levy, GA Hitman, M Sampson,
and M Walker. Heritability estimates for beta cell function and features of the insulin
resistance syndrome in uk families with an increased susceptibility to type 2 diabetes.
Diabetologia, 47(4):732–738, 2004.
[107] Andrew P Morris. A flexible bayesian framework for modeling haplotype association
with disease, allowing for dominance effects of the underlying causative variants. The
American Journal of Human Genetics, 79(4):679–694, 2006.
[108] Andrew P Morris. Transethnic meta-analysis of genomewide association studies. Ge-
netic epidemiology, 35(8):809–822, 2011.
[109] Andrew P Morris, Benjamin F Voight, Tanya M Teslovich, Teresa Ferreira, Ayellet V
Segre, Valgerdur Steinthorsdottir, Rona J Strawbridge, Hassan Khan, Harald Grallert,
Anubha Mahajan, et al. Large-scale association analysis provides insights into the ge-
netic architecture and pathophysiology of type 2 diabetes. Nature genetics, 44(9):981,
2012.
[110] Kiran Musunuru, Alanna Strong, Maria Frank-Kamenetsky, Noemi E Lee, Tim Ah-
feldt, Katherine V Sachs, Xiaoyu Li, Hui Li, Nicolas Kuperwasser, Vera M Ruda, et al.
132
From noncoding variant to phenotype via sort1 at the 1p13 cholesterol locus. Nature,
466(7307):714–719, 2010.
[111] Akiko Nagai, Makoto Hirata, Yoichiro Kamatani, Kaori Muto, Koichi Matsuda, Yutaka
Kiyohara, Toshiharu Ninomiya, Akiko Tamakoshi, Zentaro Yamagata, Taisei Mushi-
roda, et al. Overview of the biobank japan project: study design and profile. Journal
of epidemiology, 27(3):S2–S8, 2017.
[112] Michael Neale and Lon Cardon. Methodology for genetic studies of twins and families,
volume 67. Springer Science & Business Media, 1992.
[113] Schizophrenia Working Group of the Psychiatric Genomics Consortium et al. Biologi-
cal insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510):421–427,
2014.
[114] Yukinori Okada, Di Wu, Gosia Trynka, Towfique Raj, Chikashi Terao, Katsunori Ikari,
Yuta Kochi, Koichiro Ohmura, Akari Suzuki, Shinji Yoshida, et al. Genetics of rheuma-
toid arthritis contributes to biology and drug discovery. Nature, 506(7488):376–381,
2014.
[115] Aysu Okbay, Bart ML Baselmans, Jan-Emmanuel De Neve, Patrick Turley, Michel G
Nivard, Mark Alan Fontana, S Fleur W Meddens, Richard Karlsson Linne´r, Cor-
nelius A Rietveld, Jaime Derringer, et al. Genetic variants associated with subjec-
tive well-being, depressive symptoms, and neuroticism identified through genome-wide
analyses. Nature genetics, 2016.
[116] Aysu Okbay, Jonathan P Beauchamp, Mark Alan Fontana, James J Lee, Tune H
Pers, Cornelius A Rietveld, Patrick Turley, Guo-Bo Chen, Valur Emilsson, S Fleur W
Meddens, et al. Genome-wide association study identifies 74 loci associated with edu-
cational attainment. Nature, 533(7604):539–542, 2016.
[117] Luigi Palla and Frank Dudbridge. A fast method that uses polygenic scores to estimate
the variance explained by genome-wide marker panels and the proportion of variants
affecting a trait. The American Journal of Human Genetics, 97(2):250–259, 2015.
[118] C Pallaud, R Gueguen, C Sass, M Grow, S Cheng, G Siest, and S Visvikis. Genetic
influences on lipid metabolism trait variability within the stanislas cohort. Journal of
lipid research, 42(11):1879–1890, 2001.
[119] Bogdan Pasaniuc and Alkes L. Price. Dissecting the genetics of complex traits using
summary association statistics. Nat Rev Genet, advance online publication, Nov 2016.
Review.
[120] Bogdan Pasaniuc and Alkes L Price. Dissecting the genetics of complex traits using
summary association statistics. Nature Reviews Genetics, 18(2):117, 2017.
[121] Bogdan Pasaniuc, Sriram Sankararaman, Gad Kimmel, and Eran Halperin. Inference
133
of locus-specific ancestry in closely related populations. Bioinformatics, 25(12):i213–
i221, Jun 2009.
[122] Bogdan Pasaniuc, Noah Zaitlen, Huwenbo Shi, Gaurav Bhatia, Alexander Gusev,
Joseph Pickrell, Joel Hirschhorn, David P Strachan, Nick Patterson, and Alkes L Price.
Fast and accurate imputation of summary statistics enhances evidence of functional
enrichment. Bioinformatics, page btu416, 2014.
[123] Cristian Pattaro, Alexander Teumer, Mathias Gorski, Audrey Y Chu, Man Li, Vladan
Mijatovic, Maija Garnaas, Adrienne Tin, Rossella Sorice, Yong Li, et al. Genetic
associations at 53 loci highlight cell types and biological pathways relevant for kidney
function. Nature communications, 7, 2016.
[124] John RB Perry, Felix Day, Cathy E Elks, Patrick Sulem, Deborah J Thompson, Teresa
Ferreira, Chunyan He, Daniel I Chasman, To˜nu Esko, Gudmar Thorleifsson, et al.
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menar-
che. Nature, 514(7520):92–97, 2014.
[125] Joseph K Pickrell, Tomaz Berisa, Jimmy Z Liu, Laure Se´gurel, Joyce Y Tung, and
David A Hinds. Detection and interpretation of shared genetic influences on 42 human
traits. Nature genetics, 2016.
[126] John E. Pool, Ines Hellmann, Jeffrey D. Jensen, and Rasmus Nielsen. Population
genetic inference from genomic sequence variation. Genome Res, 20(3):291–300, Mar
2010.
[127] Alice B Popejoy and Stephanie M Fullerton. Genomics is failing on diversity. Nature,
538(7624):161, 2016.
[128] P Poulsen, K Ohm Kyvik, A Vaag, and H Beck-Nielsen. Heritability of type ii (non-
insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-
based twin study. Diabetologia, 42(2):139–145, 1999.
[129] Alkes L Price, Chris CA Spencer, and Peter Donnelly. Progress and promise in under-
standing the genetic basis of common diseases. In Proc. R. Soc. B, volume 282, page
20151684. The Royal Society, 2015.
[130] Alkes L Price, Arti Tandon, Nick Patterson, Kathleen C Barnes, Nicholas Rafaels, Ingo
Ruczinski, Terri H Beaty, Rasika Mathias, David Reich, and Simon Myers. Sensitive
detection of chromosomal segments of distinct ancestry in admixed populations. PLoS
Genetics, 5(6):e1000519, Jun 2009.
[131] Alkes L Price, Michael E Weale, Nick Patterson, Simon R Myers, Anna C Need,
Kevin V Shianna, Dongliang Ge, Jerome I Rotter, Esther Torres, Kent D Taylor, et al.
Long-range ld can confound genome scans in admixed populations. American journal
of human genetics, 83(1):132, 2008.
134
[132] Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas, Manuel AR Fer-
reira, David Bender, Julian Maller, Pamela Sklar, Paul IW De Bakker, Mark J Daly,
et al. Plink: a tool set for whole-genome association and population-based linkage
analyses. The American Journal of Human Genetics, 81(3):559–575, 2007.
[133] LJ Rasmussen-Torvik, JS Pankow, DR Jacobs, LM Steffen, AM Moran, J Steinberger,
and AR Sinaiko. Heritability and genetic correlations of insulin sensitivity measured
by the euglycaemic clamp. Diabetic Medicine, 24(11):1286–1289, 2007.
[134] Cornelius A Rietveld, Sarah E Medland, Jaime Derringer, Jian Yang, Tonu Esko, Nico-
las W Martin, Harm-Jan Westra, Konstantin Shakhbazov, Abdel Abdellaoui, Arpana
Agrawal, et al. Gwas of 126,559 individuals identifies genetic variants associated with
educational attainment. science, 340(6139):1467–1471, 2013.
[135] Noah A Rosenberg, Lucy Huang, Ethan M Jewett, Zachary A Szpiech, Ivana Jankovic,
and Michael Boehnke. Genome-wide association studies in diverse populations. Nature
Reviews Genetics, 11(5):356, 2010.
[136] Sharon A Savage, Lisa Mirabello, Zhaoming Wang, Julie M Gastier-Foster, Richard
Gorlick, Chand Khanna, Adrienne M Flanagan, Roberto Tirabosco, Irene L An-
drulis, Jay S Wunder, Nalan Gokgoz, Ana Patio-Garcia, Luis Sierrasesmaga, Fernando
Lecanda, Nilgn Kurucu, Inci Ergurhan Ilhan, Neriman Sari, Massimo Serra, Claudia
Hattinger, Piero Picci, Logan G Spector, Donald A Barkauskas, Neyssa Marina, Silvia
Regina Caminada de Toledo, Antonio S Petrilli, Maria Fernanda Amary, Dina Ha-
lai, David M Thomas, Chester Douglass, Paul S Meltzer, Kevin Jacobs, Charles C
Chung, Sonja I Berndt, Mark P Purdue, Neil E Caporaso, Margaret Tucker, Nathaniel
Rothman, Maria Teresa Landi, Debra T Silverman, Peter Kraft, David J Hunter, Nuria
Malats, Manolis Kogevinas, Sholom Wacholder, Rebecca Troisi, Lee Helman, Joseph F
Fraumeni, Meredith Yeager, Robert N Hoover, and Stephen J Chanock. Genome-wide
association study identifies two susceptibility loci for osteosarcoma. Nature Genetics,
45(7):799–803, Jul 2013.
[137] Paul Scheet and Matthew Stephens. A fast and flexible statistical model for large-scale
population genotype data: applications to inferring missing genotypes and haplotypic
phase. The American Journal of Human Genetics, 78(4):629–644, 2006.
[138] Shayle R Searle. Linear models, page 65. John Wiley & Sons, Inc., 1971.
[139] Nuala A Sheehan, Vanessa Didelez, Paul R Burton, and Martin D Tobin. Mendelian
randomisation and causal inference in observational epidemiology. PLoS Med,
5(8):e177, 2008.
[140] Huwenbo Shi, Gleb Kichaev, and Bogdan Pasaniuc. Contrasting the genetic archi-
tecture of 30 complex traits from summary association data. bioRxiv, page 035907,
2016.
[141] Huwenbo Shi, Bogdan Pasaniuc, and Kenneth L Lange. A multivariate bernoulli
135
model to predict dnasei hypersensitivity status from haplotype data. Bioinformatics,
31(21):3514–3521, 2015.
[142] Dmitry Shungin, Thomas W Winkler, Damien C Croteau-Chonka, Teresa Ferreira,
Adam E Locke, Reedik Ma¨gi, Rona J Strawbridge, Tune H Pers, Krista Fischer, Anne E
Justice, et al. New genetic loci link adipose and insulin biology to body fat distribution.
Nature, 518(7538):187–196, 2015.
[143] Mary A Silles. The causal effect of education on health: Evidence from the united
kingdom. Economics of Education review, 28(1):122–128, 2009.
[144] Xueling Sim, Rick Twee-Hee Ong, Chen Suo, Wan-Ting Tay, Jianjun Liu, Daniel
Peng-Keat Ng, Michael Boehnke, Kee-Seng Chia, Tien-Yin Wong, Mark Seielstad,
et al. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from
southeast asia. PLoS genetics, 7(4):e1001363, 2011.
[145] Annemarie Simonis-Bik, Elisabeth MW Eekhoff, Michaela Diamant, Dorret I
Boomsma, Rob J Heine, Jacqueline M Dekker, Gonneke Willemsen, Marieke
Van Leeuwen, and Eco JC De Geus. The heritability of hba1c and fasting blood glucose
in different measurement settings. Twin Research and Human Genetics, 11(06):597–
602, 2008.
[146] George Davey Smith and Gibran Hemani. Mendelian randomization: genetic anchors
for causal inference in epidemiological studies. Human molecular genetics, 23(R1):R89–
R98, 2014.
[147] Nicole Soranzo, Serena Sanna, Eleanor Wheeler, Christian Gieger, Do¨rte Radke, Jose´e
Dupuis, Nabila Bouatia-Naji, Claudia Langenberg, Inga Prokopenko, Elliot Stolerman,
et al. Common variants at 10 genomic loci influence hemoglobin a1c levels via glycemic
and nonglycemic pathways. Diabetes, 59(12):3229–3239, 2010.
[148] Nicole Soranzo, Tim D Spector, Massimo Mangino, Brigitte Ku¨hnel, Augusto Ren-
don, Alexander Teumer, Christina Willenborg, Benjamin Wright, Li Chen, Mingyao
Li, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hema-
tological parameters in the haemgen consortium. Nature genetics, 41(11):1182–1190,
2009.
[149] Doug Speed, Na Cai, Michael R Johnson, Sergey Nejentsev, David J Balding, UCLEB
Consortium, et al. Reevaluation of snp heritability in complex human traits. Nature
genetics, 49(7):986, 2017.
[150] Zhan Su, Jonathan Marchini, and Peter Donnelly. Hapgen2: simulation of multiple
disease snps. Bioinformatics, 27(16):2304–2305, 2011.
[151] Cathie Sudlow, John Gallacher, Naomi Allen, Valerie Beral, Paul Burton, John
Danesh, Paul Downey, Paul Elliott, Jane Green, Martin Landray, et al. Uk biobank:
136
an open access resource for identifying the causes of a wide range of complex diseases
of middle and old age. PLoS medicine, 12(3):e1001779, 2015.
[152] Patrick F Sullivan, Kenneth S Kendler, and Michael C Neale. Schizophrenia as a
complex trait: evidence from a meta-analysis of twin studies. Archives of general
psychiatry, 60(12):1187–1192, 2003.
[153] Alan R Templeton. Haplotype trees and modern human origins. American journal of
physical anthropology, 128(S41):33–59, 2005.
[154] Tanya M Teslovich, Kiran Musunuru, Albert V Smith, Andrew C Edmondson, Ioan-
nis M Stylianou, Masahiro Koseki, James P Pirruccello, Samuli Ripatti, Daniel I Chas-
man, Cristen J Willer, et al. Biological, clinical and population relevance of 95 loci for
blood lipids. Nature, 466(7307):707, 2010.
[155] Alexander Teumer, Adrienne Tin, Rossella Sorice, Mathias Gorski, Nan Cher Yeo,
Audrey Y Chu, Man Li, Yong Li, Vladan Mijatovic, Yi-An Ko, et al. Genome-wide
association studies identify genetic loci associated with albuminuria in diabetes. Dia-
betes, page db151313, 2015.
[156] B Towne. Heritability of age at menarche in girls from the fels longitudinal study.
American journal of physical anthropology, 128(1):210, 2005.
[157] Gosia Trynka, Cynthia Sandor, Buhm Han, Han Xu, Barbara E Stranger, X Shirley
Liu, and Soumya Raychaudhuri. Chromatin marks identify critical cell types for fine
mapping complex trait variants. Nature genetics, 45(2):124–130, 2013.
[158] Stephen Turner, Loren L Armstrong, Yuki Bradford, Christopher S Carlson, Dana C
Crawford, Andrew T Crenshaw, Mariza Andrade, Kimberly F Doheny, Jonathan L
Haines, Geoffrey Hayes, et al. Quality control procedures for genome-wide association
studies. Current protocols in human genetics, pages 1–19, 2011.
[159] C Tysk, E Lindberg, G Ja¨rnerot, and B Floderus-Myrhed. Ulcerative colitis and
crohn’s disease in an unselected population of monozygotic and dizygotic twins. a
study of heritability and the influence of smoking. Gut, 29(7):990–996, 1988.
[160] Pim van der Harst, Weihua Zhang, Irene Mateo Leach, Augusto Rendon, Niek Verweij,
Joban Sehmi, Dirk S Paul, Ulrich Elling, Hooman Allayee, Xinzhong Li, et al. Seventy-
five genetic loci influencing the human red blood cell. Nature, 492(7429):369–375, 2012.
[161] Peter M Visscher, Matthew A Brown, Mark I McCarthy, and Jian Yang. Five years
of gwas discovery. The American Journal of Human Genetics, 90(1):7–24, 2012.
[162] Benjamin F Voight, Gina M Peloso, Marju Orho-Melander, Ruth Frikke-Schmidt, Maja
Barbalic, Majken K Jensen, George Hindy, Hilma Ho´lm, Eric L Ding, Toby Johnson,
et al. Plasma hdl cholesterol and risk of myocardial infarction: a mendelian randomi-
sation study. The Lancet, 380(9841):572–580, 2012.
137
[163] Jeffrey D Wall and Jonathan K Pritchard. Haplotype blocks and linkage disequilibrium
in the human genome. Nature Reviews Genetics, 4(8):587–597, 2003.
[164] Danielle Welter, Jacqueline MacArthur, Joannella Morales, Tony Burdett, Peggy Hall,
Heather Junkins, Alan Klemm, Paul Flicek, Teri Manolio, Lucia Hindorff, et al. The
nhgri gwas catalog, a curated resource of snp-trait associations. Nucleic acids research,
42(D1):D1001–D1006, 2014.
[165] Andrew R Wood, Tonu Esko, Jian Yang, Sailaja Vedantam, Tune H Pers, Stefan
Gustafsson, Audrey Y Chu, Karol Estrada, Jian’an Luan, Zolta´n Kutalik, et al. Defin-
ing the role of common variation in the genomic and biological architecture of adult
human height. Nature genetics, 46(11):1173–1186, 2014.
[166] Naomi R Wray, Patrick F Sullivan, et al. Genome-wide association analyses identify
44 risk variants and refine the genetic architecture of major depression. bioRxiv, page
167577, 2017.
[167] Ying Wu, Lindsay L Waite, Anne U Jackson, Wayne HH Sheu, Steven Buyske, Devin
Absher, Donna K Arnett, Eric Boerwinkle, Lori L Bonnycastle, Cara L Carty, et al.
Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic
heterogeneity that increases the trait variance explained. PLoS genetics, 9(3):e1003379,
2013.
[168] Jian Yang, Beben Benyamin, Brian P McEvoy, Scott Gordon, Anjali K Henders, Dale R
Nyholt, Pamela A Madden, Andrew C Heath, Nicholas G Martin, Grant W Mont-
gomery, et al. Common snps explain a large proportion of the heritability for human
height. Nature genetics, 42(7):565–569, 2010.
[169] Jian Yang, Teresa Ferreira, Andrew P Morris, Sarah E Medland, Pamela AF Madden,
Andrew C Heath, Nicholas G Martin, Grant W Montgomery, Michael N Weedon,
Ruth J Loos, et al. Conditional and joint multiple-snp analysis of gwas summary
statistics identifies additional variants influencing complex traits. Nature genetics,
44(4):369–375, 2012.
[170] Jian Yang, S Hong Lee, Michael E Goddard, and Peter M Visscher. Gcta: a tool
for genome-wide complex trait analysis. The American Journal of Human Genetics,
88(1):76–82, 2011.
[171] Jian Yang, Michael N Weedon, Shaun Purcell, Guillaume Lettre, Karol Estrada,
Cristen J Willer, Albert V Smith, Erik Ingelsson, Jeffrey R O’Connell, Massimo
Mangino, et al. Genomic inflation factors under polygenic inheritance. European
Journal of Human Genetics, 19(7):807–812, 2011.
[172] Wen-Yun Yang, Farhad Hormozdiari, Eleazar Eskin, and Bogdan Pasaniuc. A spatial-
aware haplotype copying model with applications to genotype imputation. In Research
in Computational Molecular Biology, pages 371–384. Springer, 2014.
138
[173] Noah Zaitlen, Bogdan Pas¸aniuc, Tom Gur, Elad Ziv, and Eran Halperin. Leveraging
genetic variability across populations for the identification of causal variants. The
American Journal of Human Genetics, 86(1):23–33, 2010.
[174] Noah Zaitlen, Bogdan Pasaniuc, Sriram Sankararaman, Gaurav Bhatia, Jianqi Zhang,
Alexander Gusev, Taylor Young, Arti Tandon, Samuela Pollack, Bjarni J Vilhja´lmsson,
et al. Leveraging population admixture to characterize the heritability of complex
traits. Nature genetics, 46(12):1356–1362, 2014.
[175] Jian Zeng, Ronald Vlaming, Yang Wu, Matthew R Robinson, Luke R Lloyd-Jones, Loic
Yengo, Chloe X Yap, Angli Xue, Julia Sidorenko, Allan F McRae, et al. Signatures of
negative selection in the genetic architecture of human complex traits. Nature genetics,
page 1, 2018.
[176] Hou-Feng Zheng, Vincenzo Forgetta, Yi-Hsiang Hsu, Karol Estrada, Alberto Rosello-
Diez, Paul J Leo, Chitra L Dahia, Kyung Hyun Park-Min, Jonathan H Tobias, Charles
Kooperberg, et al. Whole-genome sequencing identifies en1 as a determinant of bone
density and fracture. Nature, 526(7571):112–117, 2015.
[177] Hou-Feng Zheng, Jon H Tobias, Emma Duncan, David M Evans, Joel Eriksson, Lavinia
Paternoster, Laura M Yerges-Armstrong, Terho Lehtima¨ki, Ulrica Bergstro¨m, Mika
Ka¨ho¨nen, et al. Wnt16 influences bone mineral density, cortical bone thickness, bone
strength, and osteoporotic fracture risk. Plos Genetics, 2012.
[178] Xiang Zhou, Peter Carbonetto, and Matthew Stephens. Polygenic modeling with
bayesian sparse linear mixed models. PLoS Genet, 9(2):e1003264, 2013.
139
